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Abstract
Changes in glomerular permselectivity are the physiological basis for proteinuria, which typically
accompanies chronic kidney disease. Traditionally, changes in the size-restrictive properties of the
glomerular barrier have been quantified by measuring the fractional clearance () of exogenous
infused dextrans and interpreting the results using the hindered transport theory for uncharged,
solid spheres in cylindrical pores. The observed values of O for dextran in normal rats and healthy
humans are unexpectedly large, however, given the normal absence of proteinuria. Recent in vitro
diffusion studies show that dextran's hindered transport behavior is better represented by a random
coil with attractive pore/solute interactions, while Ficoll follows the predictions for a neutral solid
sphere. Thus, Ficoll sieving data should provide a better indication of the size-selective properties
of the glomerular capillary wall. In one of the studies for this thesis, healthy Munich-Wistar rats
were infused with either 3 H-dextran or 3 H-Ficoll. Plasma and urine samples were fractionated
on gel chromatography columns which had been calibrated with narrowly-sized dextran and Ficoll
standards. While values of O for Ficoll were similar to those measured for nearly-neutral proteins,
dextran values were significantly higher at all molecular sizes. On this basis, the glomerular capillary
wall is shown to be considerably more size-restrictive than had been previously determined. The
random coil model was applied to the dextran data, and the attractive energy required to explain the
dextran/Ficoll discrepancies in vivo was nearly the same as that required in vitro. Thus it appears
that dextran's enhanced transport is nearly independent of the medium through which it travels.
The implications of the more size-restrictive barrier were examined in a second experimental
protocol, in which 3 H-Ficoll was infused into four groups of fawn-hooded (FH) rats: a two-kidney
(2K) control group, a uninephrectomized (UNX) group, a UNX group treated with the angiotensin
converting enzyme inhibitor enalapril (ENA), and a UNX group treated with the nitrous oxide in-
hibitor NAME. The UNX and NAME groups had significantly higher glomerular filtration pressures
(aP) and more proteinuria than the 2K and ENA groups, but the membrane pore size parameters
of the four groups were essentially the same. The extent of albuminuria correlated strongly with
AP, while the total rate of excretion of non-albumin proteins did not. Because albumin is negatively
charged, these findings imply that albuminuria in FH rats results from a specific defect in glomer-
ular charge-, rather than size-, selectivity, induced by chronic glomerular hypertension. Finally, to
examine the potential for using fractional clearances to estimate filtration pressures in the clinical
setting, the mathematical model was modified to make AP an adjustable parameter, and fitted
values were compared with those actually measured in the FH rats. The fitted and measured AP
did not show significant correlation, suggesting that 0 may not be sufficiently sensitive to AP to
allow such estimations.
Thesis Supervisor: William M. Deen
Title: Professor of Chemical Engineering
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Chapter 1
Introduction
1.1 Clinical Relevance of Glomerular Function
The spectrum of glomerular diseases includes both primary entities such as the glomerulonephrites,
whose principal involvement is with the kidney, and systemic diseases such as diabetes and essential
hypertension, where the renal involvement is a secondary outgrowth. Leaf and Cotran1 63 classify
the mechanisms for the pathogenesis of glomerular injury into three types: those that are immune-
mediated, those that result from altered glomerular hemodynamics, and those that are related to
loss of glomerular charge-selectivity (which can more generally be extended to a loss of overall
permselectivity). This classification scheme is not mutually exclusive, as changes in hemodynamic
patterns and permselectivity have been observed in both immune- and non-immune mediated disease.
Perhaps a better method of categorization is to divide into those disorders in which there is a primary
chemically- or immune-mediated derangement in the glomerular wall and those in which the injury
is secondary to hemodynamic changes. Again, however, the distinction is not clear-cut since, as
described in the following section, primary disease affecting some glomeruli can lead to altered
hemodynamics and secondary disease in other healthy glomeruli.
The two most important clinical manifestations of glomerular disease are a decreased urinary
output, a consequence of a reduction in the glomerular filtration rate (GFR), and proteinuria, the
loss of serum proteins-predominantly albumin-in the urine, which results from a loss of the ability
of the glomerulus to retain large and anionic molecules in the intracapillary space.
Several models of glomerular disease in the rat and other animals have been used to explore
the etiologies and pathophysiologies of renal disorders. These models have the advantage over
clinical studies in that hemodynamic parameters such as the transmural hydraulic pressure and the
ultrafiltration coefficient can be directly measured. In addition, such experiments pioneered the use
of exogenous polymers to study the permeability properties of the glomerular capillary wall. An
important result of these studies is the hypothesis for the hemodynamically-mediated progression of
glomerular disease.
1.2 Hemodynamically-Mediated Damage of the Glomerulus
The role of altered glomerular hemodynamics in the pathogenesis of renal injury is of interest because
of the adaptive response of the kidney to reductions in renal mass: an increase in glomerular pressure
results in a higher filtration rate plus structural and functional hypertrophy. 12 8 Surgical ablation of
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renal tissue is a common animal model for this process. Total glomerular filtration rate is maintained
through hyperfiltration, but at a cost of a progressive sclerotic process which eventually reduces
function in the surviving nephrons. Data also suggests losses in the ability of the glomerular capillary
wall to discriminate on the basis of both size and charge. 19 8
An example of a disease in which this mechanism appears to play an important role is diabetes
mellitus.4 9 ,10 1,180,1 87 , 226, 242, 255 A hallmark of the renal involvement in clinical diabetes is sustained
hyperfiltration in the early years followed by a reduction in GFR and increased proteinuria. Histo-
logically, characteristic nodular sclerotic lesions develop in the glomerulus. The filtration barrier to
large molecules is reduced, and evidence suggests that the charge selectivity is also impaired. 4 9 ,10 1, 2 42
Animal models of streptozotocin- and alloxan-induced diabetes show similar pathological changes
and alterations in hemodynamics and size-permselective properties. 2 9 ,1 77,178 ,205 ,26 6 The charge-
selectivity of diabetic glomeruli has not been studied extensively, but one study of alloxan-induced
diabetes indicates a unique and unexplained enhancement of this property.' 7 8
A different example of the connection between renal performance and hemodynamics is in patients
who are postoperative from cardiac surgery, where impaired cardiac output is sometimes associated
with azotemia or renal failure. One report indicates that glomerular hypofiltration is associated
with a decrease in the intrinsic ultrafiltration ability of the membrane.l8 6 There was no apparent
change in the permselective properties in this study nor in a study in the rat of decreased perfusion
pressure,25 3 but the data is too limited to be conclusive.
It is therefore of considerable interest to find a means to ameliorate the damage caused by
hyperfiltration. Dietary protein restriction has been shown as one way by which glomerular pressure
and filtration rate can be reduced, accompanied by diminished glomerulosclerosis.3 8 L28, 175 The
therapeutic use of angiotensin I converting enzyme (ACE) inhibitors in arresting the progression
of renal damage has been investigated in models of renal ablation 6,7 ,175 and diabetes. 2 66 Three
generalizations emerge as a result of this work:
1. Anatomical damage to the glomerular capillary wall and progressive proteinuria can be arrested
by normalization of the transmural hydraulic pressure difference, even if the filtration rate per
se remains high.6' l 2 8
2. Renal damage is prevented by purely hemodynamic interventions even if an underlying systemic
abnormality, such as diabetes, persists.l 75 '2 66
3. Specific normalization of glomerular pressure by angiotensin I converting enzyme inhibitors
has a therapeutic advantage over treatment for systemic hypertension. 7
Thus there is a growing body of evidence which suggests that primary alterations in renal hemo-
dynamics affect the permselective properties of the glomerular capillary wall. Furthermore, the
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development of a method for estimating glomerular filtration pressures in humans is strongly moti-
vated for monitoring the efficacy of therapeutic interventions.
1.3 Thesis Summary
The goals of this thesis were to extend the applications of sieving curve analysis, in particular to
the study of the interactions between renal hemodynamics, proteinuria, and the progression of renal
disease. Chapter 2 summarizes glomerular anatomy and physiology and the relevant mathematical
models. The remaining chapters address specific issues related to the thesis goals:
1. Methodological issues of gel chromatography calibration and dispersion and their effects on
the accuracy of sieving data were examined (Chapter 3).
2. Dextran and Ficoll tracer studies were performed in Munich-Wistar rats to determine the
effect of molecular configuration on glomerular sieving (Chapter 4). The dextran data was
then analyzed using recent theoretical developments in the transport of linear chains through
pores (Chapter 5).
3. To examine more systematically the interaction between hemodynamics and size-selectivity,
Ficoll tracer studies were performed in groups of fawn-hooded rats in varying states of chronic
renal disease (Chapter 6).
4. Finally, a computational approach for estimating glomerular transmural hydraulic pressure
from sieving data was developed and applied to the data from the fawn-hooded rats (Chap-
ter 7).
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Chapter 2
Background
2.1 Overview of Kidney Anatomy and Function
The kidneys are paired retroperitoneal organs lying on opposite sides of the vertebral column, be-
tween the twelfth thoracic and third lumbar vertebrae. The primary function of the kidney is to
maintain the so-called internal milieu of the body by regulating the volume and composition of the
extracellular fluid. The initial mechanism is the filtration of blood through a specialized capillary
wall into the renal tubules. Blood constituents that are too large (such as cells) or too highly an-
ionic (such as proteins) to pass through the capillary wall are retained in the blood stream. The
rest of the kidney serves to reabsorb the vast majority of the water and important solutes from the
tubules, to secrete other solutes at various stages, and ultimately to form a urine concentrated in
waste materials.
Each kidney obtains its blood supply from a renal artery which branches into smaller segmental,
interlobar, and interlobular arteries, until the level of the afferent arterioles is reached. The afferent
arteriole feeds into the functional unit of the kidney, the nephron. A nephron is responsible for
the filtration and downstream processing of the ultrafiltrate from a single afferent arteriole. Each
nephron consists of a glomerulus, a tubule, and a collecting duct. Broadly speaking, the glomerulus
is the site of filtration, the tubule is the location of water and solute reabsorption and secretion,
and the duct is the site of urine concentration. The high level of activity required at each of these
three stages is indicated by the volume flow rates: renal blood flow (RBF) in a 70-kg human being
is about 1.2 /min, one-fifth of the resting cardiac output,3 6 which translates to a renal plasma flow
(RPF) of about 0.54 /min. The total glomerular filtration rate (GFR) is about 0.13 l/min.3 7 Since
normal urine output over a 24-hour period is approximately one liter, 163 only 0.5% of the filtered
volume is actually excreted.
The animals most commonly studied as models for human kidney function are rats and dogs. A
human kidney has around 1.2 x 106 nephrons, while a dog's has approximately 4.3 x 105 and a rat's,
about 3.2 x 104.240 On the basis of total renal blood flow rate per mass of kidney tissue, all three
species have comparable values ranging from 3 to 5 ml/min/g. 4 1
2.2 The Glomerular Capillary Wall
The glomerulus is the site of the first step in urine formation-the creation of a cell- and protein-
free filtrate of the blood. A glomerulus is a tuft of interweaving and interconnecting capillaries
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about 200 Am in diameter enclosed by Bowman's capsule, a bi-layer of squamous epithelium over
basement membrane (Figure 2-1a). Ultrafiltrate flows from the capillary into the cavity-known as
Bowman's space-between the vessel tuft and Bowman's capsule. A glomerulus has four histological
components: the mesangial cells, which provide the architectural support, and the three layers of the
glomerular capillary wall-the vascular endothelium, glomerular basement membrane, and visceral
epithelium. Under normal circumstances, the bulk of filtration occurs through the capillary wall,
with a small but undetermined percentage filtering through the mesangium. 17 In some pathological
conditions, the amount of mesangial filtration may be increased. 22 2
There have been several attempts to pinpoint anatomical sites which demonstrate size or charge
selectivity. Permeability studies with electron-dense tracers indicated that the glomerular basement
membrane was a primary source of restriction,9 7 but as emphasized by Skorecki et al.,23 l the numer-
ous interactions between the cellular and acellular components of the capillary wall make it difficult
to attribute selective properties to any one particular component. Rather, it appears that the charge
and structure of the combined endothelium, basement membrane, and epithelium all contribute to
the filtration properties of the glomerulus.
2.2.1 Endothelium
The vascular endothelial cells of the glomerulus, which line the inner lumen of the capillaries, are
perforated by small openings, or fenestrae, 500 to 1000 A wide. These fenestrae are unique in
that they allow for direct exposure of the basement membrane to the plasma, in contrast to fenes-
trated capillaries of endocrine glands and intestine which have diaphragms. Thus it appears that
the endothelium provides almost no resistance to the passage of macromolecules. 9 7 Endothelial cell
membranes have sialic acid-containing glycoproteins which are postulated to be important for main-
taining the structure of the capillary wall and for some charge-selectivity.
2.2.2 Glomerular Basement Membrane
Histologically, the glomerular basement membrane (GBM) is seen to have three distinct layers. Two
lucent layers, the lamina rarae interna and externa, are adjacent to the endothelium and epithelium,
respectively. The more opaque lamina densa lies between the two (Figure 2-lb).
The GBM, with a thickness of 3500 A in humans and 1500 A in rats,2 40 is a sheet of extracellular
matrix composed of type IV collagen, proteoglycans (heparan sulfate and chondroitin sulfate), and
the glycoproteins laminin and fibronectin. 9 7 The absolute relative amounts and distribution of the
components is a subject of active research, but it appears that collagen makes up the bulk of the
lamina densa, while the proteoglycans and glycoproteins are localized to the lamina rarae. Laminin
and fibronectin are postulated to be important in the attachment of epithelial and endothelial cells
to the extracellular matrix.
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(a) Anatomy of the glomerular capillary network. Arrows indicate direction of blood flow. From
Elias et al. '9s
(b) Cross-sectional schematic of the glomerular capillary wall. end-endothelial cell, ep-
epithelial cell. 1-epithelium, 2-lamina rara externa, 3-lamina densa, 4-lamina rara interna,
5-endothelium. From Peace.20 3
Figure 2-1: Glomerular capillary structure.
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Anionic glycosaminoglycans in the lamina rara interna and externa have been proposed as
the principal determinants of charge selectivity, i.e., the hindered transport of negatively-charged
molecules such as proteins and the facilitated transport of cationic molecules.l4' Cationic staining
studies of the basement membrane by Kanwar and Farquhar 4 0 resulted in staining of clumps of
anionic sites within both lamina rarae, spaced about 600 A apart, indicating that charge distribution
may not be homogeneous in the GBM.
2.2.3 Epithelium
The visceral epithelial cells, or podocytes, are distinguished by their arrangement of interdigitating
"foot processes" which rest on the lamina rara externa (Figure 2-lb). The spaces between the
foot processes, which are 250-600 A wide, are known as filtration slits and are covered by a thin
diaphragm. Like the endothelial cells, the epithelial membranes are coated with anionic glycoprotein.
In several nephrotic pathological conditions, the foot processes of the epithelial cells are replaced
by a continuous rim of cytoplasm with variable degrees of vacuolization, a phenomenon often referred
to as "fusion" of the foot process, although there is no true fusion of the cells. 8 This histological
pattern can be mimicked in rat kidneys by the infusion of polycations such as protamine sulfate,2 2 3
and thus has been suggested to result from a loss of the endothelial fixed charges.44 ,50 256
2.3 Control and Chemical Mediation of Glomerular Ultrafiltration
The details of glomerular filtration have been extensively reviewed by Maddox et al..169 Conceptually,
glomerular ultrafiltration is controlled by the adjustment of three parameters: the afferent and
efferent arteriolar resistances RA and RE and the ultrafiltration coefficient Kf, where
RA PA - PGC (2.1a)
AABF
PGC - PERE -E, (2.1b)EABF
SNGFR
Kf SpUF. (2.1c)
P UF
The afferent and efferent arteriolar pressures in the above equations are designated by PA and
PE, respectively, and the afferent and efferent arteriolar blood flow rates are AABFand EABF.
PGC is the length-averaged pressure in the glomerular capillary, while PUF is the length-averaged
ultrafiltration driving pressure, a function of both hydrostatic and osmotic pressure as described in
Section 2.5.1. SNGFR is the single nephron glomerular filtration rate. Alterations in vascular tone
result in corresponding changes in RA and RE, while changes in intrinsic capillary permeability and
filtration surface area are manifested in Kf.32 Afferent renal plasma flow (QA) is modulated by
the total renal vascular resistance RT = RA + RE; AP is a function of RAIRT; and SNGFR is
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Angiotensin II
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Table 2.1: Chemical modulators of glomerular hemodynamics. Abbreviations: ADH-anti-diuretic
hormone, PAF-platelet activating factor, EDRF-endothelium-derived relaxing factor, ANP-atrial
natriuretic peptide. *Caused by reduction in PT. #Excluding effect on renin synthesis. Information
summarized from Maddox et al..l69
a function of QA, Kf, and the transmural hydraulic pressure lAP (= PGC - PT, where PT is the
pressure in the tubule).3 6
Physiologic control of glomerular function involves many complex interactions, the relative impor-
tance of which are not yet fully determined. The major chemical mediators of glomerular filtration
are summarized in Table 2.1. Two mechanisms have been relatively well-defined: autoregulation and
tubuloglomerular feedback.
2.3.1 Autoregulation
In the absence of any neural or hormonal control, the kidney can respond to variatons in systemic
arterial perfusion pressure in such a way as to keep renal plasma flow and AP, and consequently
GFR, relatively constant. This autoregulation of RBF is seen for mean arterial pressures above
80 mm Hg in rats218 and is an intrinsic response to changes in the tangential wall tension of the
arterioles; it is seen in de-ennervated and isolated kidney preparations.9 3 ,10 0 Physiologically, au-
toregulation is demonstrated as the kidney's ability, in the face of decreasing arterial pressure, to
maintain RE constant while lowering RA 218
23

·1
1
T
T
T
T
T
T
0
0
I
0
I
I
1
1
0
0,
T
T
0
T
2.3.2 Tubuloglomerular Feedback and the Renin-Angiotensin-Aldosterone System
The macula densa cells of the early proximal tubule and the afferent and efferent arterioles of the
glomerulus are located close together. It has been observed that high flow rates past the macula
densa cells lead to a reduction in SNGFR, apparently signaled by increased chloride uptake.2 5 8 This
reduction in SNGFR is a result of reduced QA and Kf with constant AP, suggesting an increase in
RA and RE brought about by a contraction of mesangial cells. 83 2
The renin-angiotensin-aldosterone system has been proposed as the effector mechanism of tubu-
loglomerular feedback, but this has as yet not been proven conclusively. Renin is a proteolytic
enzyme stored in the granules of afferent arterioles in the juxtaglomerular appartus. It is secreted in
response to increased intracellular levels of cyclic AMP or decreased intracellecular levels of calcium.
The factors that regulate renin secretion include (1) sympathetic control (3-adrenergic,stimulation,
f3-antagonistic or a-adrenergic inhibition), (2) baroreceptor control (stimulation by reduced arterial
wall tension, inhibited by increased tension), (3) hormonal regulation (histamine, glucagon, and
parathyroid hormone stimulation or angiotensin II and vasopressin inhibition), (4) prostaglandin
stimulation, and (5) an as-yet-undetermined signal from macula densa cells when the concentra-
tion of chloride ion in the proximal tubule fluid increases. Renin cleaves a circulating ca2-globulin,
angiotensinogen, into the inactive peptide angiotensin I (A-I). Angiotensin I is transformed in pul-
monary microvessels into angiotensin II (A-II) by angiotensin I converting enzyme (ACE).
Angiotensin II is a powerful vasoconstrictor which also serves to release the hormone aldosterone
from the adrenal cortex. Aldosterone stimulates sodium reabsorption in the tubules, leading to
an increased intravascular volume. These two substances counteract hypotension and/or decreased
perfusion of the kidney.
Studies by Myers et al.l8 5 and Ichikawa et al.136 indicate that the principal glomerular effect of
angiotensin II is to specifically increase RE, leading to an increase in AP. A secondary rise in RA
is seen in response to the systemic pressor actions of A-II. Angiotensin II has also been shown to
lower K ,24 apparently through a loss of parenchymal volume in the glomerular tuft which results
from contraction of the mesangial cells. 1' 2 1 2'
Chemical inhibition of A-II effects may be accomplished by two classes of compounds-the an-
giotensin receptor antagonists and the ACE blockers-both of which are important in experimental
studies of glomerular ultrafiltration. Saralasin is a receptor antagonist frequently used clinically as
a tool for establishing a diagnosis of renovascular hypertension. Captopril and enalapril are ACE
inhibitors used clinically for systemic hypertension and experimentally for lowering aP.
24
2.4 Theoretical Models of Glomerular Function
Theoretical models of glomerular function address the question of to what extent ultrafiltration and
permselectivity are modulated by variations in the system hemodynamics-renal plasma flow and
glomerular pressure-versus the extent to which they are affected by changes in properties of the
glomerular capillary wall-permeability and available surface area for filtration. For example, a
reduction in GFR may result from a lowered perfusion, a reduction in the driving force, a decrease
in the intrinsic membrane permeability, or a loss of filtration surface area. Similarly, proteinuria
could be postulated as a manifestation of an increased bulk filtration or as a loss of the capillary's
power to restrict transport. The success of these models has been their ability to explain specific
renal pathophysiological processes in terms of such changes.
2.5 Glomerular Ultrafiltration
2.5.1 Determinants of Glomerular Ultrafiltration
The progress in the understanding of the process of glomerular ultrafiltration has come about over
the last twenty years primarily from two advances: the development of servo-nulling techniques for
pressure measurement and the discovery of a strain of Munich-Wistar rats which have glomeruli
located at the surface of the renal cortex, allowing for direct access to the glomerular capillary and
Bowman's space. The theoretical approach to ultrafiltration in the glomerulus was developed by
Deen et al.81 If each glomerular capillary is idealized as a tube of length L (Figure 2-2), the local
transmural flux J, at a point y along the capillary can be expressed as the product of a permeability
and a driving force:
J (y) = k [P(Y) - Ar(Y)] (2.2a)
k [P - GC(Y)] (2.2b)
where k is the (empirical) effective hydraulic permeability of the wall, AP(y) = PGC(Y)- PT
is the radially-averaged transmural hydraulic pressure difference (often simply referred to as the
filtration pressure), and A7r(y) = rGc(Y) - rT is the radially-averaged transmural oncotic pressure
difference. (The subscripts GC and T represent glomerular capillary and tubule [Bowman's space]
values, respectively). The approximation in Eq. 2.2b results from observations that the axial drop
in hydraulic pressure over the capillary length is small, on the order of 2 to 3 mm Hg, and the
hydraulic pressure in Bowman's space is assumed to be independent of position. Thus the local
pressure difference can be replaced by the length-averaged value, Ap.37,127 Inclusion of the axial
pressure drop makes for a more physically realistic model but requires exceptional accuracy in
the experimental measurement of the afferent and efferent protein concentrations.8s The osmotic
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Figure 2-2: Model of glomerular ultrafiltration. Top: Afferent (QA) and efferent (QE) plasma flow
is axial in a tube of length L, while solvent flux (J,) is radial. Hydraulic and osmotic pressures in
the capillary (PGC, rGC) vary with position, while those in Bowman's space (PT, rT) are constant.
Filtration is governed by opposing hydraulic and osmotic pressure differences, resulting in the net
flux of solvent (J,) into Bowman's space. Bottom: Hydraulic and osmotic pressure profiles along
the length of the glomerular capillary. Hdraulic pressure is nearly constant, while osmotic pressure
increases significantly. Shaded area represents the net ultrafiltration driving pressure (PUF).
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pressure difference is assumed to result entirely from the difference in protein concentration, since
even in states of heavy proteinuria Bowman's space normally contains a negligible amount of protein
compared to plasma'9 3 (i.e., rT 0 and A7r(y) 7lrGc(y)). The oncotic pressure is calculated from
plasma protein concentration by the relation s l
r = 1.629c, + 0.2935ci, (2.3)
where cp is in units of g/dl (valid over the range 4 to 10 g/dl) and r is in mm Hg.
Near the inlet, the loss of fluid from ultrafiltration with concomitant retention of protein causes
the oncotic pressure within the capillary to rise, resulting in a diminishing of the driving force and
less filtration toward the outlet. Physiologically, the opposing hydraulic and oncotic pressure come
close to balancing at the efferent end (Figure 2-2).
The effective membrane hydraulic permeability k differs from the true hydraulic permeability
of the glomerular capillary wall ko because the effects of radial protein concentration gradients are
not included. Concentration polarization within the capillary lumen results in a higher protein
concentration at the wall surface than at the midline axis. The actual Air, and therefore k0o, is
underestimated by approximately 10% when using bulk protein concentrations. 8 2
If the total volumetric flow rate of plasma is Q(y) and the total surface area of the capillary
is S, then assuming no protein transport across the membrane (a valid approximation for the os-
motic pressure difference even with massive proteinurial9 3 ) we have the following expressions for
conservation of mass:
dQ
dQ ^ = -SAT (A)'(2.4a)
d(Qcp)d(Q ) = 0. (2.4b)
where Cp(y) is the plasma protein concentration and = y/L is a normalized length scale.
Eqs. 2.2b, 2.3, and 2.4, plus the afferent plasma flow rate QA = Q(O) and afferent protein
concentration Cp,A = Cp(O) are needed to solve for the complete flux, and osmotic pressure profiles.
Of particular interest are the flux and permeability integrated over the capillary length, which can
be obtained by substituting Eq. 2.2b in Eq. 2.4:
SNGFR = K PUF (2.5)
where
SNGFR - SJ ()dy (2.6a)
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PUF [P- rGc(y)] d (2.6b)
Kf - S.k (2.6c)
Eq. 2.5 is the whole-glomerular analog to Eq. 2.2b. Here it can be seen that Kf is the product
of the capillary hydraulic permeability and the surface area, while PUF is the difference of the
mean hydraulic and mean osmotic pressures, given by the shaded graphical area of Figure 2-2. A
closed-form expression for Kf as a function of QA, SNGFR, AP, and cp,A is given by Deen et al.8 '
Implicit in the derivation of Eq. 2.5 is the assumption that the glomerular capillary network
can be represented as a number of identical capillaries in parallel. Anatomical studies of the rat
glomerulus in fact suggest that there is significant heterogeneity in both capillary length and radius
within a single glomerulus. 15 72 2 5 Remuzzi and Deen2 1 ' investigated the theoretical implications of
independent distributions in capillary length and radius and found that for a fixed K!, increasing
heterogeneity in either dimension reduced SNGFR, but a distribution in length had a more noticeable
effect. Based on literature data estimating the length distribution for rat glomeruli, Remuzzi and
Deen established that a K1 calculated using identical capillaries underestimates the actual K by
about 30%.211
The situation pictured in Figure 2-2 represents one of filtration pressure disequilibrium; that
is, the efferent osmotic pressure 7rE is smaller than AP. This is a condition found experimentally
in euvolemic animals, where surgical fluid losses are replaced by continuous infusion. Filtration
pressure equilibrium (rE = AP) is the physiologic condition commonly found in hydropenic rats,
where fluid volume replacement is not performed. 13 5 It is not possible to calculate a unique value
for K! in this instance, since the exact point along the capillary where equilibrium is reached, and
therefore PUF is not known. The best that can be done is to establish a minimum value for K by
assuming that the osmotic and hydraulic pressure balance just at - = 1 .
2.5.2 Theoretical Dependence of Ultrafiltration Coefficient on Parameters
As previously stated, QA, AP, and SNGFR are controlled by the interaction of RA, RE, and Kf.
According to the model, at filtration pressure equilibrium SNGFR increases directly with QA; the
single nephron filtration fraction (SNFF), defined as
SNGFR
SNFF SNGFR (2.7)
QA
is a constant. For conditions of filtration pressure disequilibrium, SNGFR increases proportionally
less than the increase in QA, and SNFF decreases. These theoretical predictions have been verified
experimentally in rats. 40' 80 84' 1 35 218 From the basic tenet of filtration pressure equilibrium versus
disequilibrium, the effect of specific changes in the other hemodynamic parameters on glomerular
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ultrafiltration can be summarized:
* As K! increases, SNGFR and SNFF increase until filtration pressure equilibrium is reached,
and then they hold constant with further increases. Variations in the ultrafiltration coefficient
are not independent of the other hemodynamic parameters, as discussed next. Changes in K!
are important in several pathophysiological states (see Section 2.5.3).
* As afferent osmotic pressure 7rA increases, SNGFR and SNFF decrease until they become zero
at rA = AP. Experimental studies on rats have shown, however, that decreasing rA leads
to a fall in K, and thus a smaller increase in SNGFR than would be predicted. 1 7 '23s 2s ,24 4
Multivariate statistical analysis of this association shows a direct dependence which is not a
result of an intermediate relationship with QA or Ap.244 The mechanism of this interaction
has not been elucidated, but Brenner et al.3 7 suggest that protein concentration may be a
factor in the regulation of K! by vasoactive hormones.
* As AP increases above rA, SNGFR and SNFF also rise. This increase is not a linear relation-
ship, because the larger local fluxes (J,(y)) along the capillary lead to higher values for cp(y)
and local osmotic pressures, partially offsetting the hydraulic pressure increase. Experimen-
tally, as for osmotic pressure changes, there is a significant relationship with the ultrafiltration
coefficient, but here an inverse correlation. 2 4 4 Thus increasing pressure is associated with an
offsetting decrease in Kf.
2.5.3 Pathophysiological Behavior of Ultrafiltration Parameters
A reduction in Kf is believed to be an important clinical mechanism in the pathogenesis of acute
renal failure4 3 and several forms of glomerulonephritis, 2 3 1 although it can only be documented in
animal models. Animal models of nephrotoxic serum nephritis (NSN, an analogue to human anti-
GBM disease) show a change in SNGFR that is proportional to the severity of the injury. In response
to mild treatment with anti-GBM antibody, the glomeruli maintained a relatively normal SNGFR
despite a lower K! by increasing p.168 For major injuries of the same type, SNGFR dropped by
50%, principally caused by a reduction in Kf (offset by a larger AP), although a contributing factor
was a rise in RA and RE leading to a reduced QA 26
Studies of Heymann's nephritis, a model resembling human membranous glomerulopathy, have
shown an intrarenal heterogeneity in SNGFR determined by variances in K! and QA. 1 34 Values for
AP and r were found to be constant for all glomeruli regardless of the particular SNGFR . Other
studies have confirmed that AP is not significantly elevated in Heymann's nephritis. 2 62
Puromycin aminonucleoside (PAN) nephrosis is a non-immunological model for human minimal
change disease. Rats infused with PAN demonstrate a decrease in SNGFR which is related to a
lowered Kf.137 As with Heymann's nephritis, AP remains normal. 2 9
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Hemodynamic alterations in adriamycin nephrosis are similar to those observed in severe NSN
injury. QA decreases as a result of an elevated RA and RE, and a AP increase is accompanied by a
reduced Kf. The net effect is a smaller SNGFR while SNFF is relatively constant. 192 , 25 2
Studies of renal ablation (surgical infarction of functional renal tissue) in rats indicate that Kf is
not altered in response to a purely hemodynamic increase in QA and p.80, 128 When filtration pres-
sure is normalized, however, either by ACE inhibitors or dietary protein reduction, the ultrafiltration
coefficient increases to maintain SNGFR relatively constant. 6 7 , 175
Hyperfiltration in streptozotocin (STZ)-treated diabetic rats appears to be a function of increased
perfusion and filtration pressure resulting from a specific decrease in RA, as Kf does not differ
significantly from normal controls.L2 9 ,2 66 In more severe STZ-induced diabetic conditions, RA and
RE are high, QA and SNGFR are markedly reduced, but AP is normal. Conversely, the situation
in alloxan-induced diabetes seems to be one of hypofiltration or increased RA, where SNGFR and
AP are slightly reduced from controls, while Kf is unchanged.l 77 Insulin therapy of alloxan-infused
rats reduces RA while having no effect on Kf.
2.6 Glomerular Permselectivity
2.6.1 General Aspects
Normally, the glomerular capillary wall serves as a very effective discriminator on the basis of both
molecular size and charge. Small uncharged molecules are filtered without measurable restriction,
but the resistance to transport increases with larger or more anionic molecules. The concentration
of inulin in the glomerular ultrafiltrate equals that in the afferent arteriole, as opposed to albumin,
where the ultrafiltrate concentration is less than 0.1% of the afferent arteriole.1 95
Many disease states are characterized by a deficit of these permselective abilities, most seriously
manifested as protein loss in the urine. Development of theoretical models of glomerular permselec-
tivity has led to greater understanding of the importance of molecular size, charge, and configuration
to the normal ultrafiltration process, and to an understanding of the pathophysiological changes in
system hemodynamics and membrane properties in the disease state.
2.6.2 Clearance
The concept of clearance allows the relation of measurable solute concentrations in arterial blood and
excreted urine to concentrations in Bowman's space, which is not, in general, available for sampling.
The clearance of solute i is symbolized by Ci and defined as
_ Uci,UC- _ -i-, (2.8)
Ci,A
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here Ci has units of volume/time, U is the urinary flow rate in volume/time, ci,u is the concentration
of solute in urine, and Ci,A is the concentration of solute in the afferent arteriole. The clearance is
the hypothetical rate at which blood is completely "cleared" of solute i by the kidney. If the solute
is one such as the fructose polymer inulin-which is uncharged, freely filtered through the glomerular
capillary wall, and does not undergo reabsorption or any further secretion downstream-then its
clearance is equal to GFR. The fractional clearance FRC is a dimensionless quantity
FRC GFR' (2.9)
A fractional clearance less than unity indicates that the solute undergoes some combination of
restricted filtration or tubular reabsorption. A fractional clearance greater than one indicates that
the solute is secreted in the tubules.
The sieving coefficient of a solute Oi is defined with respect to its concentration in the afferent
arteriole Ci,A and its average concentration in Bowman's space (Ci,B):
ejOi- (Ci,B) (2.10)
Ci,A
For a solute which is neither secreted nor reabsorbed in the tubules, it can be shown that
FRCi = ei, (2.11)
and thus this parameter of theoretical interest can be obtained directly from blood and urine concen-
trations. If a polydisperse polymeric substance such as dextran (a polymer of D-glucopyranose) is
infused as a marker, then the plasma and urine samples can be fractionated by size, and subsequent
determination of the sieving coefficients as a function of molecular size leads to the construction of
sieving curves. As discussed below, these sieving curves are affected by both hemodynamic changes
and alterations in the membrane properties and potentially can be used as tools for the clinical
estimation of parameters not directly measurable.
2.6.3 Early Models
In the 1950s, Pappenheimer, Renkin, and Borrero 20 0 ,20 1 ,21 4 performed the pioneering theoretical
and experimental work which lay the foundation for much of the progress in modeling restricted
transport in pores. The results from these early studies are somewhat limited in their application
to glomerular filtration in that the blood vessel and extravascular space were each taken to be well-
mixed reservoirs. The dependence of transport on afferent plasma flow rate and on the gradients
of concentration, flux, and osmotic pressure in the capillary were not considered until the cross-
flow filtration models of the 1970's.6s 2 ,8 This more complete modeling was coupled with increased
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sophistication in the theoretical analysis of the restricted transport of solid spheres in cylindrical
pores. 5,4 2 ,4 7
The pore model originally derived by Chang et al.62 is summarized below. Additional models
based on alternative membrane geometries or without the assumption of any particular membrane
structure (nonequilibrium thermodynamics) have been proposed,6 2 ,20 0 but none have had extensive
application.
2.6.4 Isoporous Solid-Sphere Model of Permselectivity
In the simplest model, the capillary walls are assumed to be perforated by right cylindrical pores
with pore radius rp = r0 (Figure 2-3). Capillary flow occurs along direction y while filtration
is conducted in direction z. The porosity of the membrane (equal to the fractional pore area of
the membrane surface) is given by f and the total membrane surface area is S. The plasma and
glomerular filtrate are modeled as aqueous continua into which salts, proteins, and various tracer
molecules are dissolved. The tracer molecule concentration CT is small so that it does not contribute
to osmotic pressure or to electrostatic interactions within the membrane. Traditionally, all solute
molecules are assumed to behave as spheres with a radius equivalent to that of the Stokes-Einstein
radius
r, 6Dk'T (2.12)
6rp'D
where kB is Boltzmann's constant and T is the absolute temperature at which the solvent viscosity
p and diffusion coefficient Di are measured.
The solute flux Ji (y) of a neutral macromolecule through the pores is governed by both diffusional
and convective forces and is given by62
Ji(y) = (Y)C(1 -(Y)W (2.13)
Pey Wi(SJ,) (2.14)Pe(y)- fHiTi - (f$/t)H, )' (2.14)
where ci(y) is the solute concentration in the capillary, t is the thickness of the membrane (the
length of the pore), Di is the diffusion coefficient of the solute in bulk solution, f is the fractional
porosity of the wall, and Hi and Wi are solute pore hindrance factors for diffusion and convection,
respectively.
The Peclet number Pe(y) is a dimensionless quantity indicating the relative magnitude of the
convective to diffusive forces driving the solute through the pore. The second equality in Eq. 2.14
is written to emphasize that parameters related to the physical dimensions and porosity of the
membrane-f, S, and e-are not explicitly known. Only fS/I must be calculated, and for an array
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Figure 2-3: Pore model of glomerular permselectivity. Renal plasma flow (Q) is parallel to the inner
surface of the glomerular capillary wall. Cross-flow filtration from the capillary is assumed to be
conducted through pores of radius rp and length in the wall. Filtration is governed by opposing
hydraulic (P) and osmotic (Air) pressure differences, resulting in the net flux of both solvent (J,)
and solute (J,) into Bowman's space. Possible solute configurations include those of a solid sphere
(bottom pore, left) or a flexible coil (bottom pore, right).
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of uniform cylindrical pores it can be shown from the Poiseuille equation62 that
= 8Kf /ro (2.15)
where i is the viscosity of the solvent passing through the pores.
Methods for calculation of the hindrance factors Hi and Wi are reviewed in depth by Deen. 76 They
will be summarized here and will be discussed in greater detail in Chapter 5. Briefly, Hi and Wi are
functions of the relative molecule-to-pore size dimensions. In the absence of energetic interactions,
they equal one for small, freely filtered molecules and equal zero for molecules completely excluded
from the pores. Hindrance factors can be approximated as the product of a steric term (the partition
coefficient or its convective equivalent 0), which accounts for the difference between the solute
concentration in the capillary lumen and that in the pore, and a hydrodynamic term (the inverse
enhanced drag coefficient K -1 or the lag coefficient G), a measure of the increased frictional force
the molecule experiences in moving through the pore:
Hi - *K - 1, (2.16)
Wi x G. (2.17)
For a solid-sphere in a cylindrical pore, expressions of Bungay and Brenner 4 7 are most commonly
used:
H = E',' (2.18)
-W =K',(2-Kt) (2.19)2K'q
9Kt = r2(1 A, )-5/ 2 1 - 3(1 - ) + 50, 400 (1 - A,)2]
4 60 50,400
-22.5083 - 5.6117A, - 0.3363A,2 - 1.216A3 + 1.647A4, (2.20)
9 7 2227K's = -r2v/2(1 - A,)- 5 /2 1- -(1-A, ) + 50400(1- s )2]
+4.0180 - 3.9788A, - 1.9215A,2 - 4.392A3 + 5.006A4, (2.21)
where the partition coefficient = (1- A,)2 .
The sieving coefficient of the solute is calculated by performing mass balances on the total volume
flux and protein flux as described in Section 2.5.1, plus an additional balance on solute flux:
d(Qci) - -SJ.(). (2.22)
dEq. 2.22 is numerically integ ated along thlen th of the capillary using E. 2.13. The average solute
Eq. 2.22 is numerically integrated along the length of the capillary using Eq. 2.13. The average solute
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concentration in Bowman's space, (ci,B), and the sieving coefficient, Oi, may then be calculated from
QACi,A -- QCi,(Ci,B) - SNGFR (2.23)
(Ci,B)
el-- (C,,) (2.24)
Ci,A
where ci,A and ci,E are the solute concentrations in the afferent and efferent arterioles.
The nature of the boundary condition in Bowman's capsule is worth some discussion. If Bow-
man's space is considered well-mixed, then the appropriate boundary condition would be
Ci(, Y) = (Ci,B) = i Ci,A (2.25)
This was the original assumption employed by Chang et al..62 Deen et al.,83 using an analysis of
characteristic times based on the dimensions of Bowman's space, concluded that the well-mixed
assumption was probably not valid and that a preferable condition was spatially-dependent:
c (,y) J,(y) (2.26)
Du Bois et al.,8 9 showed that the theoretical sieving coefficients for these two cases are not substan-
tially different when the model assumes no axial pressure drop in the capillary. If, however, such a
pressure drop is included, relatively significant differences in predicted sieving coefficients occur for
small solutes (r, < 30 A): Oi using Eq. 2.26 was 5-10% lower than for the well-mixed case.
2.6.5 Heteroporous Models
The principal failing of the simple isoporous model is that it predicts a sharp cutoff of O at r, = ro.
Typical values for ro are 45-50 A in the rat, yet small but significant filtration of macromolecules
with r, = 60 A or greater occurs. Deen et al.79 addressed this discrepancy by comparing various
heteroporous models. Recent work has centered around two approaches: a continuous lognormal
distribution of pore sizes and the so-called isoporous + shunt distribution, which postulates a small
number of infinitely-sized pores in parallel with the isoporous membrane. Both of these models
require two parameters to describe membrane size-selectivity, as opposed to the one-parameter
isoporous membrane. They are discussed in more detail in Section 4.2.5 and Appendix B.
Additional models based on principles of distribution moments 14 5 ,1 4 6 or on non-equilibrium
thermodynamics 62 '2 0 0 have been proposed, but none have received extensive application in anal-
ysis of glomerular sieving.
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2.6.6 Pathophysiological Behavior of Permselectivity Parameters
Permselectivity changes in clinical disease states are usually characterized by a loss of both size-
and charge-selective properties. The size changes are manifested in the theoretical model as larger
values of the pore radius parameters. For neutral dextrans, a characteristic pattern in deviations
from normal sieving behavior is seen in almost all cases, both animal and clinical: sieving coeffi-
cients of small-to-medium sized molecules are normal or slightly lowered, while e for large (, > 50
A) molecules are elevated. This pattern is generally consistent with an increased filtration pres-
sure and/or decreased K! and an increased number of large pores compared to controls. These
changes have been observed in NSN,6 0 PAN nephrosis,3l"9 9 adriamycin nephrosis, 2 5 2 Heymann's
nephritis,2 62 renal ablation,l 98 clinical diabetes,4 9 ,1 0 1, 8 7,24 2 ,2 55 and minimal change disease.79 One
model where it has not yet been documented is for experimental diabetes, where studies of STZ-
and alloxan-induced diabetes showed no change in sieving from controls.l 77 ,2 05 It must be noted,
however, that in these two studies the maximum dextran size measured extended only up to around
48 A, and so it is quite probable that larger sizes must be examined to demonstrate the larger shunt.
· 2.6.7 Charge Selectivity
To date only limited modeling of the charge-selective properties of the glomerular capillary wall has
been performed. Deen et al.8 3 superimposed a homogeneous charge distribution on the isoporous
model and, based on studies of anionic dextran sulfate and cationic DEAE-dextran, calculated a
charge density of around -165 mEq/l for the normal capillary wall. Studies of charge permselectivity
have also been relatively limited in number. A significant increase in the fractional clearance of
dextran sulfate has been shown in both NSN and PAN nephrosis,2029 as well as a inhibition of
cationic DEAE dextran transport in NSN.28 These alterations have been correlated to reductions
in the fixed membrane charge from -165 mEq/l to -25 and -100 mEq/l for NSN and PAN,
respectively. 8 3 Interpretation of this data is made difficult by recent findings that dextran sulfate
binds to albumin in vivo.' 7 4 Hence, while the qualitative conclusions of lost charge selectivity are still
valid, quantitation based on dextran sulfate data probably is not. A suitable charged test molecule
for evaluation of capillary charge selectvity remains to be developed.
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Chapter 3
Calibration of Gel Permeation Chromatography Columns
with Narrowly-Sized Polymer Standards
3.1 Introduction
If sieving curve analysis is to be used to estimate filtration pressures, great care must be taken to
minimize methodological errors in the determination of tracer size and concentration. Two possible
sources of error in gel chromatography which have not been previously considered in great detail are
the calibration of the chromatography columns and the effect of column dispersion on the elution
profiles.
3.2 Theory of Gel Chromatography and Column Calibration
Separation of infused polymers into narrow fractions is performed by gel permeation chromatography
(GPC). The sample is eluted through a column packed with a porous material which will allow small
molecules access to the interstitial volume while excluding large molecules. Smaller molecules will
thus be retained longer in the column. Solute molecules are sized according to Kt, the fraction of
the column volume to which they have access, or by K,,, a commonly-used approximation for Kt:
Kt = V-- V' (3.1a)
Ve - Vo
K V ' (3.lb)
where V is the elution volume of the solute, Vo is the void volume (the solvent volume external
to the gel beads), Vt is the total column volume, and V, is the volume of the gel stationary phase.
K., is more frequently used because values for V, are generally not available. A solute completely
excluded from the packing interstitium (such as Blue Dextran 200, m.w.= 2 x 106 daltons) will have
a K., of 0, while solvent or molecules with unrestricted passage into the stationary phase will have
a K,, near 1, with the difference from unity due to V,.
Determination of the Stokes-Einstein radius (r,) of polysaccharide fractions is traditionally done
with calibration curves derived from globular protein standards. The assumption is that for polysac-
charides r, = ,, where , is the Stokes-Einstein radius of a globular protein with the same Kv,.
Chang et al.63 found that r, for commercial dextrans T10 and T20 preparations correlated well with
a linear calibration plot of Kv vs. In r, on Sephadex G-100 columns.
More recently, however, work by Jrgensen and M0ller 139 on Sephadex G-200 columns and by
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Squire23 2 and Frigon et al.'0 2 on silica gel (TSK-SQ) columns indicates that protein calibration is
not a suitable method of determining dextran size. In both of these studies, dextran samples were
seen to have smaller values for r, than proteins at equivalent K.,. In other words, dextrans on these
columns were more excluded from the gel interstitium than proteins and r, < ,. The magnitude
of this difference in silica gels is on the order of 10-20% for mid-sized dextrans (15-40 A).10 2 In
contrast, another study by Deen et al.77 employing Sephadex G-100 columns showed discrepancies
in the opposite direction (r, > ,).
Frigon et al.102 corrected for configurational effects using a model of Benoit et al.21 in which an
effective hydrodynamic volume vh is employed as the metric of molecular size. This volume is given
by
M[77]
vh ' (3.2)
where M is the molecular weight of the polymer, [7] is the intrinsic viscosity, v is a shape factor
equal to 2.5 for spherical particles, and NA is Avogadro's number. Values for [] for protein were
taken from the literature, while those for dextrans were calculated from an empirical relationship to
molecular weight. Thus vh for spherical particles scales as [77]M. When []M was substituted for r,
in the calibration, differences between proteins and dextrans were diminished.
In the study by Frigon et al.,'0 2 the values for dextran r, were based on measurements by
Granath l l9 in a diffusion cell. The Frigon study neglected to account for the fact that the dextran
fractions used by Granath were not monodisperse, with polydispersity indices (defined as the weight-
averaged molecular weight divided by the number-averaged molecular weight) ranging from 1.09 to
1.8, with most around 1.3-1.4. Thus their correlation of molecular weight to r, may not have been
particularly accurate.
More importantly, there is evidence that the Benoit hydrodynamic volume model does not com-
pletely explain gel permeation phenomena. Data by Belenkii et al.'9 on Sephadex columns indi-
cates that dextran and polyvinylpyrrolidone are less excluded (have higher retention volumes) than
polyethylene oxide at equivalent hydrodynamic volumes. Since all three molecules have random-
coil configurations, the lack of agreement suggests that additional mechanisms such as solute-gel
interactions may be important.
It would seem logical to expect that the behavior of macromolecules in gel exclusion would
follow the observed sieving trends in the glomerulus; that is, that dextrans, which experience a more
facilitated transport through the glomerulus than neutral globular proteins of equivalent Stokes-
Einstein radius,21 6 would also be retained to a greater extent in the stationary phase of the gel
beads. While this appears to be true for the data of Deen et al.7 7 and Belenkii et al.,1 9 the reverse
holds for the data of Frigon et al.'0 2 and J0rgensen and M0ller.'3 9 It therefore appears that the
degree and manner to which molecular configuration influences retention volume is dependent upon
the type of gel matrix in the column. Of particular note, the Belenkii et al. results, where dextran and
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PVP show similar degrees of transport into the gel and are less restricted than PEO, are consistent
with findings in glomerular filtration. 13 9 '2 4 6
The consequences of calibration errors on the analysis of sieving curves are shown in Figure 3-1.
The shifting of a sieving curve along the r, axis by calibration errors will lead to errors in fitted pore
parameters and, when performed, to fitted filtration pressures (P). The baseline curve, shown by
the solid line, was calculated directly from the isoporous solid-sphere model with ro = 50 A, AP =
35 mm Hg, and the other hemodynamic inputs as described in Figure 3-1. The dotted lines are the
same data as the solid line, but shifted 2 and 4 A to the left, equivalent to a calibration error where
r, > ,. Values of To and AP were then fit to the shifted curves using the methods of Section 7.3.1.
The error in ro is seen to be approximately equal to and in the same direction as the calibration
error, while the the fit overestimates AP by 8 mm Hg or more. The dashed lines show analogous
results for r, < ,. Again, the ro error scales with the calibration error, but the AP error is an
underestimation on the order of 5 mm Hg.
A possible discrepancy of 5 to 10 A in r, is thus seen to be of enough significance to warrant a
more accurate way of sizing the polymers. Since it will not be feasible to routinely calibrate with
narrowly sized fractions, it is proposed instead to develop simple correction functions from protein
calibration curves.
The most direct way to determine correct molecular sizes is to calibrate the GPC columns using
narrow molecular weight-range fractions of the polymers of interest. We report in Section 3.6.1
a comparison of calibration results obtained with proteins or with nearly monodisperse dextran
or Ficoll standards using Sephadex G-100 and Sephacryl S-300 HR columns. The r, values of the
various dextran and Ficoll samples were measured using quasielastic light scattering, and correlations
of r, versus molecular weight are given for both polymers. We also derive correction factors that
may be used in conjunction with protein calibrations of this type of column.
3.3 Effect of Column Dispersion on Sieving Curves
Dispersion causes backmixing as the sample elutes through the column and decreases the resolution
of the fractionation. For a monodisperse sample, dispersion leads to broadening of the elution peak;
for a polydisperse sample, it causes a "smearing" of the elution profile. The phenomenon is described
by a modified diffusion equation:
we X it 82 c(3.3)
where is the concentration averaged over the column cross-section, t is time, Ki is the Taylor
dispersion coefficient, and z is axial position in the frame of reference of the moving solute, with
z = 0 corresponding to the solute peak concentration. The solution for a pulse input at the top of
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Figure 3-1: Theoretical effect of a shift in sieving curve due to r, calibration error. The other
hemodynamic inputs are QA =172 nl/min, SNGFR =49.8 nl/min, Cp,A = 5.2 g/dl. The baseline
case is shown by the solid line. Dotted lines demonstrate shifts to the left of 2 and 4 A, dashed lines
indicated analogous shifts to the right. New values for ro and AP were fitted for the shifted curves
using the isoporous, solid-sphere model.
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the column is 9'23 8
A/ rR4 exp - Z (3.4)
where A is the amount of solute in the pulse and Rc is the column radius. For fully developed
laminar flow in an open tube, the dispersion coefficient can be shown analytically to be equal to
D + (UR,) 2 /48D, where U is the average fluid velocity in the column. 6 9 Several theories exist for
describing the functional dependence of K for gel columns, 12 2 ,2 60 but all rely on some degree of
empiricism.
The theoretical effect of dispersion on column elution is shown in Figure 3-2. As a first ap-
proximation, data from typical plasma and urine elution curves in Sephacryl 300-HR columns were
used as the inputs into a theoretical column. (Rigorous analysis would require use of the data as
output and calculation of the input by deconvolution.) The quantity of labeled tracer was measured
in counts per minute per microliter of sample. Input samples were modeled as a combination of
discrete pulses with sizes corresponding to elution volumes 3 ml apart (equal to the volume collected
in each tube of the fractionator). With no spreading in the column (K = 0, solid lines) there is
perfect separation and the elution curves are exactly the same as the size distribution of the sam-
ples. For a dispersion coefficient of 10 - 4 cm 2/s, there is minimal deviation of the elution curves
from perfect separation. In the plasma sample, the deviation is -0.6% at 20 A, -4.8% at 40 A, and
2.3% at 60 A. In urine, the respective deviations are 1.6%, 4.2%, and 8.3%. For K = 10 - 3 cm 2/s,
dispersive effects become more noticeable, especially for the urine sample, leading to a "flattening"
of the profiles. The deviations in the plasma samples are -0.6%, -18.3%, and 17.8% at 20, 40, and
60 A, respectively, and for urine the deviations are -10.5%, 47.3%, and 144%, respectively. Because
the plasma profile is more nearly constant than the urine profile, it is less affected by dispersion.
(Values for O were calculated from Eq. 4.1 with the inulin ratio and protein correction factor given
in Figure 3-3.) The effect of dispersion on the resultant sieving curve is shown in Figure 3-3. The
sieving curve is altered in a manner similar to that of the urine profile, with values lowered at small
r, and raised at large r,. Again, dispersion coefficients of 10 - 4 are not significant, changing by
2%, 9.4%, and 6% at 20, 40, and 60 A, respectively, while those of 10- 3 noticeably affect the sieving
curve, changing O by -10.1%, 80.5%, and 107%.
3.4 Effect of Elution Volume Errors on Sieving Curves
A final possible source of error is in the measurement of elution volume. If the error is the same
for both plasma and urine samples (i.e., Ve is incorrectly measured by the same amount), then the
effect is equivalent to that of an r, calibration error. Alternatively, there may be a relative "tube
shift" error (so called because the elution volumes are collected into numbered tubes), where V, for
one sample does not correspond to V, for the other. This situation is examined in Figure 3-4. The
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Figure 3-2: Theoretical effects of column dispersion on plasma and urine elution curves. Curves
calculated using column height = 56 cm, R, = 1.3 cm, and solvent velocity = 0.0126 cm/s. The
fluctuations in the solid lines represent normal scatter in the data
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Figure 3-3: Theoretical effects of column dispersion on sieving curves. Sieving coefficients calculated
from Eq. 4.1 using plasma and urine elution curves of Figure 3-2 and (U/P)inulin = 119.03, f' = 0.95.
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Figure 3-4: Theoretical effects of "tube shift" on sieving curves. O calculated as in Figure 3-3. Shift
is denoted by a change in urine V from the zero shift case. Curve for zero shift is the same as the
KC = 0 curve of Figure 3-3.
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Dextran FDR 7314+403 Fr 4 87,500 76,700 1.14 72
70 Fr I-1 72,100 62,600 1.15 64
FDR 7314+403 Fr 8 53,300 48,100 1.11 58
FDR 7314 Fr 22 41,200 38,000 1.08 52
RMI T8630 Fr 3 40,400 38,900 1.04 47
FDR 7314 Fr 32-36 25,600 24,200 1.06 42
FDR 7314 Fr 32 25,600 24,200 1.06 41
T5558+7650 Fr 2 10,000 9,200 1.09 26
PD T5558 Fr 10 9,860 9,430 1.05 26
T5558+7650 Fr 5 4,300 3,880 1.11 20
Ficoll T1800 Fr 20 132,000 - - 69
T2580-IVB Fr 2 71,800 64,600 1.11 49
T2580-IVB Fr 4 58,700 53,000 1.11 44
T2580-IVB Fr 8 37,500 34,500 1.09 35
T2580-IVB Fr 11 21,800 20,300 1.07 29
T2580-IVB Fr 12 17,500 16,200 1.08 30
Table 3.1: Polymer standards used for GPC calibration. Abbreviations: Mw-weight-averaged
molecular weight, Mn-number-averaged molecular weight. Sample ID, M,, and Mn are those
provided by manufacturer. Values of r, were determined by quasi-elastic light scattering.
KX = 0 case of Figure 3-3 is used as the baseline case. Shifting the urine elution curves by 3 ml
(equivalent to one tube volume for the experiments of this work) in either direction is seen to have a
small effect on e9. The deviation from baseline is around 5% at 20 A and 30% at 40 and 60 A. This
will be true as long as the tracer distribution in the plasma is relatively uniform, as in Figure 3-2.
If the plasma profile has significant gradients, then tube shift effects will be large in the region of
the gradients.
3.5 Materials and Methods
3.5.1 Polymer Standards
Ten relatively monodisperse samples of dextran and six of Ficoll were obtained courtesy of Dr.
Kirsti Granath of Pharmacia, Uppsala, Sweden. The weight-averaged molecular weights (M, ) and
number-averaged molecular weights (M,), as supplied by Dr. Granath, are given in Table 3.1. The
polydispersity index (M,I/M,) for all samples was < 1.15.
3.5.2 Quasi-elastic Light Scattering
The diffusion coefficients (D) for the dextran and Ficoll standards were measured by quasielastic
light scattering. Polymer samples (2 or 5 mg/ml) were prepared by dissolving dextran or Ficoll
in high-purity water (MilliQ, Millipore Corporation, Bedford, MA) and filtering the solution five
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Polymer M. M /Mn r )Sample ID
times through 0.22 ptm pore diameter films. (Millex-GV, Millipore). The light scattering apparatus
consisted of a 2 W argon-ion laser (Model-95-2 Ion Laser, Lexel, Fremont, CA), goniometer (Model
BI-2000 SM, Brookhaven Instruments Corp., Holtsville, NY,), and 136-channel digital correlator
(Model BI-2030 AT, Brookhaven Instruments). The sample temperature was maintained at 25 °C
by a circulating water bath (System II Liquid/Liquid Recirculator, Neslab, Newington, NH). The
wavelength of the measured light was 488 nm, the aperture was 200 nm, and the scattering angle
was 1350. Sampling time varied from 01. to 0.5 s, depending on molecular weight, with a total
counting time of one minute. Diffusion coefficients were fitted to the autocorrelation function by a
second-order cumulant method.14 7
The Stokes-Einstein radius r, is related to D by
kBT
67r-6' (3.5)
where kB is Boltzmann's constant, T is absolute temperature, and M is the viscosity of water.
3.5.3 Gel Permeation Chromatography
A set of GPC columns of 2.6 cm diameter (Model C 26/100, Pharmacia Fine Chemicals, Piscataway,
NJ) was packed with Sephacryl S-200 HR (Pharmacia). The packed column height was 56 cm and a
buffer flow rate of 3.8-4.0 ml/min was maintained by a peristaltic pump (2232 Microperpex S, LKB,
Bromma, Sweden). The eluent buffer was 0.05 M ammonium acetate at pH 7. The void volume
(Vo) of the columns was determined by the elution of blue dextran (Sigma Chemical Co., St. Louis,
MO). Continuous dextran and Ficoll elution curves were determined by differential refractometry
(Series R-400 Differential Refractometer, Waters Associates, Milford, MA). The elution volumes
of colored proteins were measured by collection of 3 ml aliquots in an automatic fraction collector
(2070 Ultrorac II, LKB) and reading of light absorbance at 415 nm (DU-50 Spectrophotometer,
Beckman Instruments, Fullerton, CA). The proteins used were ferritin (horse spleen), horseradish
peroxidase, myoglobin (horse heart), and cytochrome c (horse heart) (Sigma Chemical). Based on
published diffusivities, 5 4' 1 71,21 9' 23 9 their molecular radii were taken to be 59.4, 30.4, 19.0, and 16.5
A, respectively.
A second set of columns of 2.5 cm diameter were packed with Sephadex G-100 (Pharmacia) to a
column height of 46.5 cm. As a pump could not be used with this packing, elution was performed by
a constant pressure head of 90 cm of water. Four ml aliquots of dextran, Ficoll, and protein elutions
were collected in the fraction collector. Dextran and Ficoll elution peaks were determined by batch
refractometry and protein peaks were determined by absorption.
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Figure 3-5: Graphical method of calculating peak variance.
3.5.4 Calculation of Dispersion Coefficients
Dispersion coefficients were calculated graphically from the elution peaks. Each peak was assumed
to approximate a Gaussian curve, and the variance oap for each peak was calculated by measurement
of either Wb or W1/2 as shown in Figure 35.280 The dispersion coefficient is then given by l °
KC = .
2t, (3.6)
This method is strictly true only for a monodisperse pulse. Any polydispersity in the sample will
also contribute to widening of the peak, so the values reported are in fact upper limits for KC.
3.6 Results and Discussion
3.6.1 Quasi-elastic Light Scattering
The values of r, obtained by quasielastic light scattering are shown in Table 3.1, and are plotted
as a function of Mo, in Figure 3-6. The dependence of r, on M, is described to within 9% by the
correlations
r, = 0.488M° 437for dextran
r, = 0.421M 427for Ficoll
(3.7a)
(3.7b)
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Figure 3-6: Stokes-Einstein radius (r,) of dextran and Ficoll as a function of weight-average
molecular weight (M, ). The present results for dextran are compared with those from the
literature.4 8 ,119 la3 9 The curves are correlations given by Eqs. 3.7.
48
250
200
150
100
50
10 3
I
106
I I I 1 11171 -· I · · TlrT· -I · · · · ·--
I I
In\
_I 
105
Gel Polymer a b
Sephacryl S-300 HR Dextran 0.3150 1.522
Ficoll 0.2924 1.438
Proteins 0.3048 1.458
Sephadex S-100 Dextran 0.5798 2.277
Ficoll 0.6330 2.407
Proteins 0.5543 2.135
Table 3.2: Constants in correlations of Kay versus r, (Eq. 3.8).
where r, is given in A.
Also shown in Figure 3-6 are r, values reported previously for dextran using three different
methods. The data of Granath" 9 were obtained by measurements in a diffusion cell, Callaghan
and Pinder4 8 used pulsed field gradient NMR, and Jrgensen and M0ller s39 used analytical cen-
trifugation. The first two of these studies used commercial dextran fractions having significant
polydispersity (M-/M, > 1.3), while Jrgensen and Moller used narrow fractions comparable to
those employed here. Our results for dextran coincide fairly closely with those of Callaghan and
Pinder4 8 and Jrgensen and M0ller, 1 39 while the r, values of Granath l9 are larger at any given
value of Mw. For the same M, the Stokes-Einstein radius of Ficoll tends to be somewhat lower than
that for dextran. There appear to be no previously published data for r, versus M, for Ficoll.
3.6.2 Gel Permeation Chromatography
The calibration results for the Sephacryl and Sephadex columns are shown in Figure 3-7 as semilog
plots of Kay versus r,. Unlike the columns used by Jrgensen and M0ller139 and Frigon et al.,'0 2
the differences between protein and polysaccharide elution volumes on Sephacryl S-300 HR columns
are fairly small. The differences are also small for Sephadex G-100 columns, in agreement with the
previous measurements by Chang et al.63
The best-fit lines for the data in Figure 3-7 are of the form
Kav = -aln , + b, (3.8)
with r, expressed in A. The values of the constants a and b for the various polymers and gel materials
are given in Table 3.2 These results may be used to derive correction factors for r, of dextran or
Ficoll which compensate for the use of proteins as the calibration standard. These correction factors,
defined as A = r, - ,, are shown in Figure 3-8 for dextran and Ficoll. As shown, Sephacryl S-300
HR columns calibrated with proteins would yield slight underestimates of r, for both dextran and
Ficoll (A > 0), while such calibrations on Sephadex G-100 would also underestimate r, for dextran
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Figure 3-7: Fractional retention volume (Ka,) as a function of Stokes-Einstein radius (r,) for dextran,
Ficoll, and various globular proteins on Sephacryl S-300 HR columns. The lines represent the
correlations given by Eq. 3.8 and Table 3.2.
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Figure 3-8: Molecular radius correction factors for dextran and Ficoll on Sephacryl S-300 HR and
Sephadex S-100 columns.
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3.6.3 Dispersion Coefficients
Figure 3-9 shows the estimated dispersion coefficients for eight dextran and four Ficoll samples
for which calculations could be performed. There is no discernible difference between dextran and
Ficoll results. A linear dependence of K on r, is indicated, supported by theoretical formulations
which indicate that ap oc 1/VD. 2 6 The dispersion coefficients are on the order of 10-8 -10- 4 cm 2 /s,
placing them at the border of significantly affecting the elution curves. The actual values of K are
somewhat lower than those shown in Figure 3-9 because of sample polydispersity. Thus sieving
coefficients below 40 A should be only minimally affected by dispersion. For e at r, > 60 A, c
may be more on the order of 10- 3 cm 2 /s, and Figure 3-3 suggests that the error due to dispersion
may be as high as a factor of two. However, standard errors for e at large r, are on the order of O,
and so correcting for dispersion would probably not contribute significantly to the normal analysis
of sieving data.
3.7 Summary and Conclusions
In this chapter, we have used monodisperse dextran and Ficoll standards to demonstrate the dif-
ferences between calibration curves derived from globular proteins and those derived from linear
(dextran) and cross-linked (Ficoll) polysaccharides. On the Sephacryl 300-HR columns empolyed by
this study, the differences were found to be small, on the order of 5 A or less. The effect of column
dispersion on a polydisperse elution profile was determined by estimation of Taylor dispersion coef-
ficients from the monodisperse elution peaks. For typical plasma and urine samples obtained from
sieving analysis, column dispersion was shown to be negligible for small (r, < 40 A) tracers. While
dispersion effects may be theoretically important for larger (r, > 60 A) molecules, it probably has
no practical significance due to the high degree of experimental scatter in measured values of 9 at
these sizes.
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Figure 3-9: Estimated dispersion coefficients for dextran and Ficoll on Sephacryl S-300 HR columns.
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Chapter 4
Comparison of Ficoll and Dextran Sieving in the Normal
Munich-Wistar Rat
4.1 Introduction
Ideally, the fractional clearance of a neutral tracer at a given molecular size would be independent of
the polymer used and identical to that of a neutral endogenous protein of the same size. In practice,
using the Stokes-Einstein radius r, as the metric of molecular size, considerable variation exists in
the values of O from different macromolecules. In animal studies comparing dextran sieving to that
of Ficoll,31 polyethylene oxide (PEO),' 3 9 polyvinylpyrrolidone (PVP),2 4 6 and horseradish peroxidase
(HRP),l9 s,8 99, 216 , 252 dextran O exceeds those of the other tracers, although only slightly in the case
of PVP. In terms of the traditional pore model of glomerular permselectivity-which assumes that
all tracers behave as solid spheres of radius r,-the dextran values correspond to a membrane of
comparatively larger pore radius.
Consequently, although the pore-size parameters derived from dextran sieving data for nephrotic
humans often account quantitatively for the observed levels of proteinuria, the pore-size parameters
in healthy controls fail to explain the absence of appreciable protein excretion. 79 120 Because albumin
has a net negative charge under physiological conditions, the presence of at most trace levels of
albumin excretion in healthy individuals might be explained largely by the charge-selectivity of
the normal glomerular capillary wall.3 0 ' 1 ' 21 5 The charge-selectivity of the filtration barrier does
not, however, explain the virtual absence in normal urine of IgG, which is nearly neutral. Protein
reabsorption by the tubules certainly contributes to the discrepancy between the urinary clearances of
dextran and protein in normal individuals, but the reported values of fractional protein reabsorption
of _ 90%1041196 would account for only a ten-fold difference between dextran and proteins such as
IgG. Therefore, some factor in addition to charge-selectivity and protein reabsorption is needed to
explain the differing urinary excretion rates of dextrans and proteins of similar r,.
The sieving coefficient in normal rats has been measured in the range of 1.9 x 10 - 4 to 1.1 x 10 - 3
for albumin'14 2 29 4 '98 "104 ' 10 5 61 ' 164 ' 166 ,193 - 19 5 235 249' 26 4 (r, = 35.5 A), at approximately 0.07 for
neutral HRPl9 8s' 99 '216 ' 2 52 (r, = 30.4 A), and at 5.2 x 10- 3 for IgGl0 5 (r, = 55 A). In comparison,
reported ranges for dextran values at 30, 40, and 50 A are 0.20-0.86, 0.01-0.49, and 0.002-0.13,
respectively.' 6 9 Again, while the difference between dextran and albumin may be explained in part
by charge-selectivity, this rationale does not hold for neutral HRP or IgG.
The applicability of theoretical modeling is thus limited in that membrane pore parameters are
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specific for a particular tracer and do not provide an absolute measure of the ability of the glomerulus
to retain proteins. There is considerable evidence that, in addition to the effects of molecular size
and charge, differences in molecular configuration may have an important influence on the relative
filtration rates of proteins and various exogenous macromolecules. Dextran, PEO, and PVP are
linear, flexible chains of varying degrees of solvation, while Ficoll and proteins are cross-linked and
comparatively rigid. Of particular interest is the fact that the relative ranking of filtration rates in
vivo is mimicked by the diffusion rates of these polymers through synthetic porous membranes; that
is, edextran - OPVP > OFicoll > ePEG. Thus, the transport rates of various neutral macromolecules
differ appreciably and the relative rates seem more dependent on the type of permeating molecule
than on the chemical composition of the barrier.
Especially noteworthy is the fact that in track-etched polycarbonate membranes of known pore
size, the measured diffusivity for Ficoll has been found to closely match the theoretical predictions
for a neutral, solid sphere, whereas that for dextran is much larger.32 ,71 These findings and the
aforementioned similarities among transport rates in vivo and in vitro suggest that Ficoll should
provide accurate absolute values of effective glomerular pore size, values which might be extrapolated
reliably to proteins. These results also imply that using dextran together with the customary solid
sphere theory will lead to systematic overestimates of glomerular pore size. In other words, Ficoll is
probably a more accurate marker for filtration of neutral, globular proteins than is dextran. As with
dextran, Ficoll is not secreted or reabsorbed by the tubules,3s and it can be prepared in a broad
range of sizes.
There has been only one previous physiological investigation using Ficoll, where Bohrer et al.3
performed sieving measurements in Munich-Wistar rats and found that Ficoll sieving coefficients
were considerably lower than those for dextran at r,= 24 to 44 A. While the results are significant,
the data are inadequate for in-depth analysis for three reasons:
1. It was a two-period study: in a given animal, a 3 H-dextran sieving measurement was followed
by a 3 H-Ficoll sieving measurement, or vice versa. The time between polymer infusions was
approximately three hours, which may not have been sufficient for complete removal of the
first tracer, especially at larger sizes, and so residual activity may have influenced the second
set of values.
2. Micropuncture measurements of flow rate and pressures were not performed, so direct calcu-
lation of pore parameters cannot be made.
3. The largest size examined was only 44 A. Advances in separation technology now make it
possible to examine O at r, up to 65-70 A-where the effects of glomerular permselectiv-
ity are more important. Additionally, gel chromatographic calibration in the Bohrer study
was performed with globular proteins, which as seen in Chapter 3 may lead to errors in the
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determination of molecular size.
In the following study, we compared dextran and Ficoll sieving in a manner which addresses
the deficiencies above. Separate animals were used for each tracer, micropuncture and whole kidney
hemodynamic measurements were performed, and permselectivity data was taken over a wider range
of r,. Several heteroporous membrane models were used to analyze the data. In the following chapter
a theoretical model for random coil permselectivity is used to quantitate the effects of molecular
configuration and to suggest a possible explanation for dextran/Ficoll sieving differences.
4.2 Materials and Methods
4.2.1 Preparation of Radiolabeled Polymers
Tritiated dextran (#TRA 382, M, 70,000) was obtained from Amersham Corp. (Arlington
Heights, IL). Ficoll was tritiated using the following modified version of the protocol of Bohrer et
al.:31 One gram of Ficoll 70 (Pharmacia Fine Chemicals, Piscataway, NJ) was dissolved in 5 ml of
water and oxidized by adding 0.525 g of NaIO4 and reacting in the dark for 18 h. The solution
was desalted by elution through disposable PD-10 gel chromatography columns (Pharmacia LKB
Biotechnology AB, Uppsala, Sweden). The pH was adjusted to 8.0 by addition of NH 4OH. One
hundred mCi of tritiated sodium borohydride (New England Nuclear, Boston, MA) was added to the
oxidized Ficoll in a fume hood. After 4 h, excess (0.2 g) unlabeled NaBH 4 was added and the reaction
was allowed to proceed for an additional hour. A few drops of acetic acid were added to remove
residual borohydride, and then the unreacted label was removed by elution with phosphate-buffered
saline (pH 7.0) through disposable PD-10 columns.
The resulting stock 3 H-Ficoll solution was approximately 10 ml in volume with a total activity
of 11 mCi. Dilutions of this stock were used for infusion in the rats as described in the next section.
4.2.2 Animal Studies
All animal care and preparation, whole kidney measurements, and micropuncture studies were per-
formed by Dr. Sharon Anderson and Julia L. Troy at the Laboratory of Kidney and Electrolyte
Physiology at Brigham and Women's Hospital.
4.2.2.1 Animals
Sixteen healthy male Munich-Wistar rats with weights ranging from 240-306 g were used in these
studies. All were fed ad libitum standard rat chow (Wayne Rodent Blox, Allied Mills, Chicago, IL)
containing 24% protein by weight and allowed free access to water. Sieving measurements were
performed in each animal using either radiolabeled dextran (7 animals) or Ficoll (9 animals) as the
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infused tracer. Micropuncture measurements of single nephron pressures and flows were performed
immediately before the sieving studies in eight of the animals (2 with dextran, 6 with Ficoll).
4.2.2.2 Surgical Preparation
The rats were anesthetized with Inactin (100 mg/kg i.p.) and placed on a temperature-regulated
table. The left femoral artery (FA) was catheterized with a polyethylene tube (PE-50 Clay Adams,
Parsippany, NJ), and a baseline collection of blood was obtained for hematocrit and inulin "blank"
measurements. The FA catheter was used for subsequent periodic blood sampling, for the continuous
arterial collection of dextran or Ficoll tracer, and for estimation of mean arterial pressure (AP) via
an electronic transducer connected to a recorder. A tracheostomy (PE-240) was performed, and
PE-50 catheters were inserted into the left and right jugular veins for infusions of inulin, para-amino
hippurate (PAH), plasma, and radiolabeled tracer. The left kidney was exposed and suspended on
a lucite holder, and its surface was illuminated and bathed with isotonic saline. The left ureter was
catheterized (PE-10 Clay Adams) for urine collections.
Since the rats lose approximately 20% of their plasma volume in surgical preparation, 135 euv-
olemia was maintained using the following protocol: isoncotic rat plasma was infused at 0.1 ml/min
to a volume equal to 1% of the body weight, followed by a sustained infusion rate of 1.6 ml/kg/h
for the duration of the experiment. Intravenous infusions of 10% inulin + 0.8% PAH in 0.9% NaCl
at 1.2 ml/h were started one hour before measurements and continued through the experiment.
4.2.2.3 Whole Kidney Hemodynamic Measurements
FA blood samples were obtained for determination of hematocrit and plasma concentrations of
protein (Cp,A), inulin, and PAH. Timed urine collections were obtained for determination of flow
rate and inulin and PAH concentration. These measurements permitted calculation of GFR (from
inulin clearance), RPF (from PAH clearance), and FF (= GFR/RPF).
4.2.2.4 Micropuncture Measurements
In the animals subjected to micropuncture, timed samples of tubule fluid were collected from su-
perficial proximal tubules for determination of flow rate and inulin concentration and calculation of
SNGFR. Blood samples from efferent arterioles were obtained for determination of the efferent pro-
tein concentration (Cp,E). The FA measurements described above were used for glomerular afferent
arteriole values. From these, single nephron filtration fraction (SNFF) and glomerular plasma flow
rate (QA) could be calculated.
Time-averaged hydraulic pressures were measured in surface glomerular capillaries (PGc), prox-
imal tubules (PT), and efferent arterioles (PE) with a servo-null micropipette transducer system
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(Instrumentation for Physiology & Medicine, San Deigo, CA). The glomerular transcapillary hy-
draulic pressure difference was calculated as AP = PGC - PT.
4.2.2.5 Tracer Infusion and Collection
Immediately after the micropuncture measurements had been completed, a 0.4 ml bolus of isotonic
saline solution containing either tritiated dextran or Ficoll of broad molecular size distribution
(dextran concentration < 100 mg/dl, specific activity & 50 tCi/ml; Ficoll concentration < 700
mg/dl (estimated assuming 70% of the original Ficoll was recovered in the labeled stock solution),
specific activity m 110 gtCi/ml) was infused intravenously over 1.5 min, followed immediately by a
constant infusion of the same solution at the rate of 1.2 ml/h.
The oncotic pressure due to the tracer can be approximately calculated using the estimated Ficoll
concentration of 700 mg/dl (which is a conservative upper bound). Using an average time of an
hour for an experiment, the total amount of tracer infused is (700 mg/dl x 0.4 ml) + (700 mg/dl
x 1.2 ml/h x 1 h) = 11.2 mg. Assuming the total plasma volume of a 0.265 kg rat is proportional
to that of a 70 kg man with a hematocrit of 45 and circulating volume of 6 1, plasma volume = 6 1
x(1-0.45) x 0.265/70 = 0.125 dl. The maximum possible tracer concentration is then 11.2 mg/0.125
dl ~ 0.1 g/dl, which is just low enough to have a negligible effect on total oncotic pressure.
Ten to fifteen minutes after the the priming bolus, a continuous FA blood collection was begun at
a rate of 24 til/min for 15 minutes. These samples were drawn into capillaries containing heparinzed
saline. Urine collection were initiated and terminated 1.5 minutes after the arterial blood collections,
to allow for transit time from Bowman's space to the tip of the ureteral catheter.
The FA sample was spun at 3000 rpm in a refrigerated centrifuge (Sorvall Model RT6000B,
DuPont, Wilmington, DE) to remove cells, yielding a supernatant plasma volume of approximately
150 /l. Duplicate aliquots of 25-75 utl of FA plasma or 50-100 p1 of urine were added to 1 ml of 2
mg% blue dextran (Sigma Chemical Co., St. Louis, MO). These samples were then fractionated and
counted as described in Section 4.2.3.
4.2.2.6 Analytical Methods
The volume of fluid collected from individual proximal tubules was estimated from the length of the
fluid column in a constant bore capillary of known internal diameter. Tubule inulin concentration was
measured by the micro-fluorescence method of Vurek and Pegram.25 0 Inulin concentrations in plasma
and urine were measured using the macro-anthrone method of Fiihr et al.10 3 Protein concentrations
were determined using the fluorometric method of Viets et al.2 4 8 PAH concentrations were measured
by the method of Chasis et al.65 Colloid osmotic pressure of plasma entering and leaving glomerular
capillaries was estimated from Cp,A and C,E using the equation of Deen et al.8 4
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4.2.3 Fractionation of Radiolabeled Plasma and Urine Samples
Labeled plasma or urine samples was drawn into a syringe, and the empty vial was rinsed twice with
a volume of 0.5 ml distilled water. The rinsings were added to the sample. The total 2-ml volume
was fractionated on a Sephacryl S-300 HR column (Pharmacia) which had been calibrated with
polymer standards as described in Chapter 3. The eluent buffer was 0.05 M ammonium acetate at
pH 7, and the method of operation was as described in Section 3.5.3. The samples were fractionated
into 3 ml aliquots, and 2 ml from each aliquot was mixed with 4 ml of scintillation fluid (Ultima
Gold, Packard Instrument Co., Inc., Downers Grove, IL). Activity was measured in a scintillation
counter (Tri-Carb Model 4530, Packard Instrument Co.). Based on an analysis of the minimum
significant activity above background, cpm rates below 120 were rejected (see Appendix C).
4.2.4 Calculation of Sieving Coefficients
It has been shown previously using relatively monodisperse dextran62 or Ficoll s1 samples that there
is close agreement between values of E9 obtained from Bowman's space collections and from urinary
fractional clearances in the same animal. Sieving coefficients from plasma and urine activity were
calculated from
3 - (U/P)iul x f', (4.1)
f' = -0.007895Cp,A + 0.9916, (4.2)
where (U/P)pm is the urine-to-plasma ratio of scintillation counts per unit volume of sample,
(U/P)inuin is the urine-to-plasma ratio of inulin concentration, and f' is a plasma volume correction
factor which accounts for the fact that the inulin plasma concentrations were measured in protein-free
plasma water, while the labeled plasma samples contained protein. A typical value for f' was 0.95.
Finally, O was calculated at integer values of r, from the raw sieving curve using the interpolation
scheme of Akima.3 4
4.2.5 Data Analysis
The approximate method of Deen et al.7 9 was used to fit membrane pore parameters to heteroporous
models. Modifications to the numerical method which reduced computation time are discussed in
Appendix B.
Several hypothetical pore-size distributions were considered. The isoporous + shunt and lognor-
mal models79 are the most frequently employed in the literature. Briefly, the isoporous + shunt
model is described by the parameters ro and wo, where ro is the radius of the overwhelming ma-
jority of the pores, while w describes the fraction of the volume flux transported through a tiny
number of pore of effectively infinite size ("shunt" pores). The lognormal distribution is described
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by parameters u and s, where the pore-size probability distribution g(r) is given by
1 (ip [1ln(r/) 2\
g(r) =exp - n (4.3)
rlns (2 L Ins 
Here we introduced two new models, logical extensions of the previous two. The lognormal
+ shunt model assumes a small number of infinitely large pores in conjunction with a lognormal
distribution, using parameters u, s, and wo0 .
The double lognormal model assumes two populations of pores each distributed lognormally, with
a parameter q2 indicating the fractional number of pores from the second distribution. Then
() = 2 ex 2 nr/u) 2 -exp in(r/u 2)]) (44)
r In sv L ex lnsj + r ns 2 v/ exp lns2
and g(r) is the pore probability distribution function discussed in Chapter 2. Issues pertaining to the
use of the approximate model for the lognormal + shunt and double lognormal models are discussed
in Appendix B.
(A third new model, an intermediate of the lognormal and double lognormal models, was briefly
examined. This model had parameters u, sl, 2, and q2 where
1 - q2 ( ln(r/U) + q2 1 [ln(r/u)J2
r In slV 2 In sl , +r 2 -2 exp 2 In S2 ' (4.5)
It was discarded because fitting results were indistinguishable from the lognormal distribution.)
Powell's method2 0 6 was used to fit the pore parameters for a given model by minimizing X2 ,
defined as
m 1- - -- 2
x2 =i (i,exp i,calc (4.6)
where m is the number of data points, ei,exp and ei,ci,, are the experimental and calculated sieving
coefficients, respectively, for molecular size i, and ai,,xp is the standard error of Oi,exp.
Standard errors orj for each fitted parameter aj were estimated by20 6
j = lCj, (4.7)
where Cjj are the diagonal elements of the covariance matrix C of the fit with respect to the
parameter vector a:
C = a-l (4.8)
i=kl [ aa aa (4
i=1 ' Ok 9a
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The partial derivatives were calculated numerically using a finite-difference scheme. This method
assumes that the model can be approximated linearly near the optimization point, and tends to
underestimate the true value of the standard error.
Statistical comparisons between two groups were made using the unpaired two-sample Student's
t-test. Comparisons between more than two groups were made by analysis of variance, with Scheffe's
test used to determine conservatively if values were significantly different and Tukey's test used to
determine conservatively if values were not significantly different. [220, pp. 941-948]
4.3 Results
4.3.1 Hemodynamic Data
The mean values of various systemic and whole kidney quantities are shown in Table 4.1 for the
rats given dextran, those given Ficoll, and the two groups combined. There were no statistically
significant differences in body weight, hematocrit, GFR, FF, or Cp,A between the dextran and Ficoll
groups. There were modest differences in RPF (20%) and AP (10%) between the two groups which
did achieve statistical significance. As will be discussed, a difference in RPF of this magnitude is
expected to have little effect on the measured dextran or Ficoll sieving curves.
The single nephron quantities obtained in the 8 rats which underwent micropuncture are sum-
marized in Table 4.2. The value of the single nephron glomerular ultrafiltration coefficient (Kf)
computed from the data in the "total" column of Table 4.2 was 4.25 nl/min/mm Hg. All of these
values are within typical ranges for normal euvolemic Munich-Wistar rats in this laboratory. Because
of this, and the aforementioned similarities in whole kidney hemodynamics quantities, the data in
the "total" column of Table 4.2 were taken as representative of the entire group of rats studied
(including those which did not undergo micropuncture).
4.3.2 Sieving Data
The sieving coefficients (fractional clearances) measured for dextran and Ficoll are shown in Table 4.3
and Figure 4-1. As the Stokes-Einstein radius (r,) increased from 19 to 65 A e for dextran decreased
from 7.1 x 10-1 to 7.7 x 10-3; the corresponding range of e for Ficoll was 3.3 x 10- 1 to 7.1 x 10 - 4 .
At any given value of r,, e for dextran greatly exceeded that for Ficoll, with a nearly constant
dextran-to-Ficoll ratio of 10 for r, > 30 A. The differences between dextran and Ficoll were
highly significant (p < 0.01) for all molecular radii examined. The differences in log(e) between the
groups, which is a more valid comparison as - 0, are even more significant (p < 0.0001).
4.3.3 Pore Size Parameters
The membrane pore parameters derived from the dextran and Ficoll data are shown in Table 4.4.
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SNGFR (nl/min)
QA (nl/min)
SNFF
AP (mm Hg)
Cp,A (g/dl)
Dextran
(n = 2)
58.0±4.0
191+20
0.30±0.01
37.0±2.9
5.2±0.2
Ficoll
(n=7)
47.0±3.4
166±14
0.29±0.01
32.7±1.6
5.2±0.1
Total
(n = 9)
49.8+3.2
172±12
0.29±0.01
33.8±1.5
5.2±0.1
Table 4.2: Single nephron pressures and flows for dextran- and Ficoll-infused normal Munich-Wistar
rats rats. All values shown are mean ± one standard error.
r () Dextran (n=7)
19 7.06 x 10-1±8.72 x 10-2
21 5.74x 10-1i7.65x 10 - 2
23 4.81 x 10-1±8.02 x 10- 2
25 3.72 x 10-1±6.94 x 10-2
27 2.84x 10-1±5.57 x 10- 2
29 2.16 x 10- 14.26 x 10- 2
31 1.64 x 10-1±3.36 x 10-2
33 1.35 x 10-1±3.34 x 10-2
35 8.94 x 10- 21.89 x 10 - 2
37 6.99 x 10-2±1.45 x10-2
39 5.26 x 10- 2±1.05 x 10-2
41 4.18 x 10-2I8.11 x 10- 3
43 3.03 x 10- 2±6.12 x 10-3
45 2.34 x 10- 2± 4.03 x 10- 3
47 2.14 x 10- 2 /3.56 x 10- 3
49 1.80 x 10-2±2.95 x 10-3
51 1.55 x 10- 2±2.43 x 10- 3
53 1.36 x 10-2±2.06 x 10-3
55 1.18 x 10-2±1.78 x 10- 3
57 1.05 x 10- 2±1.61 x 10-3
59 9.46 x 10-3±1.54x 10-3
61 9.00 x 10-3-1.48 x 10- 3
63 8.34x 10-3±1.41 x 10- 3
65 7.71 x 10-3±1.33 x 10-3
Ficoll (n=9)
3.28 x 10-1±3.68 x 10-2
2.01 x 10-1'2.66 x 10-2
1.20x 10-1±1.80 x 10-2
7.39 x 10-2±1.25 x 10-1
4.09 x 10-2±8.09 x 10- 3
2.65 x 10- 24.61 x 10- 3
1.65 x10-2±3.05x 10- 3
1.13 x10-2±2.19 x10 - 3
8.15 x 10-3±1.71 x 10- 3
6.04x 10-3±1.35 x 10- 3
4.79 x 10- 3±1.10 x 10- 3
3.76 x 10-3±9.06 x 10-4
3.32 x 10-3±8.50x 10- 4
2.57 x 10-36.79 x 10 - 4
2.23 x 10-3±5.96x 10- 4
1.94 x 10-3±5.27 x 10- 4
1.66 x 10-34.53 x10 - 4
1.41 x 10-3±3.74 x 10- 4
1.23 x 10-33.30x 10- 4
1.10x 10-323.11 10- 4
9.75 x 10-4±2.62 x 10- 4
8.68x 10-4±2.27 x 10- 4
7.83x 10-4±2.01 x 10- 4
7.10 x 10-41.72 x 10- 4
Table 4.3: Sieving coefficients for dextran- and Ficoll-infused normal Munich-Wistar rats. All values
are given as mean ± standard error.
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Figure 4-1: Sieving coefficients (0) for dextran- and Ficoll-infused normal Munich-Wistar rats as
a function of molecular radius (r,). Error bars denote ± one standard error of the mean. Curves
plotted are fits of various heteroporous distribution models to the data as described in the text.
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Isoporous ro (A) 44.341.1 29.1±0.8
+shunt wo x10- 3 5.02±0.55 5.26±0.12
Xz 103 208
Lognormal u (A) 15.4±1.7 6.19+1.53
s 1.52±0.03 1.64±0.06
r* (5%) (A) 61.7 37.2
r'(1%) (A) 82.1 52.1
Xz 35.4 64.6
Lognormal u (A) 20.8±0.4 11.4±0.1
+shunt s 1.40±0.01 1.46±0.01
wo x 10 - 3 3.04±0.10 0.382±0.035
r' (5%) (A) 58.0 37.6
r*(1%) (A) 78.8 49.0
X~ 1.05 12.5
Double ul (A) 20.8±0.4 0.46±0.06
Lognormal s, 1.40±0.01 2.31±0.03
u2 (A) 104±72 24.1±1.2
82 1.90±0.79 1.20±0.02
q2 x 10- 6 1.01±1.04 22.2±9.9
r (5%) (A) 56.9 30.4
r* (1%) () 71.5 53.8
Xz 1.05 0.37
Table 4.4: Membrane pore parameter fits of dextran vs. Ficoll sieving coefficients to single nephron
hemodynamic values. Fitted values are shown ± one standard error.
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The calculations used the single nephron quantities given in Table 4.2, as well as the sieving data
of Table 4.3. The fits for each model are graphically compared to the data in Figure 4-1. Based
on the visual appearance of the curve fits and on the values of x2 , the isoporous + shunt model
provided the poorest fit to either set of data, although it was much better for dextran than for
Ficoll. The values of ro and wo for Ficoll were much smaller than those for dextran, reflecting
the smaller sieving coefficients for Ficoll. The lognormal pore-size distribution, which also contains
two parameters, performed better than the isoporous + shunt model in either case. However, the
lognormal distribution become noticeably less accurate at large or small r, than at intermediate r,
(Figure 4-1).
Additional improvements in goodness of fit were obtained with the lognormal +shunt model.
Although any lognormal distribution theoretically includes some shunt-like pore of infinite size, for
the parameter values in Table 4.4 (u = 20.8 A and s = 1.40 for dextran, u = 11.4 A and = 1.46 for
Ficoll), the contributions to 9 of pores over 100 A were calculated to be negligible. Thus, adding
a shunt to the lognormal distribution did not lead to any appreciable double counting of very large
pores. The values of w0o obtained from the lognormal + shunt model were fairly similar to those
from the isoporous + shunt case. With either type of shunt model, the value of w0 calculated for
Ficoll was . 1/10 that for dextran.
The double lognormal model showed still more improvement in X2 over the lognormal + shunt
model. For dextran, ul and sl for the double lognormal model were exactly equal to u and s for the
lognormal distribution, indicating that the second lognormal distribution was the functional equiva-
lent of a shunt. X2 did not improve for dextran, indicating that the double lognormal model afforded
no advantage over the lognormal + shunt model. For Ficoll, the improvement was substantial. The
Ficoll double lognormal parameters also indicated a predominate number of pores of one distribution
(q2 < 1) but there was little resemblance to the lognormal or lognormal + shunt results. A double
lognormal fit of the Ficoll data fixing ul and sl at the lognormal fit values (11.4 and 1.46) gave
u2 = 102, s2 = 1.64, q2 = 2.52 x 10- 7, and x2 = 9.3.
Because of the difficulty in relating u and s in terms of the net number of large pores, Remuzzi et
al.210 developed the concept of an r*(V) value, where V is defined as the fraction of volume filtrate
passing through pores of r > r*:
V = g(r)d (4.10)
For the lognormal + shunt model, V is defined as
V = r4 g(r)d (1 - (w)) + (w), (4.11)fo r 4 g(r)dr
where (w) is the fraction of the filtrate that passes through the shunt. Typically, r*(5%) and r*(1%)
values are reported. As expected, r' values were considerably smaller for Ficoll than for dextran
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Dextran Ficoll
Enhanced model:Simpler model pvalue pvalue
Lognormal+shunt:L;ognormal 3 x 10 - 7X ' x 10-
Double lognormal:Lognormal+shunt N.S. 6 x 10-15
Table 4.5: F-test comparisons of heteroporous model fits to dextran vs. Ficoll data. p values are
those for the significance of the x2 reduction by the "enhanced" model over the "simple" one. N.S.=
not significant.
(Table 4.4).
The performance of the various heteroporous models was compared objectively by an F-test,
which weighs the trade-off between lowering X2 and increasing the number of parameters.' 8 4 The
F-test results, given in Table 4.5, indicate that the improvement of the lognormal + shunt model
over the lognormal distribution is significant in both cases, but that the improvement provided by
the double lognormal model is significant only for Ficoll.
Pore-number probability densities for g(r) and the integral volume flux 1 - V are plotted for
the different distributions in Figures 4-2 and 4-3. In all cases, the number of pores of the shunt or
second distribution are so small that they contribute little to g(r) or to volume flux.
4.3.4 Sensitivity of Calculations to Hemodynamic Inputs
To determine the sensitivity of the pore-size parameters to the hemodynamic inputs used in the
calculations, we employed four different sets of inputs. The single nephron values shown in Table 4.2,
which were used to obtained the parameter values in Table 4.4 and the theoretical curves in Figure 4-
1, are denoted as Case 1. Cases 2-4 were based on various choices for the pertinent whole kidney
quantities (GFR, RPF, and Cp,A). Case 2 used the whole kidney data averaged for all animals
studies (right-hand column of Table 4.1). Cases 3 and 4 differed from Case 2 only in the assumed
value value of RPF. The average RPF for the dextran group (4.8 ml/min) was used in Case 3, while
the average RPF for the Ficoll group (4.0 ml/min) was used in Case 4. In each case the value of
AP employed was that obtained from micropuncture.
The range of each membrane-pore parameter obtained from the four cases is shown in Table 4.6.
In general, changing the hemodynamic inputs results in only minor variations in the computed pore-
size parameters. The similarity of the results for Case 1 to those for Cases 2-4 indicates that the
choice of single nephron vs. whole kidney hemodynamic inputs does not affect the trends observed
in the pore-size parameters. Likewise, the similarity between Cases 3 and 4 demonstrates that the
measured difference in RPF between the dextran and Ficoll groups also has a negligible effect on
the computed pore sizes.
The possible significance of the measured difference in RPF between the dextran and Ficoll
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Figure 4-2: Pore number density distributions g(r) for dextran and Ficoll heteroporous fits to data.
Plots are based on the values of Table 4.4. Curves for dextran lognormal + shunt and double
lognormal models are indistinguishable. Ficoll double lognormal curves appears to merge with the
dextran lognormal + shunt and double lognormal curves around r, = 6 . The curves are actually
separate with one going to zero and the other two rising from zero.
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Figure 4-3: Integral volume flux (1- V) for dextran and Ficoll heteroporous fits to data. Plots based
on the values of Table 4.4. Curves for dextran lognormal + shunt and double lognormal models are
indistinguishable.
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1 2 3 4 1 2 3 4
Isoporous TO (A) 44.3 45.1 45.5 44.8 29.1 29.7 30.0 29.5
+shunt wo x103 5.02 5.86 6.22 5.52 0.526 0.617 0.657 0.579
Lognormal u (A) 15.4 12.6 12.7 12.7 6.19 5.03 6.18 6.19
8 1.52 1.58 1.58 1.58 1.64 1.70 1.64 1.64
Lognormal u (A) 20.8 20.8 20.8 20.8 11.4 11.4 11.4 11.4
+shunt s 1.40 1.40 1.40 1.40 1.40 1.46 1.46 1.46 1.46
w0 x103 3.04 3.54 3.75 3.34 0.382 0.452 0.479 0.424
Double ul (A) 20.8 21.6 21.7 21.4 0.46 0.46 0.46 0.46
Lognormal sl 1.40 1.39 1.38 1.39 2.31 2.31 2.31 2.31
U2 (A) 104 103 102 103 24.1 24.3 24.4 24.3
s2 1.90 1.89 1.88 1.89 1.20 1.20 1.20 1.20
q2 x106 1.01 1.22 1.29 1.18 22.2 22.2 21.4 22.2
Table 4.6: Sensitivity of parameter fits to hemodynamic inputs. Case numbers correspond to values
reported in the text.
groups was also considered in terms of its expected effect on the sieving curves. To do this, we chose
as a reference condition the theoretical sieving curves obtained by fitting the dextran or Ficoll data
(with single nephron hemodynamic inputs) with the isoporous + shunt, lognormal, and lognormal +
shunt models. We then varied QA by ±: 10% from the reference value of 172 nl/min, for both dextran
and Ficoll. The resulting set of sieving curves encompasses a variety of situations, including up to a
20% difference in plasma flow rates between the dextran and Ficoll groups. As shown in Figures 4-4
and 4-5, altering QA had relatively minor effects on the computed sieving curves, and the range of
sieving coefficients for dextran remained very distinct from that for Ficoll. This demonstrates that
variations in plasma flow rate of this magnitude are incapable of explaining the large differences in
the observed sieving behavior of the two polymers.
4.4 Discussion
The present study confirms the finding of Bohrer et al.31 that, for a given value of r,, dextran passes
across the glomerular capillary wall more readily than does Ficoll. While qualitatively similar to the
earlier results, the present data show a significantly greater separation between the sieving curves
for dextran and Ficoll. One factor which may have contributed to these quantitative differences is a
difference in experimental design. The study by Bohrer et al.3 ' involved two experimental periods in
each animal, one with dextran and one with Ficoll. The order of the dextran and Ficoll infusions was
varied and an effort was made to wait long enough between the experimental periods to allow the
first polymer to be cleared completely. Nonetheless, a small amount of the tritiated polymer from
the first period may have been present during the second. This would tend of minimize the observed
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Figure 4-4: Sensitivity of theoretical sieving curves to changes in QA for isoporous + shunt and
lognormal models.
72
I I I ' I I I I I I I I . I I I I 
ran
Lognormal
1' UUJ]
I I I I , I , I , , , I , , , ,] . . . . . . . . . . . . . - - - - - - - - -
I I1
10' I
10- 2
10 -3
10-4
10 °
10-t
0) 10- 2
10- 3
10- 4
- I I I I I I I I I I I I I I I I I I I I I I -
20 30 40 50 60 70
r (A)
Figure 4-5: Sensitivity of theoretical sieving curves to changes in QA for lognormal + shunt and
double lognormal models.
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differences between dextran and Ficoll, especially for the largest molecules, which are cleared more
slowly. To avoid this potential problem in the present study, we deliberately chose to study dextran
and Ficoll in separate groups of animals. This was especially important because the present study
included molecular radii up to 65 A, whereas that of Bohrer et al.s l did not go beyond 44 A.
A second possible explanation is suggested by the observation that, while dextran values for this
study are comparable to that of Bohrer et al.,3' the Ficoll values of the present work are consid-
erably lower. This would be consistent with a hypothesis of some sort of reversible or irreversible
adsorption to the Sephacryl columns of this study relative to the Sephadex columns of Bohrer et
al.3 l This possibility motivated the work described in Chapter 3, in which it was shown that Ficoll
chromatography in both Sephadex and Sephacryl columns was not concentration dependent, and
thus polymer absorption plays no discernible role in Ficoll elution.
For dextran radii up to approximately 40-50 A the values of O obtained by us are comparable to
those reported previously for normal rats. 30 ,31 ,63,1 9 8,210,2 52,2 61-26 3 For larger dextran sizes, however,
the present values of O begin to exceed those in other studies,l 98 ,210, 252, 26 1-26 3 reaching more than
a ten-fold difference at r, = 60 A. The reasons for this discrepancy are not clear, but a contributing
factor may have been differences in gel column calibration. As discussed in Chapter 3, the customary
use of protein standards for column calibration may lead to errors in the molecular radius of dextran
(or other non-protein polymers such as Ficoll), the magnitude of the error being dependent on the
column packing material. To avoid this source of error, we employed nearly monodisperse samples
of dextran or Ficoll for column calibration, with r, determined for each standard by quasielastic
light scattering. Because different column packings were employed in the various studies cited
above, the correction factors of Chapter 3 are not applicable, and we are unable to estimate the
extent to which this factor may have contributed to the discrepancies in O for dextran. Of course,
physiological differences among the groups of animals studies, or other technical differences, may
also have contributed.
The diffusion rates of Ficoll through synthetic membranes of known pore radius suggests that
Ficoll molecules behave as ideal, neutral, rigid spheres.3 2 ,71 Given that Ficoll is uncharged, that its
crosslinked structure should confer rigidity, and that sedimentation and viscosity data suggest that
it is approximately spherical,3 l this behavior is not unexpected. In contrast, the diffusion rates of
dextran through the same synthetic membranes have been found to greatly exceed theoretical pre-
dictions for neutral spheres. There appears to be no simple explanation for the behavior of dextran.
The most obvious difference between dextran and Ficoll is that whereas Ficoll is crosslinked and ap-
proximately spherical, dextran is flexible and roughly linear, existing in solution as an approximately
random coil. The available theory for neutral random coils, 7 2 however, suggests that the observable
rate of transmembrane diffusion should be less rapid, not more rapid, than that of a neutral solid
sphere of equivalent r,. Consistent with this prediction is the finding that the effective diffusivity
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of PEG in track-etch polycarbonate membranes is lower than that of Ficoll. 7' The anomalous en-
hancement of dextran diffusion rates might be explained by weak attractive interactions between
dextran and the membrane material, which would tend to elevate dextran concentrations in mem-
brane pores. 71 ' 74 Whatever the explanation, the relative rates of dextran and Ficoll diffusion through
synthetic membranes mimic the behavior of these polymers in the glomerulus.
The structure of Ficoll, and its diffusion behavior in vitro, suggest that it may be a much better
marker than dextran for the glomerular filtration of neutral, globular proteins. Supporting this is
our finding that the ratio of O for Ficoll to O for dextran at r, = 30 A is x 0.11. This value is
very similar to the analogous sieving coefficient ratio for a neutral globular protein of ~ 30 A radius
(horseradish peroxidase) and dextran.2 1 6 With regard to IgG, a group of molecules with r, : 55 A
and little net charge on average, less precise comparisons are possible because O for IgG has not been
determined simultaneously with that for Ficoll or dextran. Our value for O for Ficoll at r, = 55 A
(1.23 x 10- 3) is roughly comparable to that reported for IgG in rats (5 x 10-3), the latter value based
on tubule fluid samples.' 0 4 Thus, the available evidence in vivo supports the view that Ficoll is a
good marker for filtration of neutral proteins. The aforementioned value of O for Ficoll at r, = 55 A
provides a much more satisfactory explanation for the normal absence of immunoglobulinuria than
does the ten-fold higher values of O for dextran.
Analyses of tubule fluid samples obtained by micropuncture in rats suggests than 0 a 3 x 10- 4
for serum albumin.14, 22 , 94 ,9 8 , 104,10 5 ,16 1,164 ,16 6 ,193-1 9 5,2 35,24 9,2 64 This is about 30 times lower than
the present value of O for Ficoll at this molecular size (r, = 35 A) and about 300 times lower than
the value of e for dextran. The fact that this negatively charged protein is filtered much less readily
than Ficoll is consistent with the concept that the normal absence of albuminuria is dependent in
part on the charge-selectivity of the glomerular barrier. The present results, however, imply that the
concentration of fixed negative charges in the glomerular capillary wall does not need to be as large
as previously reported.78 That is, attempting to explain the 300-fold difference between albumin
and dextran on the basis of charge alone requires that one postulate many more fixed charges than
are needed to account for the 30-fold difference between albumin and Ficoll. While it remains likely
that a loss of charge-selectivity would contribute significantly to albuminuria, the results for Ficoll
set a new and lower bound on the potential contribution of charge defects to proteinuria.
Previously, a variety of theoretical pore-size distributions were compared using fractional clear-
ance data for dextran in normal and nephrotic humans.7 9 In those comparisons the isoporous +
shunt model was somewhat superior to the lognormal distribution. For that reason, and because
the values of T0 and w0 have a simpler interpretation than those of u and , the isoporous + shunt
model has been preferred in subsequent clinical studies with dextran. The curve-fitting results in
Table 4.4 and Figure 4-1 indicate that for the present data the double lognormal and lognormal
distributions are superior to the isoporous+shunt model. Remuzzi et al.2 10 had previously reached
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the conclusion that the lognormal model was superior to the isoporous +shunt model based on fits
to dextran data in rats. It is less easy to judge whether the double lognormal and lognormal + shunt
models, introduced here, offer a significant improvement over the lognormal distribution. The newer
models have more degrees of freedom (5 and 3 parameters vs. 2 for the other models) and should
yield smaller values of the error measure, x2, on that basis alone. The F-test results of Table 4.5
indicate that this improvement is statistically significant for the lognormal + shunt model with both
sets of data, and for the double lognormal model with Ficoll, but not for the double lognormal model
and dextran.
Another way to judge the performance of the models is to consider the values of X2 in relation
to the number of data points per sieving curve, m. Based on the definition of x2 (Eq. 4.6), if
the computed sieving coefficients differed from the measured values by exactly one standard error
at all molecular sizes, then X2 = m. If one accepts that fitting the experimental sieving curves
more accurately than this is probably not meaningful, then one should discount the importance of
achieving values of X2 < m. In the present study m = 24, and the lognormal + shunt model reduced
X2 from 35.4 to 1.05 for dextran, and from 64.6 to 12.5 for Ficoll, relative to the lognormal model
(Table 4.4). Thus, by this measure, the improvement obtained with the lognormal + shunt model for
dextran is probably unimportant. However, the improvement seen for Ficoll is more significant. We
therefore conclude that the lognormal + shunt model merits further examination in future studies,
at least with Ficoll. By the same token, the improvement provided by double lognormal model is
probably not important. Combined with the fact that it was more difficult to achieve convergence
with the double lognormal model, it appears that there is not enough justification to further pursue
this distribution in any detail.
The alternative theoretical models for the glomerular barrier considered here are highly idealized,
in that they are all based on the concept of hindered transport of neutral spheres through cylindrical
membrane pores. We have discussed above the evidence from studies in vitro that Ficoll does in
fact closely resemble an ideal, neutral sphere. It seems likely then that the opportunities for future
advances in the description of Ficoll movement through the glomerular capillary wall lies much more
in a closer representation of the actual ultrastructure of the barrier than in some improvement in
the representation of the permeating molecule. Because Ficoll behaves much like an ideal sphere,
and because it possesses the other desirable characteristics for an in vivo tracer which have led to
the widespread use of dextran, we recommend that Ficoll be preferred over dextran in future studies
of glomerular size-selectivity.
The situation with dextran is much more complicated, in that currently available models are
unable to predict its transport rates even in synthetic membranes with well-defined pores of known
size. In Chapter 5, we examine one proposed mechanism for dextran transport and apply it to the
data of this section.
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Chapter 5
Application of the Random Coil Model of Hindered
Transport to Dextran Sieving Data
5.1 Chemical Structure of Dextran
The representation of dextran molecules as solid spheres in the model of glomerular permselectivity
is a simplification born of the previous lack of suitable hydrodynamic theories for any other type
of configuration. Since a dextran is a chain of a-1,6-D-glucopyranose monomers, it would be more
properly modeled as a flexible linear coil. The consequences of this difference can be expected to
be significant since a sphere cannot penetrate a pore with a smaller radius, while a flexible chain
will have some finite probability of access even if the pore radius r0o is much smaller than the chain
radius of gyration rg. Additionally, a coiled polymer would be permeable to solvent flow, which
would lower the frictional drag on the molecule. Such configurational effects are proposed to be the
principal reason why sieving data of different probe molecules vary substantially.31 , 139 ,216,246
As discussed in Section F.2.6, chemical analysis of dextran's structure indicates that it is a linear
molecular with only a small number of branches. Measurements of its physical properties, however,
suggest that dextran in aqueous solution behaves as a molecule with a significant degree of branch-
ing. From thermodynamic excess properties and intrinsic viscosity, dextran exhibits properties of a
random coil at molecular weights of around 2000.14 It appears that whatever effective contraction of
the molecular dimensions exists due to branching is counterbalanced by the excluded volume effects
resulting from expansion of dextran in water. Thus, though it is not strictly a theta system, dextran
in water at 20-25 C exhibits the behavior of a linear molecule with no excluded volume.
5.2 Review of Previous Theoretical Work
5.2.1 General Approach
Departures from the hydrodynamic theory for solid spheres will be manifested in the model as
alternate forms of expression for the diffusive hindrance factor H and the convective hindrance
factor W in Eq. 2.14. In their most general form, the hindrance factors for very dilute polymer
solutions in a long cylindrical pore are defined by
H 2 K-1(A )p( ) d, (5.1)
V = 41 G(A,)p(A,i )(1 - 2)rdf, (5.2)
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where A is the molecule-to-pore size ratio (usually either A, = r,/r or Ag = rg/ro, where rg is the
root-mean-square radius of gyration), is the dimensionless radial position of the molecule's center
of mass (or some other locator point), and p is the probability that the molecule will fit completely
within the pore at . K is the enhanced drag, defined as the ratio of the frictional drag on the
molecule in the pore to that in bulk solution. G is the lag coefficient, the ratio of particle-to-fluid
velocity at an equivalent radial position. Each of these quantities is an average over all possible
chain conformations.
In practice, "centerline" approximations are used, where the radial dependence of the hydrody-
namic coefficients is ignored and replaced by the value at = 0:
H K-'(A,0) 2j p(A, fidr = K-(A,0)t, (5.3)
G G(A, 0).4 A p(A, )(1 - 2)f di = G(A, O)f2, (5.4)
where
) = 2 Aj p(A, )(1- 2 ) d d. (5.5)
-- _-- 4 p(A, f)(1 _ i2)f d.. (5.6)
4 is the partition coefficient, which equals the ratio of the average solute concentration in the pore
to that in bulk solution at equilibrium. (Q is an analogous coefficient for the flow-weighted average
radial distribution. Each hindrance factor is then seen to be the product of a hydrodynamic term
(K - l or G) and a steric term (I or Q). For non-interacting solutes, /I, Q, K-l, and G all equal 1
in the limit A - 0. In the limit of large A, c4, Q, and K - 1 approach 0 and G approaches 0.5. The
next sections review methods for calculating steric and hydrodynamic factors for random coils.
5.2.2 Calculation of Steric Parameters
5.2.2.1 Monte Carlo Method
Davidson et al.74 developed a method for calculating and O for random-flight chains based on
Monte Carlo-generated ensembles of chain configurations. A chain is characterized by 1, the length of
a chain segment, and n, the number of chain segments. (Davidson et al.70 ' 74 defined n as the number
of mass points in the chain, thus their n is equal to n+ 1 of this work.) For large n, rg n2/6. 2s59
The advantage of this method is that, in theory, it can be applied to any combination of chain and
pore parameters. Practically, computational limits preclude its use for very large chains: Davidson
et al.74 obtained results for Ag < 1.2 and n + 1 < 400. Results are available only in tabular form, as
there is no satisfactory means of expressing the data analytically.
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5.2.2.2 Diffusion Equation Model
Casassa5 ' devised a method for calculating a' in the limit n - oo (= OO) based on the analogy
between a random walk of infinitesimal step size and molecular diffusion. This "diffusion equation"
approach has the principal advantage of providing a closed-form expression for '. Casassa's result
is
4ZE e (5.7a)
Jo(/3 ) = 0, (5.7b)
where /3, are the roots of the characteristic equation given by Eq. 5.7b and Jo is the Bessel function
of zeroth order. An asymptotic approach to LO is seen as n increases in the results from Monte
Carlo simulations. 70 , 74
A major disadvantage of the diffusion equation model is that ~ is very sensitive to n, especially
at large Ag. Thus, Eq. 5.7a does not provide an acceptable estimate for chains of finite n at large Ag.
Additionally, there is no analogous direct method of calculating i, although it could be estimated
from a f2/$ ratio dependence (see Section 5.5.3).
5.2.3 Hydrodynamic Parameters
Davidson and Deen 72 developed a method for calculating K and G by representing the coil as a
porous body with a radially- and axially-dependent solvent permeability. The pertinent molecular
parameters in addition to Ag are the resistance to solvent flow through the porous body (a function
of r, /rg) and the Mark-Houwink exponent. The Brinkman equation4 6 for flow through porous media
was then solved to calculate the drag on the body. Values were tabulated for Ag < 1.6.
5.2.4 Model Results
The model predicts that, for a noninteracting molecule of A, < 1, transport of a linear chain is
actually more restricted than that of a solid sphere of equivalent size (i.e., Hcoil < Hsphere, Wcoil <
Wsphere).72 This is because while the chain experiences less frictional drag (K - ' and G are larger),
it is excluded from the pore ( and Q are smaller) to a much greater degree. The model is in
good agreement with hindered diffusion studies of polystyrene in organic solvents through synthetic
porous membranes. 72
Davidson and Deen71 measured the diffusion of four polymers (dextran, Ficoll, polyethylene oxide
(PEO), and polyvinylpyrrolidone (PVP)) in water through synthetic membranes. Dextran and PVP
were found to behave similarly in vitro, with measured H values exceeding those predicted by the
theory for solid spheres and, hence, exceeding to an even greater degree those predicted by the
random coil theory. Ficoll data correlated well with the solid sphere theory, while the PEO values
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were smaller than predicted for solid spheres, though still exceeding the random coil predictions. The
data for dextran and Ficoll confirmed that reported in an earlier study by Bohrer et al.3 2 This relative
order parallels measurements of glomerular permselectivity using the same molecules.3 '1 39 21246
The in vitro data indicate that, for dextran (and PVP and, to a lesser degree, PEO), either the
hydrodynamic coefficient K - ' or the steric coefficient I is underestimated. It will be seen later, in
Section 5.9, that underestimation of K-l is not sufficient to explain the discrepancy. One possible
mechanism for an increased (I that has been examined in some depth is the existence of attractive
chain/pore interactions. Davidson et al.74 demonstrated that this effect could be achieved by a
square-well potential which affects chain segments in a region close to the pore wall. Equivalent
analyses for solute/pore interactions using the diffusion equation model also have been presented by
Davidson and Deen 73 and Lin and Deen.' 6 7
There exist unexplained discrepancies between hindered diffusion and hindered convection stud-
ies. Specifically, Mitchell and Deen' 79 report that the convective hindrance for dextran-in-water
systems is greater (W is smaller) than that predicted by the solid sphere theory. Similar results of
increased hindrance have been reported for Ficoll, 179 PEO,26 8 and bovine serum albumin.'7 9
5.3 Goals
The remainder of this chapter details work performed to incorporate the Davidson et al. random
coil method into the model of glomerular permselectivity. Because of the difficulty in representing
the steric and hydrodynamic parameters analytically, we focused our efforts on generating tables of
values covering a wide range of conditions which could be used for lookup and interpolation.
Since the steric parameters from Davidson et al.7 4 were available only for Ag < 1.2 and n+1 < 400,
we performed additional calculations to extend the range of utility. Additional work was necessary
to extrapolate values for very large Ag, where Monte Carlo computation was impractical, and these
estimated values were also added to the interpolation tables. Estimation of the hydrodynamic
parameters at large Ag was made by a straightforward analytical extrapolation. Finally, we applied
the random coil model of glomerular permselectivity to the dextran sieving data of Chapter 4, as
discussed in Section 5.9.
5.4 Calculation of Steric Parameters at Small A9
5.4.1 Methods
The method of Davidson et al.,74 described subsequently, was used to generate tables of c4 and 2
values for Ag = 0.2 to 1.8. All Monte Carlo simulations were performed at the MIT Supercomputing
Facility on a Cray X-MP EA/464. The FORTRAN code was written to maximize vectorization.
The two rate-limiting steps in the code were chain generation and testing of the configuration at
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each radial position within the pore, neither of which could be vectorized.
The model geometry (Figure 5-1) was a cross-sectional circular pore with m radial mesh positions
from the centerline to the pore wall. A square-well potential was assumed to exist: an interaction
distance d was chosen with attractive pore/solute interactions in the region m - d < r < m. For
given values of Ag and n, the segment length I is then calculated asli s
6(n + 1)I = Agm (5.8)
n(n + 2)'
The following algorithm was used for determining the weighted probability distribution p(A., i)
at the discrete mesh positions in the pore:
1. A (2m+ 1) x n array S was initialized to zero. This array was used to keep track of the number
of successful configurations.
2. A single chain was ' constructed: Beginning at the origin (0,0) with respect to the chain, a
three-dimensional random walk step of length I was taken using the method of Marsaglia. 172
The (, y) coordinate of each step was taken as the location of a mass point and the starting
point for the next step. Generation of n such steps constituted a chain.
3. The center of mass of the chain was placed at pore radial position (-m, 0).
4. Each mass point in the chain was tested to see if it fit within the pore.
(a) If every mass point fit, then the number of mass points md that fit within the square-
well was counted. The success was recorded by incrementing the ij-th element in S:
itjl = sj + 1, where i corresponded to the diameter position and j = md.
(b) If any mass point fell outside of the pore lumen, no success was recorded.
5. The chain was moved one position to the right. Step 4 was repeated over the diameter of the
pore.
6. Steps 2 to 5 were repeated for Mc chains, where Me was large enough to insure a representative
ensemble of chains.
Each mass point that lay within the interaction region was taken to have an energy ekBT,
where kB is Boltzmann's constant and T is absolute temperature. Negative values of E correspond
to attractive interactions, while positive values indicate repulsive forces. For a given ensemble of
chains and values of d and , the weighted probability of success p(Ag, #i) with center of mass at
position i in the pore was then calculated from the Boltzmann-weighted sum of success divided by
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Figure 5-1: Model geometry for Monte Carlo simulations. The pore radius is divided into m positions
with an interaction region a distance d from the wall. The chain is modeled as a three-dimensional
random walk of step size 1. The left configuration is not recorded as a success. The middle configu-
ration is recorded as a success with zero pore wall interactions. The right configuration is recorded
as a success with five mass points (labeled) experiencing pore wall interactions.
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the total number of chains generated:
p(Ag,,) = E=o Bij exp(-eij)
Ml
Once S was calculated, p(Ag, ii) could be rapidly determined for any . The steric parameters was
then calculated by Simpson's rule:
m
¢ = 2 cip(A,,, i)i(dA), (5.10a)
i=O
m
= 4 Eaip(Ag,, i)(1 - )i(Af), (5.10b)
i=O
where ai are the Simpson's rule coefficients and Af are the fixed radial step sizes. Propagation of
errors in these calculations is discussed in Appendix E.
Molecule-to-pore size ratios were varied from Ag = 0.2 to 1.8 in increments of 0.2. The number
of chain segments n ranged from 20 to 800. The energy parameter e was varied from -0.4 to 0 in
increments of 0.01. The interaction region d was set equal to I for all calculations (d = I case), as
this seemed a reasonable assumption for short-range interactions. Additionally, the limiting case
of a potential extending across the entire pore (d = r0 case), affecting all n + 1 mass points, was
calculated directly from the = 0 results as
ld=ro = exp[-e(n + 1)] ,=0 , (5.11a)
Qld=r, = exp[-(n + 1)] Q,=o. (5.11b)
5.4.2 Results
5.4.2.1 Computation Time
The amount of CPU time required to generate S for different cases is shown in Table 5.1. Compu-
tation time scaled roughly with Me, the number of chains generated, and n. For Ag = 1.8, the time
requirements had become prohibitive, as even the simplest chains required an hour.
5.4.2.2 Steric Parameters
Calculated results for and Q are tabulated in Appendix D. Values were in excellent agreement
with the results of Davidson et al.74 for Ag < 1.2, and for their small n results for Ag > 1.2.
Values for 4 and Q for the d = I case are shown in Figures 5-2 and 5-3 for varying e and constant
n = 200. As will be discussed in Section 5.4.2.3, values for Ag = 1.8 are deemed unreliable, and they
are not shown in Figures 5-2 to 5-5.
Solute/pore interactions are seen to have a large effect on the steric parameters, more so with
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Figure 5-2: Partition coefficient () as a function of energy parameter (E) for n = 200, d = I case.
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Figure 5-3: Flow-weighted average steric parameter () as a function of energy parameter () for
n = 200, d = I case.
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Ag 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
M, (in 103) 80 80 120 600 800 3000 6000 8000 20,000
n = 20 0.8 0.7 0.8 2.8 2.8 9.3 17.6 23.1 57.0
n = 50 1.3 1.1 1.4 5.3 6.0 20.6 - 41.3 54.7 134.4
n = 100 2.3 2.0 2.4 9.6 11.3 39.8 79.4 107.4 252.8
n = 200 4.2 3.7 4.5 18.1 21.8 78.0 157.3 210.7 510.7
n = 400 7.9 6.9 8.5 35.3 42.2 153.4 314.0 410.0 997.0
n = 800 15.4 13.4 16.6 69.2 84.0 304.2 623.0 828.1 1977.7
Total 31.9 27.8 34.2 140.2 J 168.1 605.3 1232.6 1633.9 l 3929.6
Table 5.1: CPU minutes required for Monte Carlo simulations on a Cray X-MP EA/464.
increasing Ag. A Boltzmann energy of -0.2kBT per mass point, less than the energy of hydrogen
bonding (which is roughly -3kBT to -16keT),16 5 is enough to increase I and by three orders of
magnitude. At -0.3, the steric parameters begin to exceed unity. This is an indication that e is
near the critical energy for absorption onto the pore wall.1 1 7' 2 69 Considerable fluctuations are seen
in the curves for < -0.3, demonstrating large statistical uncertainly in these values.
Results for the full-pore potential (d = ro) are shown in Figures 5-4 and 5-5. In this case, the
energy parameter also has a significant effect on partitioning, with two differences from the d = I
model: comparable increases are shown at energies ten times smaller, and the increase is relatively
uniform (on a log scale) at all Ag, even in the limit as Ag -* 0. It has been noted previously that t
and Q are more sensitive to changes in d than to e. 74
The effect of n on the partition coefficient (I is demonstrated in Figure 5-6 for the neutral case.
Also shown is the Casassa equation, Eq. 5.7a, for the n --- oo limit. Again the effect is most
noticeable at large Ag, with nearly two orders of magnitude separating n = 20 and n = 800 at
Ag = 1.6. Also noteworthy is that at Ag = 1.6, a significant difference still exists between n = 800
and the Casassa limit.
The analogous plot for the e = -0.2, d = I case is shown in Figure 5-7. The effect of n on in
the presence of attractive interaction is more complicated. For small Ag, exclusion effects dominate
and the curves have the same trend as the neutral case, 'I decreasing with increasing n. At Ag = 1.6,
however, crossing of the curves is observed. This happens because the interaction length d is fixed
to the segment length 1. For a given n, there is a value
n(n + 2)
AB 1I=ro = 2 (5.12)
- 6(n + 1)
where d = = ro and the d = I case collapses to the full-pore (d = rTo) potential. Thus, as Ag
increases, d/ro becomes equal to or greater than one, and md, the number of mass points in the
square well, approaches n + 1. The exponential weighting then begins to scale as n + 1, and so
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Figure 5-4: Partition coefficient () as a function of energy parameter (E) for n = 200, d = ro case.
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Figure 5-5: Flow-weighted average steric parameter () as a function of energy parameter () for
n = 200, d = ro case.
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Figure 5-6: Partition coefficient (I) as a function of number of chain segments (n) for neutral (e = 0)
case. Dashed line shows the n -, oo limit of the Casassa equation, Eq. 5.7a.
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Figure 5-7: Partition coefficient () as a function of number of chain segments (n) for E = -0.2,
d = 1. For clarity, only the interpolating lines and not the discrete calculated points are shown.
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chains with more mass points receive greater enhancement, and a reverse trend with n is obtained.
Eventually, as A becomes large enough, the exclusion effects will dominate again and the curves
will re-cross. This second reversal is shown in Figure 5-8 for the full-pore potential with = -0.02.
In this figure, for small Ag, attractive forces dominate and 4' varies inversely with n, but starting
around Ag = 1, exclusion effects dominate and the curves begin to cross.
5.4.2.3 Error Estimations
As discussed in Appendix E, any calculation of statistical variance for the derived quantities 4 and
f1 presupposes that the calculated probabilities are good estimators of the true probabilities. Thus
it is theoretically possible to calculate low variances even when the estimators are poor. Since we
have no a priori means of knowing what the probabilities should be, several different methods were
used to gauge the reliability of the results. Only 4' will be discussed here, as the results for f are
nearly the same.
In general, for a given number of chain configurations Me, errors will increase as n increases
(because more chain configurations are possible, and fewer of them are successful), as e becomes more
negative (because small fluctuations are magnified), and as Ag increases (because fewer configurations
are successful). Once convergence on the probabilities is reached, errors will scale exactly as 1/VMs
(see Appendix E).
The "gold standard" for determining convergence would be to increase M, until Var(S) and
Var(fQ) vary linearly with 1/VMs. For large chains, where M, 10 7, this is not practical. Instead,
approximate variances and confidence limits on the parameters were calculated assuming that the
Monte Carlo-derived probabilities had converged. In addition, we assessed accuracy by considering
two other parameters, the 95% confidence limits on and the asymmetry factor.
The 95% confidence limits on , defined as 2/Var(<,) and expressed as a percentage of 4', are
shown in Figure 5-9 for the limiting cases of n = 20 and 800. For n = 20, the interval is less than
6% at all . For n = 800, it is less than 10% for the neutral case when Ag < 1.4 and less than 40%
for all Ag. At Ag = 1.8, the values are unreliable for even modest negative values of e. For all Ag at
n = 800 and = -0.4, the uncertainty is near 100%. For Ag < 1.8 with n = 800 and E = -0.2, the
uncertainties are on the range of 10-60%.
The asymmetry factor is defined as Ileft- <'right I/'avg where (4 left and right are values obtained
from integration on the "left" side (mesh points -m to 0) and on the "right" side (mesh points 0 to
m) of the pore, respectively, and avg is the value obtained from integration across the entire pore
(mesh points -m to m). It is a measure of the effects of skew in chain generation, with a minimum
value of 0 and a maximum value of 2 (or 200%). Figure 5-10 shows values for the asymmetry factor
for the limiting cases of n = 20 and 800, and = 0, -0.2, and -0.4. For n = 20, the factor is less
than 5% at all values of e. For n = 800, the factor is less than 10% for all Ag when = 0, but reaches
91
10 - 1
4(D 10- 2
10 - 3
0.0 0.5 1.0 1.5
Ng
Figure 5-8: Partition coefficient () as a function of number of chain segments (n) for e = -0.02,
d = ro0. For clarity, only the interpolating lines and not the discrete calculated points are shown.
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Figure 5-9: 95% confidence limits on for n = 20 and n = 800.
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Figure 5-10: Asymmetry factor 1left - rightI/avg, for n = 20 and n = 800.
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the upper limit of 200% for even modest values when A, = 1.8. There is great uncertainty in the
results for all A, at n = 800 when the magnitude of e exceeds 0.3. In summary, the asymmetry
factor qualitatively reinforces the conclusions reached from assessing the 95% confidence limits.
The ratio of [1/t, discussed further in Section 5.5.3, was used as a third means of assessing quality
of the results. Values of this ratio for Ag = 1.8, e < 0 were not consistent with the asymptotic limit
demonstrated by values at other A,, again indicating uncertainty. Based on the asymmetry factor,
confidence limits, and ~4/[ ratio, only results for A, < 1.6 and e > -0.30 were used for further
calculations.
5.5 Estimation of Steric Parameters at Large A
5.5.1 General Approach
As mentioned previously, Davidson et al.74 were unable to find an adequate means of expressing
the Monte Carlo results in analytical form. Of particular concern for application to dextran sieving
is a means of extrapolating results to large A,. From the Ficoll results of Chapter 4, heteroporous
distributions had a mode on the order of 10 i or less. It is apparent then that a significant portion
of the large dextran (> 60 A) will be transported through pores where A > 2.0, especially when
pore attractions exist. An empirical method of extrapolating qi for large values of Ag is developed
below. was then calculated from 4 by a semi-empirical relationship.
For the purposes of modeling glomerular filtration, it is not necessary to have highly accurate
estimations at large A9. For one thing, measured sieving coefficients have a high degree of uncertainty
at large rg, as reflected in experimental standard errors. For another, it is expected that most of
the transport of large molecules will be through very large pores, even in the presence of attractive
interactions. Finally, at large Ag, 4) decreases several orders of magnitude with even small increases
in Ag. Estimation of steric parameters to within one or two order of magnitude should be suitable
for our purposes at the larger values of Ag.
5.5.2 Partition Coefficient (4)
One obvious means of performing an extrapolation would be to use limiting expressions for both
low n and n -- oo, at a constant value of the energy parameter, and then to develop expressions for
4(n)l,. For the neutral coil (e = 0), this is easily done because, as seen in Figure 5-6, iso-n lines do
not cross and are proportionally spaced as A, increases. For the attractive (e < 0) coil, however, the
iso-n lines cross as Ag increases (Figures 5-7 and 5-8).
An alternative method is suggested by comparing isoenthalpic curves in planes of constant n, as
in Figures 5-2 and 5-4. Such curves will never cross, and the relative distance of the lines from each
other remains roughly proportional. On this basis, the following empirical procedure was devised to
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calculate (A9 > 1.6, E < 0). First, the neutral value In I(A 9 , 0) was determined. We then calculated
In t at arbitrary ,, by increments from the neutral value:
n-i
ln 4(A,, e,) = In t(A., 0) + E 6Eei at (A Ei)n (5.13)
i=0
Thus the problem is reduced to finding separate expressions for the neutral partition coefficient and
the gradient at Ag > 1.6.
Values of (Ag, 0) for A > 1.6 were calculated by a polynomial extrapolation from I(1.2, 0),
*(1.4, 0), and 4(1.6, 0). Such an extrapolation will be defined as one from an endpoint of A9 = 1.6.
Similarly, an endpoint of Ag = 1.0 would imply that I(0.6, 0), I(0.8, 0), and (1.0, O0) were fit. As
a test of the extrapolation accuracy, polynomial extrapolations to Q(1.6, 0) from endpoints of 1.0,
1.2, and 1.4 were calculated. Extrapolations were found to be within 20% of the true value at all
values of n, as shown in Figure 5-11. Extrapolation to Ag > 1.6 from A. endpoints smaller than 1.6
were still within two orders of magnitude of the 1.6 endpoint results, as shown in Figure 5-12. Thus,
though extrapolation from endpoints larger than 1.6 would provide better estimates than the ones
we have obtained, Figure 5-12 indicates that the results would not be significantly different for our
purposes.
To develop a means of calculating the gradient tetm of Eq. 5.13 for Ag > 1.6 , we first examined
the behavior of the gradient for Ag < 1.6. The gradient was numerically approximately as
In(4Q) (A, Ei) ln 4(ei + 6Ei) - In ((ci) (5.14)
and calculated directly from the tabulated values, with 5 e = -0.01. The values were roughly
linear in Ag (see symbols on Figures 5-13 and 5-14). An additional consideration is that for Ag >
n(n + 2)/6(n + 1), 1 > ro and the behavior must be that of the full-pore potential (d = To). In
this case, , - exp[-E(n + 1)], and therefore
l n() =n +1. (5.15)
Calculated values of the gradient from the Monte Carlo simulations for small n, where Ag1=,ro was
not much greater than 1.6, were consistent with this asymptote (Figure 5-13). A linear extrapolation
was then used to calculate the gradient in the region between Ag = 1.6 and Ag l=,o, shown by dashed
lines in Figures 5-13 and 5-14.
Extrapolated values for 4 are compared to the Monte Carlo results in Figure 5-15. The behavior
of the extrapolations is qualitatively reasonable, with a monotonic rise in m as the magnitude of e
increases. The relative distances of the extrapolated isoenthalpic lines from each other is consistent
with those in the Monte Carlo regime.
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Figure 5-11: Polynomial extrapolation to (1.6, 0) as a function
By definition the values at endpoint Ag = 1.6 are the true values.
of the extrapolation endpoint A.
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5.5.3 Radial Flow-Averaged Steric Parameter ()
One approach to calculating Q at large Ag would be to use a similar procedure to that just described
for . As an alternative to explicit calculation, we can devise a semi-empirical means of relating Q
to 4. To begin, we note that, from Eqs. 5.3 and 5.4,
= 2 - 4 p(A, f)3 d. (5.16)
Then, theoretically, limp-o DO = 2/. We then ask whether the limit as A - oo is equivalent:
lim 0 lim = 2. (5.17)
A,-oo p-O
For a solid sphere, this is true because p = 0 for A. > 3/5 (e.g., A, > 1). For a random coil, Eq. 517
appears to be valid from the Monte Carlo results (see Figure 5-16). In fact, 0/4 is rather insensitive
to both n and e and can be approximated by a simple exponential dependence on Ag. It should be
noted that in the limit of large Ag, the full pore potential is reached and Q/4f will be the same for
all values of e. At Ag > 1.6,
// -1 2 (5.18)
provides a reasonable approximation, and this was the relation used to calculate Q. Values of f for
n = 200 are plotted in Figure 5-17.
As mentioned in Section 5.4.2.3, the ratio was also used a means of assessing the quality of the
Monte Carlo results. Anomalous behavior such as that shown by the data for A = 1.8, e = -0.2
(Figure 5-16) was one of the reasons the results at Ag = 1.8 were not used for further calculations.
The physical significance of this ratio and its asymptotic limit is not clear. The ratio can be
written as
= 2 ' ) 2- 2, (5.19)
/folp(Ag, ) df
where is the ratio of the third moment of p to its first moment. From moment theory254 we can
construct bounds on :
~~( ) P~) < ~ <  '(5.20a)
(P) j p(A9 , i) di: = Oth moment. (5.20b)
(5.20c)
And so it seems a more detailed examination of 4/(p) would give some insight into the physical
significance. Unfortunately, since information on (p) is not normally available, this is not generally
useful.
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Figure 516: for n =20andn =800. Solid sphe e theory is shown by solid curve.
Figure 5-16: Q/¢ for n = 20 and n = 800. Solid sphere theory is shown by solid curve.
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Figure 5-17: Extrapolated values (Ag > 1.6) of Q as a function of e
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for n = 200.
5.6 Estimation of Hydrodynamic Parameters at Large Ag
Extrapolation of the hydrodynamic parameters K-1 and G to large A. is less problematic because
they vary roughly as exp(-A 9 ), as opposed to · and SI which vary almost as exp(-A'). Thus, the
order of magnitude of H and W are insensitive to K - ' and G at large A9, and any simple function
which satisfies the asymptote should be acceptable. We fit the data of Davidson and Deen 72 to the
following exponentials:
K - 1 = exp(-1.798A9 ), (5.21a)
G = 0.5 exp(-0.6146Ag) + 0.5. (5.21b)
These equations were fitted using their data for all three values of acH, a parameter which is a
measure of the flow resistance through the interior of the coil and which is a function of r,/g:7r2
5.77 x (2.5981(r,/r,))
2.22 - (2.5981(r/r,))' (5.22)
The values of aH used (10, 34, and 60) correspond to r,/r. = 0.54, 0.73 and 0.78. The hydrodynamic
coefficients are actually relatively insensitive to caH, and in fact use of any one the three values would
give nearly the same result for the sieving coefficient,
5.7 Interpolation Procedure for Sieving Calculations
Tables of In ' and In Q as functions of number of chain segments (n = 20, 50, 100, 200, 400, 800),
Ag (= 0.0 to 7.0 by 0.2) and (= -0.30 to 0.0 by 0.01) were created, with values for 0 < A < 1.6
calculated by Monte Carlo simulation and values for 1.6 < A < 7.0 calculated by the extrapolation
procedure of Section 5.5. For the full-pore potential, and Q were calculated for the neutral case,
and energetic attractions were added by applying Eqs. 5.11.
Similar tables for K - 1 and G as functions of Ag (= 0.0 to 1.6 by 0.2) and aH (= 10, 34, and 60)
were constructed from the data of Davidson and Deen. 72 Values for A > 1.6 were calculated from
Eqs. 5.21.
A multidimensional interpolation scheme20 6 was used to perform the calculations, with the al-
gorithm of Akima 3 ' 4 as the method of interpolation in each dimension.
In order to maintain consistency for comparison with the in vitro measurements of Davidson and
Deen, 71 the following correlations for dextran molecular radii were used, fitted to data of Callaghan
and Pinder4 8 for r, and that of Garg and Stivalal0 9 for r, with the radii in A:
r, = 0.245M °5 , (5.23a)
rg = 0.323M °, 5. (5.23b)
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Eqs. 5.23 were fit assuming ideal coil behavior (i.e., the exponent fixed at 0.5). For determination
of n, a monomer was taken to be an equivalent Kuhn segment, and so n = M,, /162.
5.8 Theoretical Effect of e on Glomerular Sieving
Theoretical sieving curves for dextran random coils which follow Eqs. 5.23 are compared to that of
a neutral solid sphere in Figure 5-18. An isoporous membrane radius of 50 A was assumed, using as
hemodynamic inputs the single nephron values of Table 4.2 for combined dextran and Ficoll rats.
As expected from the results for H and W of Davidson and Deen, 72 for a neutral random coil
of intermediate r, is lower than that of a neutral solid sphere. An energetic attraction of between
-0.1 and -0.2 kBT per mass point is required for ecoil Osphere. Because Osphere = 0 for rT > 50
A, 9 coil > esphere for sufficiently large r,, at any value of the energy parameter. Figure 5-19 shows
the equivalent plot for the full-pore potential. There is little qualitative difference between the two
figures, although the energy value at which Ocoil Oesphere is now approximately -0.O1ksT.
The presence of even very small attractive energies is seen to have significant effects on the
sieving coefficients, especially for large molecules. The e of a 50 A dextran is raised three orders of
magnitude when e changes from 0 to -0.25 in the d = I model, or from 0 to -0.03 in the d = ro
model.
5.9 Fit of Energy Parameter to Dextran Sieving Data
5.9.1 Methods
Values of were fit to the dextran data of Chapter 4 using Powell's method,2 0 6 as described in
Section 4.2.5. The isoporous + shunt, lognormal, lognormal + shunt, and double lognormal pore
distributions were examined, with pore size parameters fixed at those obtained from Ficoll sieving
curves (Table 4.4). The single nephron hemodynamic parameters for the combined dextran and
Ficoll rats (Table 4.2) were used as model inputs. Pore/solute attractions were assumed to have no
effect on coils traveling through the shunt.
5.9.2 Results
The best-fit values for E are reported in Table 5.2 for each pore size distribution and are plotted
in Figure 5-20 for the d = I case and Figure 5-21 for the d = r0o case. The values for the d = I
case are nearly identical for all distributions, with -0.25. In turn, this is very similar to the
value of -0.26 reported by Davidson and Deen71 using the same model for the transport of dextran
through polycarbonate membranes. Thus it seems that the nature of dextran's enhanced transport
is quantitatively independent of the medium through which it travels. The isoporous + shunt model
does not provide a good description of the data because the energy term has no effect on sieving
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Figure 5-18: Effect of energy parameter on for isoporous membrane with r = 50 A, d = I
case. Dashed lines represents results for neutral solid sphere. Hydrodynamic inputs are total single
nephron values in Table 4.2.
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Figure 5-19: Effect of energy parameter E on 9 for isoporous membrane with r = 50 A, d = o
case. Dashed lines represents results for neutral solid sphere. Hydrodynamic inputs are total single
nephron values in Table 4.2.
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Figure 5-20: Fit of energy parameter to dextran data for various heteroporous models, d = I case.
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Figure 5-21: Fit of energy parameter to dextran data for various heteroporous models, d = ro case.
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Table 5.2: Fit of energy parameter e to dextran data using Ficoll pore parameters of Table 4.4.
through the shunt and hence the transport of large molecules is not enhanced (Figure 5-20). The fits
provided by the other three distributions are similar, with the lognormal model having the best-fit
as measured by X2 values.
There is more variability in the values of e for the d = To cases, with the isoporous + shunt
value being six to seven times that of the three continuous distributions. For the d, = To case,
the isoporous + shunt model is similar to its d = I counterpart (Figure 5-21). The plots for the
other three distributions are in very poor agreement with the data. The curves anomalously reach
a minimum around 40-50 A and then begin to increase with r,.
The explanation for this is seen when one examines the degree of sieving through large versus
small pores. We define the value eextrap as the amount of the sieving coefficient that is due to
transport through pores smaller than rg/1.6 (i.e., A > 1.6):
~'g/1 6
ei,extrap = ei(r)w(r) dr, (5.24)
where Oi(r) is the isoporous sieving coefficient defined by Eq. B.la and w(r) is the fractional filtrate
volume defined by Eq. B.lb. Oi,extrap corresponds to the part of the sieving coefficient calculated
from the extrapolated approximations to large Ag. These values are shown as a fraction of the total
Oi in Table 5.3 for each distribution. For the d = I cases, the extrapolated fractions are on the
order of 5-30%, with higher percentages seen at the largest r, for the lognormal and lognormal +
shunt models, and in the middle values of r, for the double lognormal model. For the d = r cases,
the trends are similar, but the amount of extrapolation is much smaller, less than 1% in all cases
and predominantly less than 0.1%. This implies that, for the d = To cases, even though there are
very few large pores, they conduct the preponderance of the transport of large molecules due to the
energetic attractions. For example, at r, = 65 A, rg/1.6 = 53.4 A. From the pore size distributions
for the Ficoll data (Figure 4-3), 1% or less of the total volume flux is going through pores larger
than 53.4 A, yet these pores account for over 99% of the transport of the largest dextrans. This is
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Isoporous 1 -0.225±0.012 444
+shunt ro -0.0705±0.0023 386
Lognormal 1 -0.250±0.017 60.6
ro -0.0145±t0.0063 362
Lognormal 1 -0.248±0.003 112
+shunt rO -0.0192±0.0007 349
Double 1 -0.250±0.003 129
lognormal ro -0.0100±0.0007 409
Lognormal Double Lognormal Double
r, Lognormal + Shunt Lognormal Lognormal + Shunt Lognormal
19 4.2 2.8 0.9 0.027 0.021 0.004
21 4.9 3.5 0.9 0.021 0.021 0.008
23 5.3 4.5 1.1 0.019 0.023 0.005
25 6.3 5.3 1.6 0.018 0.025 0.007
27 6.9 6.5 2.6 0.017 0.027 0.013
29 7.2 7.8 4.9 0.016 0.030 0.021
31 7.7 8.9 6.8 0.016 0.034 0.030
33 7.9 9.6 9.4 0.016 0.038 0.034
35 8.6 10.7 12.8 0.017 0.046 0.043
37 9.2 13.4 17.7 0.018 0.052 0.040
39 10.1 14.7 21.6 0.018 0.059 0.035
41 11.1 15.8 25.4 0.019 0.066 0.029
43 11.9 16.9 27.8 0.019 0.074 0.024
45 12.4 18.2 28.6 0.021 0.084 0.019
47 12.9 19.3 29.1 0.022 0.094 0.015
49 13.2 20.1 27.0 0.023 0.104 0.011
51 13.6 21.0 24.6 0.024 0.115 0.008
53 14.2 22.1 21.9 0.025 0.126 0.006
55 14.9 23.0 17.8 0.026 0.138 0.005
57 14.7 23;1 18.2 0.027 0.150 0.004
59 15.7 22.9 15.0 0.028 0.163 0.003
61 17.0 23.1 12.6 0.029 0.177 0.003
63 18.6 23.4 11.1 0.031 0.193 0.002
65 20.3 23.5 10.1 0.033 0.209 0.002
Table 5.3: Oi,extrap/Ei (in %) for random coil fits.
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d= d= ro
explained by noting that in the full-pore potential, enhancements from attractive energies are seen
at all sizes, with significant adsorption at small Ag (Figures 5-4 and 5-5). In contrast, in the d = I
case, only transport of molecules at large A. is enhanced (Figures 5-2 and 5-3). Thus, the presence
of attractive energies makes transport through all pores more favorable in the d = ro case, whereas
in the d = I case it preferentially makes transport through small pores more favorable. The plots of
Figure 5-21 represent the physically unrealistic situation of molecules highly adsorbed to a few large
pores with steric parameters > 1. Since adsorption is predicted to increase with n, e is predicted
to increase with A.
The d = I results are probably more physically realistic, but Oextrap is still relatively small, on
the order of 10-20%. This suggest that greater accuracy in the extrapolation method would not
make significant differences in the modeling results.
5.10 Discussion
Alternate possibilities exist for the mechanism behind the enhanced transport of dextran. One
possibility is that the hydrodynamic coefficients K - l and G are underestimated by the theory. This
issue is easily addressed by modeling dextran as a free-draining coil, for which K-l and G equal
unity at all sizes. This case is shown in Figure 5-22 for the lognormal + shunt model in comparison
with the results for a neutral coil and a coil with = -0.248. The hydrodynamic effects are seen to
account for at most 50% of the difference for small molecules, and less than 1% of the difference for
large molecules.
A more important consideration is the determination of the values of I and n which truly char-
acterize the physical properties of a given dextran molecule. All of the above calculations were
performed assuming I corresponded to the length of one glucose monomer. This was consistent with
the analysis of the in vitro data by Davidson and Deen 71 and would allow for direct comparison with
their results. Although there is data to indicate that I may actually correspond to more monomers
(see Appendix F), the range of alternative values is rather wide (between four and ten monomers),
and this data is not consistent with other measurements that show that dextran exhibits the prop-
erties of a polymer at relative low molecular weight.ll4 If one wanted to model behavior at different
effective Kuhn lengths, a new set of Monte Carlo calculations would have to be performed since it
would probably be desirable to still scale d with the size of a monomer, and not the effective Kuhn
length.
Another possible explanation is that that chain branching reduces steric effects in a way that
cannot be simply explained. The importance of branching for dextran unperturbed dimensions has
not been resolved, but assuming that branching was significant, one would expect that a branched
chain and a linear chain with equivalent r would have quite different distributions of intramolecular
distance, with the branched chain being more compact. If each chain branch were only one or two
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Figure 5-22: Comparison of free draining (K- 1 = 1, G = 1) to neutral and attractive coil models.
Pore parameters are for the lognormal + shunt model.
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glucose residues, then a linear molecule might be justified as a suitable approximation. If, however,
there are very large branches, this could have significant consequences. Casassa and Tagami53
demonstrated that for a "star" configuration, consisting of identical random chains joined at a single
branch point, 4I increased as the number of branches increased for a fixed total number of chain
segments. Analytical expressions exist for volume correction factors for branched molecules with
long side chains of identical length, or for molecules with a random distribution of branches, 15 4 and
these could be applied as a first-order correction, but one must then determine the dependence of
effective n and I on molecular weight. Most importantly, the effect on the partition coefficients
would be much more significant than a simple adjustment for rg.
In summary, we have used recent theoretical developments in the study of hindered transport
to describe dextran sieving as the filtration of random coils through cylindrical pores. Dextran's
transport both in vivo and in vitro is enhanced over that of a neutral coil, and it can be accounted
for by the assumption of attractive solute/pore interactions. The magnitude of these interactions
is nearly identical for the glomerulus and synthetic membranes, and indicates that the nature of
the enhancement is independent of the medium through which dextran travels. This model is
strictly descriptive, as there is no physical evidence to support the idea of solute/pore attractions.
Nevertheless, such a model is the first step in attempting to understand the mechanism by which
molecules of different configuration are filtered through the glomerular capillary.
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Chapter 6
Ficoll Sieving in Fawn-Hooded Rats
6.1 Introduction
6.1.1 The Fawn-Hooded Rat
The fawn-hooded (FH) rat is a strain with a genetic predisposition to developing hypertension, hy-
perfiltration, proteinuria, and glomerulosclerosis at a young age. 15 16 S5 3 As such, the FH rat model
may serve as a closer approximation of essential renal disease in human beings than previous models.
FH rats have increased AP and SNGFR compared to normotensive Munich-Wistar rats.2 3 0 A par-
ticular inbred substrain, denoted "FHH", has the highest susceptibility to hypertension, proteinuria,
and sclerosis among the FH rats.
6.1.2 The Model of Renal Ablation
Surgical infarction of renal tissue ("renal ablation") is a well-studied model for chronic hypertension
in the rat. , 7,55,56,64,80,123,128,142,175,188,189,191,197,108, 208,227 Common protocols are for the abla-
tion of from 1/2 (uninephrectomy) to 15/16 of the renal mass. The animal responds by shifting renal
blood flow to the remaining functional nephrons, resulting in larger values of QA and SNGFR. Kf
is relatively unchanged, and thus SNFF falls. Transmural hydraulic pressure (AP) increases sub-
stantially, on the order of 5-15 mm Hg. Proteinuria ensues, and the remaining functional glomeruli
eventually become sclerotic, establishing a cycle which ultimately leads to kidney failure. If a renal-
ablated rat is treated with angiotensin I converting enzyme (ACE) inhibitor 6' 7,1 7 5 or a low-protein
diet,' 75 AP is normalized and Kf increases, with SNGFR maintained relatively constant. Depend-
ing on how early therapy commences, renal damage is either prevented or arrested. Conversely, a
traditional "triple-drug" regimen for hypertension, which lowers systemic blood pressures but not
AP, fails to stop progression of proteinuria and glomerulosclerosis. 7 Glomerular hypertension has
thus been implicated as an important mediator in the progressive impairment of renal function.3 5 ,3 8
6.1.3 Enalapril and NAME
Two pharmacological agents are of particular importance to the work described in this chapter.
Enalapril is an ACE inhibitor which has seen extensive use both clinically and in animal studies
of glomerular hypertension and hyperfiltration.7, 124,125,131,173,175,183, 202,204,212,213,221,26 Physio-
logically, it lowers efferent arteriolar resistance and increases Kf, resulting in the maintenance of
SNGFR at lowered AP. In addition to pressure normalization, ACE inhibitors are believed to have
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additional independent protective renal effects, including the raising of kinin activity. 99' 130, 131 183
NAME (Nw-nitro L-arginine methyl ester) is a substituted L-arginine compound which blocks
nitric oxide (NO) synthesis. Nitric oxide (also known as endothelial-derived relaxing factor) is
made by the vascular endothelium and relaxes adjacent smooth muscle cells.l8 ' Other data suggest
that NO and angiotensin II have directly antagonistic effects in glomerular filtration and tubular
reabsorption. 75 229,24 1 Additionally, NO has been proposed as a mediator in the hyperfiltrative
response of the glomerulus to amino acids.75 143 2 4
Blockage of NO synthesis (with NAME or other substituted L-arginine compounds) leads to
acute increases in both systemic and glomerular blood pressure. lL 1685,s08,209,265 Chronic adminis-
tration of NAME to rats has been shown to increase AP, proteinuria, and glomerulosclerosis.8, 58 217
Physiologically, NAME increases both afferent and efferent arteriolar resistances and decreases Kf.
The result is decreased capillary blood flow and increased AP, with SNGFR maintained relatively
constant.
6.1.4 Objectives
Ficoll sieving studies were performed on groups of FHH rats to study the effect of hyperfiltration
and hypertension and subsequent pharmacological interventions on glomerular size-permselectivity.
Uninephrectomy was performed on the FHH rats to accelerate the progression of the renal disease.
Untreated and treated uninephrectomized rats were compared with two-kidney controls. These
experiments also provided a database for the further study of pressure estimation from sieving
curves (Chapter 7).
6.2 Materials and Methods
6.2.1 Preparation of Radiolabeled Polymers
Tritiated Ficoll was prepared as described in Section 4.2.1.
6.2.2 Animal Studies
Animal care and preparation, whole kidney measurements, and micropuncture studies were per-
formed by Dr. Jacob L. Simons and Julia L. Troy of the Laboratory of Kidney and Electrolyte
Physiology at Brigham and Women's Hospital.
6.2.2.1 Animals
A total of 43 male FHH rats were studied. All were fed ad libitum standard rat chow (Wayne
Rodent Blox, Allied Mills, Chicago, IL) containing 24% protein by weight and allowed free access
to water for the first eight weeks of life. At eight weeks, all rats were anesthetized with ethyl ether
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and underwent either uninephrectomy or sham operation. For uninephrectomy, the right kidney
was removed after exposure by a midline incision of the body wall and careful separation from the
adrenal gland and associated connective tissue. For the sham operation, the right kidney was gently
manipulated but otherwise left intact. All micropuncture and sieving studies were performed at
twelve weeks of age.
The first group (2K, n = 17) consisted of normal two-kidney control animals which underwent the
sham operation. After the operation, they resumed the normal diet. Micropuncture without Ficoll
sieving analysis was performed on eight of the 2K animals, sieving analysis without micropuncture
was performed on five, and four animals received both.
A second group of animals (UNX, n = 9) were uninephrectomized. After surgery, the rats
resumed the standard diet and water. Both micropuncture and sieving studies were performed on
all rats in this group.
A third group of rats (ENA, n = 8) also received uninephrectomy but after surgery were given
a water supply containing 250 mg/l enalapril (Merck, Sharp & Dohme, West Point, PA). Both
micropuncture and sieving studies were performed on all rats in this group.
The fourth group of rats (NAME, n = 9) were uninephrectomized and after surgery were given a
water supply containing 50 mg/l NAME. The NAME was freshly made every other day and protected
from exposure to light. Micropuncture plus sieving analysis was performed on four of these animals,
while five received micropuncture only.
6.2.2.2 Surgical Preparation
Animals were prepared for micropuncture and tracer infusion as described in Section 4.2.2.2. Urine
was collected from rats during two successive 24-hour periods for determination of urinary protein
and albumin excretion.
6.2.2.3 Whole Kidney Hemodynamic Measurements
Whole kidney measurements were performed as described in Section 4.2.2.3.
6.2.2.4 Micropuncture Measurements
Micropuncture measurements were performed as described in Section 4.2.2.4 with the following
differences. Since FH rats do not have surface glomeruli, glomerular pressures were measured by
the stop-flow technique: time-averaged hydraulic pressures were measured directly in superficial
proximal tubules under free-flow (PT) and stop-flow (PSF) conditions using a servo-null micropipette
transducer system (Model 5A, Instrumentation for Physiology & Medicine, San Deigo, CA). Stop-
flow conditions were obtained by injecting bone wax (Ethicon W-31G) blocks into proximal tubules
using a wax blocking device (Research Instruments & Mfg., Corvallis, OR). At least 3 to 4 PSF
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recordings in different nephrons, with a minimum duration of 2 to 4 min each, were obtained during
each experiment. Glomerular capillary hydraulic pressure was then calculated as AP = PSF + rSF -
PT .115
6.2.2.5 Tracer Infusion and Collection
Tracer infusion and collection was performed as described in Section 4.2.2.5.
6.2.2.6 Analytical Methods
Inulin, serum protein, PAH, and oncotic pressures were measured as described in Section 4.2.2.6.
Urinary total protein excretion (UplV) was measured by turbidimetric assay.34 Urinary albu-
min excretion (UaV) was measured by immunodiffusion.l 70 The urinary "non-albumin" excretion
(U(p,_)V = UpV - UaV) was calculated as the difference of the two. The non-albumin proteins
are predominantly a-, -, and 7-globulins, all with isoelectric points higher than albumin's. The
fractional clearance of protein i is defined as
viv
FRCi = GF'i (6.1)GFR CiA
Since afferent albumin concentrations were not measured, they were estimated to be one-half the total
serum protein concentration. It has been shown that the fraction of plasma albumin concentration
to total plasma protein concentration does not change with uninephrectomy [Dr. A. P. Provoost,
private communication]. Thus, although the absolute values of FRCi may not be accurate, the
relative values are valid for comparison. Unlike for Ficoll, for proteins FRC $ 0 because they are
actively reabsorbed in the tubules.
6.2.3 Fractionation of Radiolabeled Plasma and Urine Samples
Fractionation of the plasma and urine samples was performed as described in Section 4.2.3.
6.2.4 Calculation of Sieving Coefficients
Sieving coefficients were calculated as described in Section 4.2.4.
6.2.5 Data Analysis
Pore size parameters and their standard errors were calculated using the models and methods de-
scribed in Section 4.2.5. Statistical comparisons were made using one-way analysis of variance, with
Scheffe's test used to determine significant differences. The Pearson correlation coefficient was used
to determine correlation between parameters.
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BW(g)
AP (mm Hg)
Hematocrit
GFR (ml/min)
RPF (ml/min)
FF
SNGFR (n/min)
QA (nl/min)
SNFF
fy,A (g/dl)
AP (mm Hg)
Kf (nl/min/mm Hg)
UpV (mg/24 h)
UaV (mg/24 h)
U(p_)V (mg/24 h)
Ua /UpV
FRC x 10- 4
FRC, x 10 - 4
FRC(,_a) x 10 - 4
OF36 GFR (ml/min)
2K
(n = 9)
2874-5
1 2 4-1(2N)
43.2-0.9(N)
1. 2 3±0.04 (UB)
4 .9 0 +0.16(U)
0.2 5 ±0.01
( N)
49.34.3( UB4 )
17 7± 20 (U4)
0.2 8 ±0.01(N)
5.4±0.1
4 8 .6±1.2 (UN4)
1.91O0. 1 9(B4)
0.0 8 63 ±0.0101
(U)
UNX
(n = 9)
265±7
12 9 ±2(BN)
45.3±0.5
1.9 8±0.1 2 (T)
6. 8 9 ±0.3 1 (TN)
0.29±0.04
85.65.5(T)
2 9 6 ±17(T)
0.3 0+0.01(N)
5.2d.1(B)
55. 9 ±1.2 (TBN)
2.6640.13(B)
40.7±6.9(B)
27.3±6.2(B)
14.5±2.5(8)
0. 6 3 ±0.05(B8)
2.76±0.44(B)
3.74±0.86(B8)
1.9040.23(")
ENA
(n = 8)
260±8
9 6 +3 (TUN)
44.540.6
1.8 6o0.18 (T)
6.42±0.51
0.29±0.01
87.3+5(T)
3 0 4±2 2 (T)
0. 2 9 ±o0.0(N)
5.6+0.1( U)
43.61.2(UN)
4 .5 7±0.2 0 (TUN)
12.0±1. 8 (U)
1.8 7±1.04 (U)
10.2±1.3
0.1 3 ±0.05(UN)
0. 8 2 ±0.1 2 (UN)
0.2 8 ±0.15(UN)
1.37±0.14
NAME
(n = 4)
263±12
1 60± 4 (TUE)
4 7 .01.1(T)
1.47±0.09
4.541.09(U)
0. 3 5o0.04 (T)
76.5±6.1
208±40
0.3 8 ±0.01(TUB)
5.4±0.1
64.6-3.3(TUE)
1.94±0.07(B)
30.3±5.2
20.9±6.6(3)
6.5±2.2(3)
0.72-13(B3 )
2.67±0.49()
3.581.11(B3)
1.190.45( 3)
0.159±0.033
Table 6.1: Hemodynamic values for fawn-hooded rats which underwent Ficoll sieving studies. OF86 =
Ficoll for r, = 36 A. Superscripted letters indicate p < 0.05: T-vs. 2K, U-vs. UNX, E-vs.
ENA, N-vs. NAME. Superscripted numbers indicate n is different from column heading; 3: n = 3,
4: n=4, 8: n=8.
6.3 Results
6.3.1 Hemodynamic Data
The mean values ± one standard error of various systemic, single nephron, and whole kidney quan-
tities are shown in Table 6.1 for rats on which Ficoll sieving was performed, and in Table 6.2 for all
rats. (The differences between rats which did and did not undergo sieving studies will be discussed
subsequently.) Considering the data for all rats (Table 6.2), untreated uninephrectomy significantly
increased plasma flow rate (RPF or QA), filtration rates (GFR or SNGFR), filtration pressures
(AP), albumin excretion (UaV), and fractional albumin excretion (UaV/UpV) compared to two-
kidney controls. Total protein excretion (UpV) also increased by a wide margin (40.7 vs. 13.3 mg/24
h), but the difference did not achieve significance because of the low number of 2K rats in which
protein excretions were measured. The difference in non-albumin excretion was not substantial.
These changes are in general agreement with those previously reported for renal ablation.8 2 1128
Relative to untreated uninephrectomized rats, enalapril treatment of uninephrectomized rats low-
ered the mean arterial and glomerular filtration pressures, increased the ultrafiltration coefficient,
and lowered total protein, albumin, and fractional albumin excretion. The changes in AP, K, and
UpV, along with the lack of significant change in QA, SNGFR, and SNFF are consistent with pre-
viously reported effect of enalapril on renal ablation. 6 71 7 Non-albumin excretion was unchanged.
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BW(g)
AP (mm Hg)
Hematocrit
GFR (ml/min)
RPF (ml/min)
FF
SNGFR (nl/min)
QA (nl/min)
SNFF
fA (/dl)
AP (mm Hg)
Kf (nl/min/mm Hg)
UpV (mg/24 h)
UaV' (mg/24 h)
U(,p_a)V (mg/24 h)
UaV/UpV
FRCP x 10- 4
FRCa x 10 - 4
FRC(p_) x 10 - 4
pF36-' GFR (ml/min)
2K
(n = 17)
283±8
12 3 42 ( RN)
43.740.6 (N )
1. 3 4+0.06(UE)
5.05s0.14(UN)
0. 2 7 +0.0(N)
58.2:2.9(U N 12)
180O9(UE12)
0. 3 2 +0.01(N12)
5.3-0.1
4 8 .8 0. 8 (UN12)
2 .2 8 -0.1 3 (EN12)
13.3+0.6( 4)
4.2-0.8(U4)
9.0+0.7(4)
0. 3 2+0.06(UN4)
1.45+0.20(4)
0.990.32(4)
1.92+0.11
0.08 6 3 +0.0101(UB9)
UNX
(n = 9)
265+6
12 9+2(E N)
4 5 .3+0.(N)
1.9 8 +0.12 (TN)
6 .8 9 40.3 1(TN)
0.2 8 +0.01(N)
85.6 t5.(T)
2 9 6 +17(TN)
0.3 00.01(N)
5.2:0.1
55.9-1.2 (TBN)
2 .6 6 +0.13 (N)
40.7+6.9(E)
27.3-6.2(T3M)
14.5-2.5(8)
0. 6 3 0.05(TB8)
2.76+0.44
3.74-0.86(E8)
1.90+0.23
0.174-0.0 2 4 (T)
ENA
(n = 8)
260+8
9 6+ 3 (TUN)
44.50.6(N)
1.860.18 (TN)
6 .4 2 +0.51(N)
0. 2 9 +0.01(N)
8 7 .3 +5(T)
304+2 (TN)
0.2 9 0.01(N)
5.6+0.1
4 3 .6+1. 2 (UN)
4 .5 7+-0.2 0(TUN)
12.04-1. 8(U)
1.8+1.0(u)
10.2+1.3
0.13+0.05(UN)
0. 8 2 o0.1 2(N)
0. 2 8 0.15(U)
1.37+0.14
0.17 6 4-0.02 4 (T)
NAME
(n = 9)
258+6
16 8- 6 (TUE )
4 9 .6-1.5(TUB)
1.05+0.14 (UE)
3 .05i:0.6 6 (TUB)
0.3 8+0. 0 2 (TUS)
66.7+5.9
169 2 (UB)
0.3 9 +0.0 2 (TUE)
5.3-0.1
67.6-2.8( TUE )
1.5 4-0.1 6 (TUB)
39.4+10(")
20.96.6 (s)
6.5-2.2(3)
0.7 2 0.1 3 (TB3)
5.07+2.42(E S)
3.58+1.11( 3)
1.19+0.45
0.159+0.033(4)
Table 6.2: Hemodynamic values for all fawn-hooded rats. F36 = Ficoll e for r, = 36 A. Super-
scripted letters indicate p < 0.05: T-vs. 2K, U-vs. UNX, E-vs. ENA, N-vs. NAME. Super-
scripted numbers indicate n is different from column heading; 3: n = 3, 4: n = 4, 5: n = 5, 9: n = 9,
12: n = 12.
Pressures and protein excretions for ENA rats were lower even than those for 2K rats.
NAME-treated uninephrectomized rats, when compared to the untreated UNX group, had in-
creased mean arterial and glomerular filtration pressures and lowered Kf, capillary plasma flow rate,
and filtration rates. These effects are the same as those reported for Munich-Wistar rats.1 8 Filtration
fractions increased significantly from ~ 0.3 for the other three groups to almost 0.4. Total protein
and albumin excretion, and fractional albumin excretion were higher than in the 2K and ENA groups
and comparable to those of the UNX group, while non-albumin excretion was unchanged. There
was also an increase in hematocrit which might have resulted from a shift of the extracellular fluid
volume from the vascular to the extravascular space, secondary to increased vascular pressures and
resistance.
Figure 6-1 compares the 24-hour urinary protein excretions from the four experimental groups.
The predominant source of the variation in UpV between groups is U~V, U(p_4 )V being relatively
constant. Stated another way, the fractional albumin excretion (UaV/UplV) increased with total
protein excretion. The ratio UaV/UpV= 0.32 in 2K rats is similar to reported normal clinical
values.33 In UNX and NAME rats, the ratio is approximately double the 2K value, while in ENA
rats, its is roughly a third of it. The sieving data will be discussed in the next section, but it is worth
noting here that while the urinary excretion of albumin was increased in the UNX and NAME groups
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Figure 6-1: Comparison of average albumin and non-albumin protein excretions for experimental
groups. Values shown are only for those rats in which both Up Vand UaVwere measured.
123
BW (g)
AP (mm Hg)
Hematocrit
GFR (ml/min)
RPF (ml/min)
FF
SNGFR (nl/min)
QA (nl/min)
SNFF
Cp,A (g/dl)
ap (mm Hg)
K! (nl/min/mm Hg)
UpV (mg/24 h)
UaV (mg/24 h)
U(p.-)V (mg/24 h)
U v/v
FRCp x 10-4
FRC, x 10-4
FRC(p_a) x 10 - 4
Sieving Micropuncture Sieving
only only +Micropuncture
(n = 5) (n = 8) (n = 4)
2.± 7± 
9±
Table 6.3: Hemodynamic values for two-kidney rats. *p < 0.05 vs. sieving + micropuncture group.
only, the filtered load of a 36 A Ficoll molecule, shown as eF36 · GFR in Table 6.2, was elevated in
all three 1K groups. Thus, albumin excretion is normal in the ENA group even though excretion of
36 A Ficoll is elevated.
Table 6.2 includes micropuncture data from eight 2K and five NAME rats which did not undergo
Ficoll sieving studies. In Table 6.3 the data for the 2K rats is split into those which underwent
sieving measurements only, those which underwent micropuncture only, and those which had both.
For unknown reasons SNGFR, SNFF, and Kf were higher in micropuncture-only rats compared to
rats with both. These could reflect effects of the various experimental procedures, methodological
differences, or true differences in the population of the rats. Since Ficoll infusion occurred after
micropuncture, it is doubtful that the sieving measurements themselves had anything to do with the
difference between the micropuncture-only and sieving + micropuncture groups. For the analysis
of the sieving data, only the average whole kidney and single nephron quantities for the rats which
had sieving studies were used.
In Table 6.4, the data for the NAME rats which did and did not have sieving studies are presented.
The rats which had sieving had larger Kf and GFR than those which did not, which was the opposite
trend of the results from the 2K rats, indicating that such differences may have simply been due to
chance.
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278+2
122±4
44.34-0.7
1.46±0.09
5.21±0.25
0.28±0.02
62.7+2.8*
182±9
0.34±0.01'
5.2±0.1
48.9±1.2
2.47±0.13*
13.3±0.6
4.2±0.8
9.0±0.7
0.32±0.06
1.45±0.20
0.99±0.32
1.92±0.11
279±7
124±2
43.41.7
1.250.04
4.940.26
0.250.02
5.40.1
298±5
125±2
43.00.4
1.21±0.08
4.85±f0.17
0.2530.013
49.34.3
177±320
0-280.01
5.3±0.1
48.61.2
1.910.19
I
B W (g)
AP (mm Hg)
Hematocrit
GFR (ml/min)
RPF (ml/min)
FF
SNGFR (nl/min)
QA (nl/min)
SNFF
Cp,A (g/dl)
AP (mm Hg)
K (nl/min/mm Hg)
UpV (mg/24 h)
U.V (mg/24 h)
U(pa)V (mg/24 h)
Ua V/UpV
FRCp x 10-4
FRCa x 10- 4
FRC(p_a) x 10-4
sieving no sieving
(n = 4) (n = 5)
Table 6.4: Hemodynamic values for NAME rats. *p < 0.05 vs. no sieving group. Superscripted
numbers indicate 7i is different from column heading; 1: n = 1, 3: n = 3.
Thus, though there were some significant unexplained variations in the subgroups of 2K and
NAME rats which did and did not undergo sieving, such differences were in opposing directions and
may have been random. In any case, the analysis of any data presented here is not affected, as
averaged values were used only for those to which they were applicable.
6.3.2 Sieving Data
Ficoll sieving coefficients for each of the four groups are shown in Tables 6.5 and 6.6, and plotted in
Figure 6-2 for the range r, = 20 to 70 A. The sieving curves in Figure 6-2 are more sigmoidal than
the Ficoll curves for Munich-Wistar rats (Figure 4-1), the values for at r, = 20 A being closer
to one. At r, < 50 A, for 2K fawn-hooded rats are somewhat greater than those for the normal
Munich-Wistar rats reported in Chapter 4, while for r, = 60 to 65 A, values are lower ( 3 x 10 - 4
for FH rats vs. t 7.5 x 10 - 4 for Munich-Wistar rats). Because different investigators performed the
micropuncture, however, it is difficult to draw absolute conclusions from the comparison.
The variances in 0 for each group were shown to be unequal by statistical analysis, violating the
requirement of homoscedasticity necessary for ANOVA. A logarithmic transformation of the data
satisfied this criterion, and so one-way ANOVA was performed on the values of log(G) to determine
significance.' 4 4 No significant difference is seen between groups for r, < 45 A. For r, > 45 A only
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263±12
160±4
47.0±1.1
1.47±0.09*
4.54±1.09 
0.35±0.04
76.5±6.1
208±40
0.38±0.01
5.4±0.1
64.6±3.3
1.94±0.07*
30.3±5.2*
20.9±6.6( 3)
6.5±2.2( 3 )
0.72±0.13
2.67±0.49*
3.58±1.11
1.19±0.45
254±7
175±10
51.62.1
0.730.05
1.860.18 
0.40±0.02
58.9±8..3 
139±17
0.390.02
5.2±0.1
70.14.3
1 1.220.18
76(l) '
14.0)'
r, (A) 2K (n=9)
20 8.51x 10-1±9.04x 10 - 2
22 7.74 x 10-1±8.09 x 10 - 2
24 6.51x 10-1'7.02 x 10 - 2
26 5.03 x 10-'±5.28 x 10 - 2
28 3.60 x 10-1I3.32 x 10- 2
30 2.71 x 10-1±3.75 x 10-2
32 1.70x10-1±1.76x10 - 2
34 1.07x 10-1±1.25x10-2
36 7.02 x 10-2±8.15 x 10-3
38 4.24 x 10- 2±4.95 x 10-3
40 2.59 x 10-2±3.61 x 10-3
42 1.57x 10-22.44 x 10 - 3
44 9.51 x 10-3±1.60 x 10- 3
46 5.64 x 10-3±1.04 x 10-3
48 3.49 x10-3±6.85 x 10- 4
50 2.29 x 10-3±4.73 x 10- 4
52 1.51 x 10-3±3.37 x 10 - 4
54 1.03 x 10-3±2.46 x 10 - 4
56 7.46 x 10-44±1.93 x 10- 4
58 5.46 x 10-4±1.44 x 10 -4
60 4.01 x 10-4+9.84 x 10- 5
62 3.09 x 10-4±7.28 x 10- 5
64 2.48 x 10-4±5.67 x 10 - 5
66 2.04 x 10-444.19 x 10 - 5
68 1.72x 10-4±3.11 x 10- 5
70 1.50 x 10-4±2.59 x 10 - 5
7.36 x 10-147.04x 10-2
6.73 x 10-1±5.97 x 10-2
5.61 x 10-1±4.89 x 10- 2
4.47 x 10-'3.48 x 10-2
3.37x 10-l±2.32x 10-2
2.47 x 10- ±1.76 x 10- 2
1.76 x 10-11.23 x 10 - 2
1.23x 10-1'1.18x 10-2
8.78x 10-2±1.01 x 10-2
6.10 x 10-2±8.45 x 10 -3
4.19 x 10-247.36 x 10- 3
3.06 x 10-2±6.12 x 10-3
2.22 x 10-2±5.12 x 10- 3
1.64x 10-2±4.34 x 10- 3*
1.24x 10-2± 3.69 x 10 - 3*
9.79 x 10-3±3.23 x 10-3*
7.97 x 10-34±2.96 x 10- 3*
6.59 x 10-3±2.71 x 10- 3*
5.52 x 10-3±2.47 x 10- a*
4.67 x 10-3±2.23 x 10-3 *
4.00 x 10-34±2.03 x 10 - 3*
3.43 x 10-3+1.86 x 10-3*
3.00 x 10-3±1.70 x 10- 3 '
2.65 x 10-3± 1.54x 10 - S
2.32 x 10-3± 1.39 x 10-3*
2.03 x 10-3±1.25 x 10- 3*
Table 6.5: Ficoll sieving coefficients for two-kidney and UNX fawn-hooded rats. All values are given
as mean 4 standard error. p < 0.05 vs. 2K. p was not significant for all comparisons to ENA and
NAME groups.
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UNX (n=9)
r, (A) ENA (n=8)
20 9.34x10- .9.00x10 -2
22 8.59x10-1'8.37x10- 2
24 7.40 x 10- ±7.13 x 10- 2
26 5.91 x 10-1±5.60 x 10-2
28 4.39 x 10-14.34x 10-2
30 3.08 x 10-3.25x 10-2
32 2.16 x 10-'1±2.25 x 10-2
34 1.44x 10-11.53 x 10-2
36 9.55 x 10-2±1.13x 10-2
38 6.36 x 10-2±8.16 x 10-3
40 4.20x 10-2±6.09 x10-3
42 2.78 x 10- 2±4.55 x 10-3
44 1.87 x 10-2±3.25 x10- 3
46 1.31 x 10- 22.53 x 10-3
48 9.49 x 10- 3±2.08 x 10-3
50 7.15 x 10-3±1.75 x 10-3
52 5.48 x10- 3 ±1.46 x 10-3
54 4.28 x 10-3±i1.22 x 10- 3
56 3.31x 10-3±9.88 x10- 4
58 2.68 x 10-3±8.67 x 10- 4
60 2.19 x 10-3± 7.60 x10 - 4
62 1.80 x 10-3±6.46x 10- 4
64 1.49 x 10-3±5.45 x 10- 4
66 1.24 x 10-3±4.74 x 10- 4
68 1.05 x 10-3±4.23 x10- 4
70 8.92 x10-4 ±3.71 x 10- 4
NAME (n=4)
8.43x 10-15.83 x 10-2
7.93 x 10-1-6.72 x 10-2
6.77x 10-1 4.57x 10-2
5.55x10-±4.05x10-2
4.30x 10-'3.75x 10- 2
3.18 x 10-2.65 x 10-2
2.19x10-l±2.72x10 - 2
1.56x 10-±2.37x 10-2
1.08 x 10-12.08x 10-2
7.32 x 10-2±1.83 x 10 - 2
4.95 x 10-2±1.48 x 10-2
3.39x 10-2f±1.22x 10-2
2.34x 10-2±9.29 x 10 - 3
1.72 x 10-2.±7.47x 10- 3
1.25 x 10- 2±5.93 x 10 - 3
8.94x 10-3±4.62 x 10- 3
6.76 x 10-3±3.72 x 10 - 3
5.12 x10-3±2.96 x 10-3
4.15 x 10-3±2.48 x 10 - 3
3.48 x 10-3.±2.18 x 10-3
2.82 x 10-3±1.85x 10- 3
2.22 x 10-31.50 x 10- 3
1.83 x 10-3±1.26 x 10- 3
1.59x 10-31 .12 x 10- 3
1.38 x 10-3±9.95 x 10- 4
1.19 x 10-38.72x 10- 4
Table 6.6: Ficoll sieving coefficients for UNX+enalapril and UNX+NAME fawn-hooded rats. All
values are given as mean standard error. p was not significant for all comparisons to each other
and to 2K and UNX groups.
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Figure 6-2: Sieving coefficients () for Ficoll-infused fawn-hooded rats as a function of molecular
radius (r,). Error bars denote 4 one standard error of the mean.
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]- I [ ~ I [ I ] I 1 I I 1 I [ I -
O Two-kidney (n=9)
0O UNX (n=9)
0 UNX+enalapril (n=8)
A UNX+NAME (n=4)
~-- ml
--
I 
)
Model 2K
(n = 9)
UNX
(n = 9)
ENA
(n = 8)
NAME
(n = 4)
Isoporous r0o (A) 47.1±0.5 48.0±0.3 49.1±0.4 50.6±0.6
+shunt wO x10-3 0.148±0.030 3.184±0.58 0.-97±0.19 1.48±0.48
Xz 153 37.6 79.4 54.9
Lognormalu (A) 30.7±1.7 28.5±1.1 36.0±2.1 36.4±1.3
s 1.23±0.02 1.27±0.02 1.20±0.01 1.17±0.02
r*(5%) (A) 51.2 53.0 55.5 52.0
r*(1%) (A) 59.0 62.4 62.8 57.9
X2 157 36.1 100 44.7
Lognormal u (A) 34.2±0.9 30.6±0.6 38.6±1.2 37.4±0.3
+shunt s 1.19±0.01 1.24±0.09 1.16±0.02 1.15±0.01
wo x10-3 0.134±0.016 2.54±0.31 0.854±0.163 1.49±0.34
r' (5%) (A) 50.8 51.9 53.9 50.9
r*(1%) (A) 57.0 61.0 60.0 56.3
X2 44.6 9.86 47.8 24.8
Table 6.7: Membrane pore parameter fits of fawn-hooded rat sieving coefficients
hemodynamic values of Table 6.1. Fitted values are shown ± one standard error.
to single nephron
Enhanced model:Simpler model 2K 
p-value
UNX
Lognormal+shunt:Isoporous+shunt 2.7 x 10- 7 7.8 x 10- 1.4 x 10 - 3 4.6 x 10 - 5
Lognormal+shunt:Lognormal 2.0 x 10-7 1.3 x 10- 7 9.1 x 10- b 5.4 x 10- 4
Table 6.8: F-test comparisons of heteroporous model fits to fawn-hooded rat data. p values are
those for the significance of the 2 reduction by the "enhanced" model over the "simple" one.
the 2K and UNX groups differed significantly, with the UNX values approximately an order of
magnitude larger.
6.3.3 Pore Size Parameters
Membrane pore size parameters were fitted to the sieving data of Tables 6.5 and 6.6 using the single
nephron hemodynamic data of Table 6.1. The results are shown in Table 6.7 for the isoporous +
shunt, lognormal, and lognormal + shunt models previously discussed (Sections 2.6.5 and 4.2.5).
For each group, the lognormal + shunt model gave the best fit of the three, with the isoporous +
shunt and lognormal models giving approximately equivalent values of X2. This is in contrast to the
Ficoll data from Munich-Wistar (Chapter 4), where the lognormal model was clearly superior to the
isoporous + shunt model. F-test comparisons of the lognormal + shunt model to the other models
are shown in Table 6.8 In all groups, the decrease in X2 provided by the lognormal + shunt model
was highly significant, even though addition of the shunt to the lognormal model made only small
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ENA NAME
AP
GFR
SNGFR
RPF
QA
FF
SNFF
AP
GFR SNGFR RPF QA FF SNFF AP
Table 6.9: Correlation coefficients of whole kidney and single nephron hemodynamic quantities in
fawn-hooded rats. Top number is correlation using rats from all four groups, bottom number is
correlation using just 1K rats. *p < 0.05.
changes in the values of u and s.
The models are plotted against the data for each of the groups in Figures 6-3, 6-4, 6-5, and 6-6.
All three models tend to underpredict /E at small r,, a characteristic of the glomerular pore model
as EO - 1.7983 The models are roughly equivalent in the range 20 A r, < 40 A. Above 50 A, the
lognormal model severely underpredicts the data.
The pore-size distributions for the lognormal and lognormal + shunt models are shown in Fig-
ure 6-7. Because of comparatively higher values of O at small r,, the pores for the fawn-hooded rats
are calculated to be considerably larger than those reported for Munich-Wistar rats in Chapter 4.
For any group of rats, the differences between the two models is not large, nor is there much dif-
ference between the four groups for any one model. The UNX distributions in Figure 6-7 actually
have the highest number of large pores, although this is not demonstrable on the scale of the figure.
6.3.4 Data Correlations
6.3.4.1 Correlation of Hemodynamic Parameters
Pearson correlation coefficients for whole kidney and single nephron parameters are shown in Ta-
ble 6.9. A coefficient of ±1 implies that the two parameters are perfectly correlated, while a value of
zero means there is no correlation between the parameters. Separate coefficients were calculated for
rats from all four groups (top number) and for rats from just the three 1K groups (bottom number),
but little difference was observed. Body weight (not shown in the table) did not correlate with any
of the hemodynamic quantities. As expected, AP and AP correlated with each other and were
similar in how they correlated with other parameters. Analogous statements could be made about
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-0.468* -0.277 -0.592* -0.518' 0.574' 0.616' 0.780' -0.778'
-0.597* -0.476* -0.668* -0.700* 0.636* 0.706* 0.796* -0.878*
1.000 0.659* 0.873* 0.767* -0.118 -0.424* -0.310 0.567
1.000 0.653* 0.911' 0.794* -0.422* -0.567* -0.468* 0.545*
1.000 0.537 0.69 -0.034 -0.256 -0.039 0.563
1.000 0.604* 0.607, -0.408* -0.474* -0.311 0.519*
1.000 0.788 -0.554* -0.653* -0.486* 0.580
1.000 0.864* -0.732* -0.759* -0.568* 0.592*
1.000 -0.341* -0.610' -0.274 0.700*
1.000 -0.676* -0.780 -0.521* 0.689*
1.000 0.741 0.581 -0.341'
1.000 0.854* 0.533* -0.558*
1.000 0.533' -0.486*
1.000 0.588* -0.604*
1.000 -0.664*
1.000 -0.835*
Kf
1 rO
lU
0) 10 - 2
10- 3
1 n- 4
20 30 40 50 60 70
rs (A)
Figure 6-3: Fits of various heteroporous distribution models to two-kidney fawn-hooded rat data.
Parameters are given in Table 6.7.
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Figure 6-4: Fits of various heteroporous distribution models to uninephrectomized fawn-hooded rat
data. Parameters are given in Table 6.7.
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Figure 6-5: Fits of various heteroporous distribution models to uninephrectomized + enalapril-
treated fawn-hooded rat data. Parameters are given in Table 6.7.
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Figure 6-6: Fits of various heteroporous distribution models to uninephrectomized + NAME-treated
fawn-hooded rat data. Parameters are given in Table 6.7.
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Figure 6-7: Pore number density distributions g(r) for fits to fawn-hooded rat data. Plots are based
on the values of Table 6.7.
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the couplets of RPF and QA, SNGFR and GFR, and FF and SNFF. In general, pressure increases
correlated with decreases in capillary flow rate, indicating an increase in total arteriolar resistance.
Glomerular filtration rates decreased due to both the drop in capillary flow rate and to an additional
decrease in Kf. Filtration fraction, however, increased. The inverse correlation between AP and
Kf has been previously noted by Tucker and Blantz.44
Hemodynamic parameters are correlated to sieving and protein excretion data in Table 6.10.
None of the sieving coefficients at any r, displayed significant correlation with the hemodynamic
parameters (shown are values for r, = 36 and 60 A). The filtered load of Ficoll (. GFR) at all sizes
correlated with GFR(as expected) and RPF, and not with AP.
Urinary excretion of total protein, Up V, showed a highly significant correlation with AP (and thus
an inverse correlation with Kf), as did the urinary albumin excretion (UaV) (Figure 6-8). Neither
correlated with GFR. In contrast, excretion of non-albumin protein correlated with GFR but was un-
correlated with AP (Figure 6-9). The fraction of albumin in the excreted urine, UaVl/Up'Vcorrelates
solely with AP (Figure 6-10). These data suggest that albumin excretion is governed by perms-
electivity alterations secondary to AP changes, while non-albumin excretion is a function of the
filtered load through the capillary, scaling with filtration rate. As albumin is the most anionic of
the major proteins, the implication is that a decrease in the charge barrier to filtration is associated
with increases in AP.
In support of this, the fractional clearance of total protein, FRCp, showed a highly significant
correlation with AP. (There were also significant correlations with GFR and RPF, though not with
the corresponding single nephron quantities.) The fractional clearance of albumin, FRCa, also was
very significantly correlated to AP, but the fractional clearance of non-albumin proteins, FRC(p_),
was not. In contrast, none of the values of 0 for Ficoll at any size demonstrated correlation with
any hemodynamic quantity.
6.4 Discussion
These studies suggest that there is a size defect introduced by uninephrectomy which persists through
pharmacological interventions which both decrease (enalapril) and increase (NAME) AP. This
defect is evidenced by the "tail" of the sieving curve at large r,. This size defect, however, does not
appear to be an important determinant of proteinuria, since e for Ficoll at r, = 36 A (corresponding
to albumin size) is not affected. Rather, it is an apparent change in charge-selectivity which increases
proteinuria, as suggested by a specific increase in albumin excretion.
A simple physical explanation for any possible charge/pressure interaction is unlikely. Compres-
sion of a membrane with a homogeneously distributed charge would increase the charge density and
the resistance to transport of anions, and therefore reduce albumin excretion.
The interaction of renal hemodynamics with size- and charge-selectivity has been examined in a
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Figure 6-8: Correlation of filtration pressure (AP) to urinary albumin excretion (UaV). Solid lines
are fit to all data, dashed lines are fit to the three 1K groups.
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Figure 6-9: Correlation of filtration pressure (P) to urinary non-albumin protein excretion
(U(pa)V). Solid lines are fit to all data, dashed lines are fit to the three 1K groups.
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Figure 6-10: Correlation of filtration pressure (AP) to fractional albumin excretion (UaV/UpV).
Solid lines are fit to all data, dashed lines are fit to the three 1K groups.
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few studies, but a comprehensive picture of the mechanism has yet to emerge. Olson et al.'9 8 mea-
sured the sieving of neutral dextran, anionic dextran sulfate, and neutral, anionic, and cationic forms
of horseradish peroxidase (HRP) in Munich-Wistar rats which had undergone 15/16 nephrectomy.
Neutral HRP sieving coefficients and dextran sieving coefficients for r, = 16 to 60 A were not signif-
icantly different from controls. Micropuncture was not performed in this study. If their sieving data
are interpreted using hemodynamic parameters from a similar study by the same investigators,l 28
then the Olson et al. results are seen to be in agreement with those of the present work: renal
ablation decreased the selectivity to large (> 50 A) neutral molecules, but that to smaller molecules
was relatively unaffected. In addition, values of e for anionic HRP and dextran sulfate were sig-
nificantly increased, while those for cationic HRP were significantly decreased. This diminished
charge-selectivity is also in concurrence with the results reported here.
Weening and van der Wal2 s s studied the effects in rats of lowered perfusion pressure on charge-
selectivity using charged horseradish peroxidases. Aortic ligation was used to lower AP from 105 to
56 mm Hg, though AP was not measured. Fractional clearances of anionic, neutral, and cationic
HRP were all unchanged. Thus, lowering of AP to levels below physiologic may have no effect on
permselectivity.
Mayer et al.174 measured dextran sieving curves in rats along with the fractional clearance of
18 A dextran sulfate. Renal ablation increased O fr both dextran sulfate and large (r, > 5 5i)
dextrans. Treatment of the ablated rats with MK954, an angiotensin II receptor blocker, did not
change O for dextran sulfate though both AP and UpV decreased and the size-selectivity to neutral
dextran was restored to normal. Unlike the ACE inhibitor used in this study, pressure ameliorization
by angiotensin II blockage demonstrated no effect on charge selectivity.
Treatment of uninephrectomized rats with ACE inhibitor did not substantially change size-
selectivity to Ficoll in this study, although it did reduce proteinuria. In contrast, ACE inhibitors have
been shown to improve size-selectivity in aging rats 213 and in patients with diabetic nephropathy1 83
and IgA nephropathy.2 12 These studies used dextran instead of Ficoll to assess size-selectivity, but
this would not be expected to change the qualitative nature of the results. The reason for the
different responses to ACE inhibition in the present study versus the others is not clear, but it may
be related to different mechanisms of action. It has been suggested that in some disease models ACE
inhibitors reduce proteinuria by increasing kinin activity rather than by decreasing angiotensin II
activity. 13 0 131
Thus, although both enalapril and angiotensin II antagonists reduce proteinuria in rats with
reduced renal mass, enalapril appears to restore charge-selectivity without changing size-selectivity
while A-II blockers restore size-selectivity without changing charge-selectivity. The possibility of
different pharmacological mechanisms influencing the selectivity underscore the need for further
research in this area.
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This study is the first to report the effect of NO inhibition on glomerular size-selectivity. Despite
changes in hemodynamics and the ultrafiltration coefficient, sieving coefficients from NAME rats
were not different than those from UNX rats. It may be that any effects of NAME on size-selectivity
are not detectable in the uninephrectomized state. Further studies of NO inhibition on two-kidney
rats should be performed.
We used the ratio of urinary albumin excretion to total urinary protein excretion as a measure
of effective membrane charge. In doing so, however, we did not distinguish the effect of changes in
glomerular charge-selectivity from any potential changes in tubular reabsorption of protein. Since it
is generally postulated that the reabsorption capacity of the tubules is overwhelmed in proteinuria,
this is not believed to be a cause for concern. It should be recognized, however, that in the normal
state cationic proteins are absorbed more rapidly along the length of the tubule, although the
net absorption of both cationic and anionic proteins are the same." 6 There is no information on
how pathological conditions such as renal ablation affect protein reabsorption, although it seems
reasonable to continue to assume that it will have no effect on urinary protein excretion because of
the high filtered load of protein. Nevertheless, to rigorously correlate charge-selectivity to proteinuria
requires measurements of both protein excretion and the sieving coefficient of a suitable charged
tracer (i.e., one that is freely filtered and neither secreted nor reabsorbed in the tubules). Given the
preference for Ficoll over dextran in sieving studies (Chapter 4) and the difficulties in interpreting
dextran sulfate clearances because it binds to plasma proteins,l 74 there is now strong motivation for
developing a charged analog to Ficoll for use in studies of charge-selectivity. Ficoll sulfate is a likely
candidate for this purpose. Ghitescu et al.l l 6 have developed anionic neutral, and cationic versions
of DNP-bovine serum albumin which might also be used for such purposes. Alternatively, Di Mario
and co-workers8s6 ' 7 have proposed using the ratio of anionic immunoglobulin (IgG4) excretion to
total IgG excretion as a clinical parameter of charge selectivity. Sensitive immunoassays have been
developed for measuring IgG4 and total IgG in urine.8 8 'l8 2 This method has the advantage of not
requiring exogenous infusions.
The results presented here are indicative of the chronic effects of altered pressure on glomerular
permselectivity. Effects of short-term pressure changes by the acute administration of enalapril and
NAME, in both 1K and 2K rats, should be examined.
142
Chapter 7
Estimation of Glomerular Transcapillary Hydraulic
Pressure in the Rat from Sieving Curves
7.1 Introduction
7.1.1 Previous Work
The clinical motivation to monitor filtration pressure is strong in light of evidence that hyperfiltra-
tion, and in particular an elevated AP, is associated with a progression of glomerular damage and
renal disease regardless of the etiology of the hemodynamic changes. Rat models in which AP has
been shown to play a significant role include surgical infarction of renal tissue, 6 ' 7 10 6 '107 ' 128, 175,198
desoxycorticosterone-salt hypertension, 92 and streptozotocin-induced diabetes mellitus.2 66 ,2 6 7 In all
of these cases AP is elevated along with the glomerular plasma flow rate QA and the single nephron
glomerular filtration rate SNGFR. Therapy in these animals which selectively reduces AP (while
leaving QA and SNGFR elevated), such as treatment with angiotensin I converting enzyme (ACE)
inhibitors, slQws the progression of glomerular sclerosis even in the persistence of systemic hyperten-
sion or underlying metabolic disease.6 , 7 10 7 ,175, 266 Additionally, treatment of systemic hypertension
in a manner which does not lower AP is not as effective at preventing further renal damage.7 ',
Acute or chronic elevations in AP are also associated with proteinuria. 2 9 ,261 ,2 62 A method for ob-
taining clinical values of AP, or at least determining changes in AP, is required to fully evaluate
the results of human trials.
The estimation of filtration pressures from sieving curve data has been of interest for some time.
Early attempts1 1'1 10 °111' 15 9'160,247 were based on the Pappenheimer-Renkin mathematical model
(Section 2.6.3) and therefore suffer from its limitations. Least-squares fit values for an effective
glomerular ultrafiltration pressure, equivalent to AP - fo1 rGC(y) dy, range from 9 to 30 mm Hg in
these early studies. The differences in the fits principally reflect variations in the method used to
calculate the hindrance factors, with the lower values obtained with the most recent methods. These
estimates are all based on data from dogs and human beings, so there are no direct measurements
of AP with which to compare. Du Bois and Stoupel90 tested the Pappenheimer-Renkin model in
vitro by measuring PVP transport through artificial membranes. Reported results showed good
agreement with the theory; the ratio of actual AP to fitted values based on sieving curves was
1.036.
Lambert and Gassee and co-workers"l2' l58 fit pressures in the dog glomerulus using a pore
model, but also included a term for the hydraulic pressure drop along the length of the capillary.
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In order to get realistic results, they found it necessary to modify the boundary condition for solute
concentration at the membrane/Bowman's space interface as a hybrid of two possibilities previously
discussed (Section 2.6.4): the first and last quarter of capillary length used the local concentration
condition while the middle two quarters used the well-mixed condition. Using this model afferent
and efferent AP values of 50 and 42 mm Hg were obtained. Again, no confirming measurements
were obtainable.
Chang,5 9 in a retrospective study, used the pore model to fit filtration pressures to dextran sieving
literature data for Munich-Wistar rats.6 0 ' 63 His fit values for AP were consistently lower than the
experimental values by 2-9 mm Hg, with corresponding higher Kf values and lower ro values than
reported originally. The range of AP measured in the studies was not wide, ranging only from 34
to 40 mm Hg.
Most recently, Chan et al. have used dextran sieving data to estimate AP in a clinical study of
dietary protein effects.5 7 Employing the isoporous model, they obtained values for control subjects
of AP = 34 mm Hg and 38 mm Hg in the preprandial and postprandial periods, respectively. Fits to
results from patients with chronic glomerular disease (preprandial AP = 34 mm Hg) were insensitive
to changes in AP up to 38 mm Hg.
This chapter begins with a discussion of the theoretical basis for estimating AP from sieving
data, followed by a comprehensive review of fitting isoporous-model pressures to available dextran
experimental data. We then examined pressure fitting using recent data with more optimal con-
ditions of exogenous tracer, greater range in measured pressures, and more recent heteroporous
models.
The fawn-hooded rat study of Chapter 6 is one of the few experiments to date in which both
micropuncture and sieving measurements were performed and in which large alterations in AP were
achieved. As such, it provides an important new source of data with several advantages pertaining
to pressure estimation. Ficoll sieving data was used, which is better suited to the theoretical model
than that for dextran. Through GPC calibration with Ficoll standards, the molecular sizes were
more accurately determined than had been previously, and a larger range of r, was used. The animal
protocols resulted in a wider range of AP than usually reported. Finally, newer and more realistic
heteroporous models were employed.
7.1.2 Theoretical Considerations
Any method which attempts to determine changes in AP from sieving curves must distinguish be-
tween those effects due to alterations in permselectivity and those from alterations in hemodynamics.
The situation of most interest for deriving pressures is that of AP changes at constant SNGFR, since
this corresponds to the clinical case where the information on flow rates (RPF, GFR) is at hand
while AP and Kf are unknown.
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Figure 7-1 compares the effects of changes in o to those of changes in AP at constant SNGFR
using the isoporous model. As would be expected, a o increase is accompanied by a rise in at
all values of r,. The effect is more noticeable at larger sizes. A rise in AP increases the net solute
clearance but increases GFR to an even greater degree, and so the fractional clearance decreases.
Decreasing plasma osmotic pressure has essentially the same effect. In contrast to a change in
ro, the sieving coefficients for large molecules are less sensitive to pressure then those for small
molecules. Good agreement with this prediction is shown by the findings of Gassee et al.,l1l where,
at comparable renal flow rates, sieving curves were generally lower in dogs with higher mean arterial
blood pressures, but the curves merged at large solute radius.
As pointed out by Du Bois and Stoupel,90 the sieving curves are steeper-the membrane show-
ing greater permselectivity-at lower pressures, where the diffusive forces play a more important
role. For large solutes, the sieving curves are relatively independent of pressure, a consequence
of convection-domination. Qualitatively, then, it can be seen that permselectivity changes have
different effects than hemodynamic changes. The question remains whether the sensitivity of the
measurements or of the models is sufficient to allow AP to be inferred.
7.2 Preliminary Calculations
As an initial assessment, we retrospectively applied the isoporous, solid-sphere model of Section
2.6.4 to all experimental studies in the rat where both fractional clearances of neutral dextrans were
obtained and AP was measured by micropuncture. These results are summarized in Table 7.1. Each
of the cases shown involves paired groups of animals; one group serves as a baseline or control group
and the other is a group in which some sort of intervention was made. Using the mathematical model,
best-fit values of AP (along with ro) were calculated from the data as described in Section 7.3.1 and
compared to those actually measured. Similarly to Chang,5 9 fitted values generally underpredict the
actual ones. The more central clinical issue of measuring changes in AP is shown in Figure 7-2 for
the paired groups. The correct direction is calculated in six of the nine cases, but the magnitude of
the change is generally lower than measured. The mathematical analysis failed to correspond to the
actual results in three cases, for no apparent reason. In summary, while the theory gives reasonable
agreement with the data, it is questionable whether the conventional model is a clinically reliable
means of estimating AP, or directional changes in AP.
7.3 Fitting of AP to Fawn-Hooded Rat Data
7.3.1 Methods
Pore size parameters plus AP were fitted simultaneously to sieving data using the X2 criterion of
Section 4.2.5. Both data from the individual rats and averaged data for the experimental groups were
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Figure 7-1: Theoretical effects of changes in isoporous ro (top) compared to changes in AP (bottom)
at constant SNGFR. Unless otherwise shown, input parameters were ro = 50 A, SNGFR = 49.8
nl/min, QA = 172 nl/min, AP = 35 mm Hg.
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Table 7.1: Comparison of measured and fitted AP from published fractional clearance data for
dextran in rats using the isoporous, solid-sphere model. Abbreviations: AII-angiotensin II, NSN-
nephrotoxic serum nephritis, PVE-plasma volume expansion, PHN-Passive Heymann's nephritis,
ACh-acetylcholine, Ver-verapamil.
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AP, mm Hg Measured/
Conditions Reference Measured Calculated Calculated
1. Normal hydropenia 30 34.0 33.8 1.01
Hydropenia + AII 43.0 45.6 0.94
2. NSN hydropenia 60 39.0 29.0 1.34
NSN + PVE 40.0 30.3 1.32
3. Normal hydropenia 63 34.0 32.0 1.06
Normal + PVE 38.0 27.0 1.41
4. Normal euvolemia 133 33.9 21.9 1.55
Normal+Histamine 39.5 23.5 1.68
5. Normal control 178 39.9 30.7 1.30
Diabetes 34.5 30.8 1.12
6. Normal euvolemia 261 33.0 36.8 0.90
Normal + RVC 42.0 39.5 1.06
7. PHN baseline 262 40.0 42.5 0.94
PHN + AII 52.0 45.6 1.14
8. PHN baseline 262 42.0 49.4 0.85
PHN + ACh 35.0 50.2 0.70
9. Renal ablation 263 51.9 41.5 1.25
Ablation + Ver 34.0 35.5 0.96
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Figure 7-2: Comparison of measured changes in AP to those fitted from dextran sieving data using
the isoporous, solid-sphere model. Case number correspond to those in Table 7.1.
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used. The group-mean sieving coefficients of Tables 6.5 and 6.6 were fitted using the appropriate
hemodynamic parameters from Table 6.1. For fits to individual rat sieving curves, data was used
only from the 25 animals (2K=4, UNX=9, END=8, NAME=4) on which both micropuncture and
sieving studies were performed. When data from a single rat was fitted, the standard error o'i,exp
was set equal to ei,exp in Eq. 4.6.
Either Powell's method 206 or the donwhill simplex method206 was used to determine the best-fit
set of parameters. Pearson's correlation coefficient was used to determine significance of correlation
between parameters.
7.3.2 Results and Discussion
In order to first determine whether specific ranges of the sieving curves showed greater sensitivity
to AP changes, we examined the individual sieving and micropuncture data from the 25 rats which
underwent both studies. Correlation coefficients between AP and O were calculated for each value
of r. The results are shown in Figure 7-3. The correlation was not significant at any value of r.,
but the trend itself is of some interest. The correlation coefficient was negative for 20 A < r, <
38 A. This implies that O varied inversely with AP at small rand varied with AP at large r,, in
agreement with the predicted effect from Figure 7-1. For 50 A< r, < 70 A, the correlation was a
constant positive value, with a lower magnitude than that for small r,. While it seems that at
small r, may be more sensitive to AP changes, the correlation is not significant enough to justify
using specific size ranges of sieving data to fit AP.
To demonstrate the equivalence of using single nephron versus whole kidney parameters in pres-
sure fits, the four sets of experimental group data were fitted using both single nephron and whole
kidney hemodynamic data of Table 6.1. The results are shown in Table 7.2. Little difference is seen
between the results from single nephron versus whole kidney parameters. Fitted AP uniformly un-
derpredicted measured values by a considerable amount. None of the models predicted that AP for
the NAME was was substantially higher than the other groups. The isoporous + shunt model gave
results closer to those measured, and it correctly demonstrated that the UNX and NAME pressures
were higher than the 2K and ENA pressure. Even though they provided better overall fits to the
sieving coefficients, the lognormal and lognormal + shunt fits indicated that the ENA and NAME
pressure were either higher than or similar to those for 2K and UNX.
Finally, pressures were fitted to the sieving data of each of the 25 double-study rats and compared
to the micropuncture value. Whole kidney hemodynamic parameters were used for the inputs. The
results are shown in Figures 7-4, 7-5, and 7-6.
Again, fitted AP tended to underestimate measured AP. For the isoporous + shunt model,
6 Pfltted - 6Pmeasured averaged -13.6 mm Hg, with a range of from +6.7 to -61.4 mm Hg. For the
lognormal model, the average was -21.2 mm Hg with a range of from -8.3 to 36.7 mm Hg, and for
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Figure 7-3: Correlation of e(r,) with AvP for fawn-hooded rats.
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Figure 7-4: Correlation of measured to fitted AP for isoporous + shunt model. Solid line is a linear
fit to the data. Dashed line is APfIt = APmeasured.
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Figure 7-5: Correlation of measured to fitted AP for lognormal model. Solid line is a linear fit to
the data. Dashed line is APft = APmeasured.
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Figure 7-6: Correlation of measured to fitted AP for lognormal + shunt model. Solid line is a linear
fit to the data. Dashed line is APflt = APmeasured.
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Lognormal+shunt model
Two-kidney
o UNX
UNX+enalapril
- A UNX+NAME -
/
r=-0.21 1
/·'~ ~p=0.312:
, I I , I I I j [II I I I [ i 1 , a 1 i i -11 111 1 1
Group 2K UNX ENA NAME
APmeasured (mm Hg) 48.6 + 1.2 55.9 ± 1.2 43.6 ± 1.2 64.6 ± 3.3
parameters WK SN WK SN WK SN WK SN
Isoporous ro (A) 46.9 46.8 47.7 47.8 48.6 48.7 49.0 48.7
+shunt wo (10 - 4) 1.07 1.05 27.4 27.3 7.18 7.23 9.43 8.69
APfit (mm Hg) 35.8 37.0 44.8 45.2 37.0 36.9 38.5 40.8
Lognormal u (A) 29.7 29.8 26.6 26.0 32.5 32.5 33.4 33.9
s 1.26 1.26 1.33 1.34 1.26 1.26 1.25 1.24
APt (mm Hg) 27.2 28.7 29.1 28.8 31.4 31.2 32.1 35.6
Lognormal u (A) 34.1 35.4 31.9 27.6 35.8 34.5 34.2 35.6
+shunt s 1.21 1.19 1.25 1.31 1.20 1.22 1.23 1.22
WO (10-4 ) 0.314 0.415 13.8 4.48 0.905 0.891 1.13 1.31
APfit (mm Hg) 27.6 29.7 35.2 28.4 31.1 30.9 31.7 35.6
Table 7.2: Fits of pore parameters plus AP to group-averaged sieving coefficients. WK: whole
kidney hemodynamic parameters; SN: single nephron hemodynamic parameters.
the lognormal + shunt model the average was -16.0 mm Hg with a range of from +52.4 to -38.1
mm Hg. For the isoporous + shunt and lognormal models, there were a few cases in which the values
were overestimated. There was no apparent pattern to the overestimation, however. None of the
correlations between fitted and measured AP were significant (p = 0.733 for the isoporous + shunt
model, p = 0.103 for the lognormal, p = 0.312 for the lognormal + shunt). For the lognormal +
shunt model, the pressures were inversely correlated.
In summary, neither the use of newer heteroporous models nor fitting of individual sieving data
instead of group means improves the ability of the present models of glomerular permselectivity to
infer glomerular hydraulic pressures. It is not clear whether this failure is intrinsic to the model or
to the experimental accuracy of the'sieving coefficients and hemodynamic data. Further evaluation
of the model and the sensitivity of pressure fitting to experimental variance in (E is necessary to
determine whether estimation of AP from sieving coefficients is viable.
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Chapter 8
Conclusions and Recommendations
In this thesis we examined several technical and theoretical aspects in the use of sieving curves to
analyze the effects of hemodynamic changes on glomerular permselectivity. In Chapter 3, errors in
dextran and Ficoll molecular radius resulting from the use of protein calibration curves were shown
to be small, on the order of 5 A, for Sephacryl 300-HR columns. Correction factors could be easily
obtained from calibrations using monodisperse polysaccharide standards. Dispersive effects were
seen to be noncontributory to the calculation of sieving curves.
The importance of molecular configuration in glomerular filtration was demonstrated in Chap-
ter 4. Ficoll and dextran were shown to behave in vivo in a fashion qualitatively similarly to their
diffusion through synthetic membranes; that is, dextran transport at all sizes was greatly enhanced
over that of Ficoll. The data from Ficoll indicates that the capillary wall is more size-restrictive
than had previously been suggested by dextran sieving curves. Since Ficoll has been shown to follow
the predicted behavior of a solid neutral sphere, pore size parameters from Ficoll studies will be
more directly interpretable in terms of the pathophysiology of proteinuria. It is recommended that
Ficoll be used for all future analysis of glomerular permselectivity. There is a vast body of dextran
sieving data in various experimental protocols, both clinically and in animals. While Ficoll would
be expected to show roughly parallel behavior, it will nevertheless be important to perform Ficoll
sieving studies in at least some of the more important protocols (e.g., renal ablation, diabetes, and
glomerulonephritis) versus control animals.
Dextran filtration in vivo was described using a recently-developed model for the transport of
random coils through cylindrical pores (Chapter 5). While the precise nature of dextran's enhanced
transport remains unknown, it was shown to be quantitatively equivalent to a solute/pore attraction
energy of about -0.25kBT, nearly the same as that demonstrated in vitro. It thus appears that
the phenomenon is independent of the system and may be intrinsic to the dextran/water system.
Along these lines, dextran's physical dimensions have been measured by several methods and seen
to be consistent with a more compact molecule than would be expected from its chemical structure
(Appendix F). It may prove interesting to model dextran's transport behavior in other ways, such as
by a factor which reduces the equivalent radius of gyration of the dextran molecule or by calculating
steric parameters for a branched molecule.
We have introduced a new means of describing the heteroporous nature of the glomerular cap-
illary wall, the lognormal + shunt model (Chapter 4 and 6). In order to reduce computation time,
the approximate methods developed by Deen et al.79 have been used in the calculation of hetero-
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porous membrane parameters. While these methods have been shown to be accurate in previous
applications, future experiments may involve other types of pore size distributions and the sieving
data will be for tracers at higher r (and hence lower O) than previously measured. With the advent
of high-speed workstations and wider access to supercomputers, the time required to implement the
full mathematical model will not be prohibitive, and it is recommended that in the future it be
employed in sieving analysis.
It should be emphasized that all such models represent only functional equivalents of the cap-
illary wall. As such, changes in pore size parameters cannot be correlated to true changes in the
wall ultrastructure. As newer ultrastructurally-based theories become available, they should be
incorporated into the model.
The fawn-hooded rat experiments of Chapter 6 represent the first use of Ficoll to evaluate changes
in glomerular disease and were performed in a species of rat for which no previous sieving data
exists. In addition to continued evaluation of the fawn-hooded rat model, further work using Ficoll
in Munich-Wistar models and in clinical studies is recommended, where results can be compared to
previous studies using dextran.
The fawn-hooded rat experiments suggest that loss of charge permselectivity is more significant
than loss of size-permselectivity in the pathophysiology of proteinuria secondary to renal ablation.
In the absence of a suitable charged tracer for evaluation of charge-permselectivity, these conclusions
were based on measurements of urinary fractional albumin excretion. Development and character-
ization of a charged analog of Ficoll such as Ficoll sulfate should be made a high priority, as it is
necessary for more direct assessments of charge-permselectivity.
Assuming the eventual development of a charged tracer, several interesting studies suggest them-
selves. A comparison of the effects of ACE inhibitors versus angiotensin II antagonists on charge-
and size-selectivity and proteinuria are recommended, as the data of Chapter 6 and the results of
Mayer et al.'74 suggest different mechanisms are at work. Such a study would ideally involve both
control and uninephrectomized animals with measurement of neutral and charged Ficoll sieving,
total urinary protein excretion, and fractional excretion of albumin, IgG, and IgG4.
A study comparing the acute effects of ACE inhibitors, angiotensin II antagonists, and NAME in
normal and uninephrectomized rats would also be of great interest. A two-period sieving study-one
before the administration of the drug and one after-would be required for these experiments.
The results from attempts to fit filtration pressures to sieving data were not encouraging (Chap-
ter 7). The worst-case scenario is that (E is not sufficiently sensitive to changes in AP to allow for
fitting. A more optimistic possibility is that the present mathematical model is simply not advanced
enough to enable accurate estimation of AP. A more sophisticated examination of the sensitivity
of the model to experimental errors may suggest an alternate approach, such as a definition of X2
modified for optimization of AP fitting.
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Appendix A
List of Principal Symbols
The dimensions are given in terms of mass (M), length (L), time (t), temperature (T), and charge
(Q). When no dimensions are listed, the units are dimensionless or variable.
AP mean systemic arterial pressure,
ML-lt-2
Ci,A afferent concentration of solute i,
ML-3
(ci,B) average concentration of solute i
in Bowman's space, ML-s
Cp,A afferent protein concentration, ML-3
cp,E efferent protein concentration, ML- 3
Ci renal clearance of solute i, L 3 t-1'
V translational diffusion coefficient,
L2t-1
d interaction distance for Monte Carlo
square-well potential, L
f capillary wall porosity
f' protein volume correction factor
FF filtration fraction = GFR/RBF
FRCi fractional clearance of solute i, =
C,/ GFR
g(r) pore radius size distribution func-
tion
G solute lag coefficient
GFR glomerular filtration rate, L3 t -1
H diffusion hindrance factor
Ji solute flux, ML- 2t - 1
J, solvent flux, Lt - '
kB Boltzmann's constant, ML 2 _-2 T - 1
K solute enhanced drag coefficient
K,, approximate fractional elution vol-
ume of solute
Kf ultrafiltration coefficient, M-1L4 t
K Taylor dispersion coefficient, L 2t - 1
I length of chain segment in random
coil, L
f capillary membrane thickness, L
L capillary length, L
m 1) number of data points to fit
2) number of radial mesh points
for Monte Carlo simulation
md number of mass points fitting within
the square-well interaction region
M molecular weight, M/g-mole
Me number of chains generated in a
Monte Carlo simulation
M, number-averaged molecular weight,
M/g-mole
M, weight-averaged molecular weight,
M/g-mole
n number of chain segments in ran-
dom coil
NA Avogardo's number, (g-mole)-l
p probability that a molecule will fit
in pore at position 
PA afferent arteriole hydraulic pres-
sure, ML-lt - 2
PE efferent arteriole hydraulic pres-
sure, ML-lt- 2
PGC glomerular capillary hydraulic pres-
sure, ML-'t - 2
PT tubular hydraulic pressure, ML-lt-2
PUF net ultrafiltration pressure, ML-lt- 2
AP average capillary transmural hy-
draulic pressure difference, ML- t-2
Pe Peclet number, = WJE/fH
q2 lognormal + shunt pore distribu-
tion parameter
QA single nephron afferent capillary
plasma flow rate, L 3t - 1
QE single nephron efferent capillary
plasma flow rate, L 3t-1
r pore radial coordinate, L
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r* characteristic pore radius for het-
eroporous distributions, L
f dimensionless pore radial coordi-
nate, = r/rp
r, root mean-square radius of gyra-
tion, L
rp pore radius, L
r, Stokes-Einstein radius, L
f, Stokes-Einstein radius as deter-
mined by protein calibrated GPC,
L
Tro isoporous pore radius, L
R chain end-to-end distance, L
RA afferent arteriole resistance, ML-4t -
RE efferent arteriole resistance, ML-4t-1
RT total arteriole resistance = RA +
RE, ML- 4 t- 1
RBF renal blood flow, L 3 t-
RPF renal plasma flow, L3t -1
s lognormal distribution parameter
S capillary wall surface area, L2
SNFF single nephron filtration fraction,
= SNGFR/QA
SNGFR single nephron glomerular filtra-
tion rate, L 3 t- '
T absolute temperature, T
u lognormal distribution parameter,
L
(U/P) urinary-to-plasma concentration
ratio
U urinary flow rate, L 3 t-1
V, elution volume of solute i, L3
Vt total column volume, L3
VO void volume of column, L3
W convective hindrance factor
z pore axial coordinate, L
y capillary axial coordinate, L
y dimensionless capillary axial coor-
dinate, = y/L
Greek symbols
ai coefficients for Simpson's rule
e dimensionless Boltzmann attrac-
tive energy term
[] intrinsic viscosity
Oi sieving coefficient of solute i, =
(Ci,B)lci,a
Ag solute gryration-to-pore radius ra-
tio, = rg/rO
A, solute Stokes-Einstein-to-pore ra-
dius ratio, = Tr/TO
p solvent viscosity, ML-t - '
ir 3.14159...
rA afferent arteriole oncotic pressure,
ML-lt-2
irE efferent arteriole oncotic pressure,
ML-lt-2
Air capillary transmural oncotic pres-
sure difference, ML-lt - 2
or standard error of the mean
/ steric partition coefficient
X2 sum of squared residuals
w0 shunt parameter for heteroporous
models
/ radial flow-weight averaged con-
centration parameter
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Appendix B
Modifications to Numerical Integrations for
Models
Heteroporous
B.1 Scheme for Faster Calculation of Approximation Integrals
For heteroporous models, the sieving coefficient is a weighted average of
the volume flux distribution:7 9
ei = w(r)O (r) dr,
W(r) t 1 r 4g(r)
o r4g(r) dr'
the isoporous values over
(B.la)
(B.lb)
where w(r) is the fractional filtrate volume through pores with radii between r and r + dr, g(r) is
the fractional number of pores with radii between r and r + dr, and
Ei(r) = 1 - C Ji(, r)d
ci,A o' J:,(~, r)d9 (B.2)
is the isoporous sieving coefficient of solute i through those corresponding pores. Ji(Y, r) is the solute
flux at dimensionless position along the capillary through pores with radii betwen r and r + dr,
while J, (, r) is the corresponding volume flux.
In the approximate method devised by Deen et al.,7 9 Eq. B.2 is calculated as
bW | [1 + ai(1 - e)] eb9
i(Q)j 1-e- J 1-e-Pe ()(1 -W~) d ,
Wi(AP - A)eb 7 br2\
Pe(P) = --- ()Hi~)i 8t '
(B.3)
(B.4)
where ai and b are constants. This approximation is necessary to reduce computation time to
reasonable lengths, and was shown to result in not more than 5% error in cases of marked filtration
pressure disequilibrium (with a maximum error of 10%), while requiring 1% of the computation
time.79
Here we show that computation time can be further reduced by making the following substitu-
tions,
bw;A = bW,
1 - e- b'
B = Pe(.)le-/-
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(B.5)
Wi(AP - A) rv2\
Him~i ( 81l ) (B.6)
C = 1-Wi, (B.7)
q(9) = e- ", (B.8)
where A, B, and C are constants and q(y) is the spatially-varying parameter. Eq. B.3 is then
rewritten as
A / - 1 - ai - aiq dq.
Oi(T) = 1 - ce- dq. (B.9)
The first two terms in the quotient of Eq. B.9 can be integrated directly, leaving only integration of
the third term to be carried out by numerical means:
- - B n Ce - B
e-b
Aai q1 C -Bn dq. (B.10)
Implementation of Eq. B.10 in place of Eq. B.3 decreased the CPU time required for parameter
fitting by approximately a factor of 2.
B.2 Endpoint Calculation for Lognormal Distribution Integrations
Calculation of Eq. B.la requires integration over the range r = 0 to oo. In the actual numerical
procedure, a value r,tp is chosen as the upper limit such that
fOC (?it...s f~-( · i~a t opr r4 g (r)Oi(r) dr
i (r)(Di(r)dr w(r)Oi(r)dr = fJo 4 (B.11)
and such that the fractional error ~ is small, where
= frop w(r)9i(r)dr' (B.12)
f"tP w(T)E (r) dr'
,Tx. T49()oi(r)dr/ Tr 49(r)dr
fO°P r4g(r)i(r)dr/ o" r4g(r) dr' (B.13)
fZ0" r4g(T)ei(r)dr fsOr"P r 4g(r)dr
ftop (B.14)
fort p r4g(r)Oi(r)d fr 7r.d r4g(r) dr,
For the lognormal distribution f.o r 4 g(r) dr can be evaluated exactly as2
n(stopU)r 4 g(r)dr = exp(4lnu+ 8n 2 s) 2 [1-erf (tstop, - n)] (B.15)
ln(rt~p/-)
stop = lns
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and therefore,
j r 4 g(r) dr = exp(4 In u + 8 In2 a). (B.16)
The approximate sieving coefficient and error bound are then given by
t P w(r)e() dr = fSo' °p 4g(r)ei(r) d f t op T4g(r)i(r) dr (
.,i o 'IO~r~l~i~d fJo r 4g(r) dr exp(4l nu+8 ln2 ) .
ff2" r4g % (o(r) dr
fI,,op 4( ()d (B.18)
Jo r4g(r)Ei (r) dr
° r 4g(r) dr exp(4ln u + 8 n2 ) 1-erf ( in)]
t< fl.,o 4 4g()()d (B.19)S repo r4 g(r)() dr 
where the inequality in Eq. B.19 holds since Oi(r) < 1 for all r. Similarly, the bound for the double
lognormal distribution is given by
T.o r4 [(1 - q2)91g() + q2g2(r)] dr
< 4 r " °p r4 [(1 - q2)gl(r) + q2g2(r)] (r) dr' (B.20)
where gl and g92 are the two distributions. Values of = 10 - 4 were used to insure accuracy to three
significant figures.
Bridges 4 5 established a single bound on the integrals f 7T r 4g(r) dr and f, r4g(r)Oi(r) dr to
estimate 4. His expression for the lognormal distribution contains an algebraic error; the corrected
result is
stop
[ r4(r) dr < u4 exp - , (B.21)8 2q
ln(rtop/U)
2t t sop t
tstop - 8 In s
Bridges4 5 used Eq. B.21 to bound both the numerator and denominator of Eq. B.11. For smaller
molecules (r, < 45 A), bounding the individual integrals also provides convergence on the quotient.
For larger molecules (r, > 60 A), however, bounding the numerator and denominator separately
does not guarantee convergence on the quotient, because the numerator is many orders of magnitude
smaller than the denominator.
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Appendix C
Statistics of Scintillation Counting and Determination of
Minimum Acceptable Levels of Detection
This Appendix summarizes the relevant statistical analysis for the counting of radioisotopes and
determination of minimal acceptable counting levels. The development is that of Tsoulfanidis [243,
Chapter 2].
C.1 Standard Error of Total Counts
The radioactive decay of nuclei is described by Poisson statistics. Thus, if m is the mean number
of decays over time t and n is the number of decays measured over one particular interval of time,
then the variance and standard deviation of n are given by
V(n) = m, (C.1)
an = Av (C.2)
Note that this is true only for the total number of counts and not the counting rate. As m -* oo,
the Poisson distribution approaches the normal distribution. For m > 20, the Poisson distribution
is for all practical purposes equivalent to the normal distribution.
Since the true mean m is not known, n (for one measurement) or W (for multiple measurements)
is taken as the best estimator of m. Though the value of a single measurement follows Poisson
statistics, the distribution of the average of N measurements is Gaussian. The standard deviation
of i is given by
n= \-N N (C.3)
C.2 Standard Error of Counting Rate
The net counting rate r is given by
G B
r = g - b = t t B (C.4)
tG tB 
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where g and b are the gross and background counting rates, equal to the total counts (G and B)
divided by the counting time (tG and tB). Assuming G, B, tG, and tB are all independent, then
(C.5)
where the zi are independent variables. Assuming that time is measured accurately, then ato<, at. <
rG, ag and
2r 
a, = 2fi
G B
V o 2 + t2 =
A
Or) 2
+ I 
tG tB I
(C.6)
where the last equality comes from the fact that ag = aG/iG = /'GtG and similarly for ab.
C.3 Minimum Acceptable Activity
One way to define a criterion for the minimum detectable activity is to set a bound f on the relative
error:
U,
f > -,
1 g b
-r tG tB
Substituting g = r + b and solving the resulting quadratic for positive r gives,
1 + V1 + 4f 2btG + 4f 2t2 2
2f 2 tG (C.8)
Thus given a known background rate b and associated error os, either the error for a given counting
rate or the counting rate required to achieve a predefined accuracy can be determined.
C.4 Calculations
The Tric-Carb Model 4530 scintillation counter (Packard Instrument Co., Downers Grove, IL) uses
a single detector and can be set to count until either a preset error (i.e., total counts) or a maximum
time is reached. The values were set for o = 2.5% (i.e., 1600 counts since a = v1600/1600 = 2.5%)
180
(C.7)
a, = 9~ r I a. iE '9xi!
or a maximum time of 5 minutes. Thus for g > (1600/5 =) 320 cpm, the counting time is given by
1600tG = 160-, (C.9)g
while for g < 320 cpm, the counting time is 5 minutes.
The minimum acceptable levels for r can then be calculated directly from Eq. C.7. For g > 320,
1 g b
r > .t
1 g2 b
f- 1600 tB
1 (rb) 2 b
> 1 / ' b + - (C.10)f 1600 tB'
while for g < 320,
1 (r + b) b
r r~~~~> ~~+ (C.11)f 5 tB
The average of 36 background counts (tb = 5 min) on the scintillation counter gave b = 19.55
cpm. When these values for b and t B are substituted in the right-hand side of Eqs. C.10 and C.11,
it can be shown that when f = 0.05 Eq. C.10 is satisfied for all r > 54.0, while Eq. C.11 is satisfied
for all r > 108.8. Thus it appears using a net counting rate of 120 cpm as a cutoff conservatively
insures no more than a 5% counting error.
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Appendix D
Tabulated Parameters from Monte Carlo Simulations
The following tables summarize the calculated values of I and 0f from the Monte Carlo simulations.
Values are shown for the d = case with A. = 0.2 to 1.6 , n = 20 to 800, and e = 0 to -0.30.
n
A, 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
6.452x10-'
3.539x 10-1
1.502x10- 1
4.898x10- 2
1.251x10- 2
2.560 x10- 3
4.415 x 10- 4
6.464x 10- 5
50
6.248x10l-
3.237 x10-1
1.245x10-l
3.451 x10-2
7.098 x 10 - 3
1.105 x 10-3
1.359 x 10- 4
1.312 x10-
100
6.147x10l-
3.091x10- 1
1.122x10l-
2.849x 10-2
5.173x10 - 3
6.834 x10- 4
6.755 x10- 5
5.024 x10-6
200
6.069x10l-
2.982 x10-1
1.039 x10- '
2.467x10-2
4.073 x 10 - 3
4.767 x10 - 4
3.933 x10- 5
2.407x 10-6
400
6.020x10l-
2.913x 10-1
9.860 x 10-2
2.212 x 10-2
3.374 x10- 3
3.551 x10- 4
2.583 x10-5
1.320 x 10-
800
5.983x10l-
2.863x10-1
9.476 x10- 2
2.053 x10-2
2.948x10-3
2.860x10- 4
1.884x10-5
8.038x10- 7
Table D.1: Monte Carlo calculations for ][, = 0, d = 1.
n
A9 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
8.613 x 10-1
5.568 x 10-1
2.582 x 10-1
8.833x10- 2
2.319x10- 2
4.828x 10 - 3
8.418 x 10- 4
1.242x10 - 4
50
8.462x10- 1
5.181 x10-'
2.173x10-l
6.306x10- 2
1.331 x 10-2
2.105x 10- 3
2.615 x 10- 4
2.545x10-5
100
8.385x10- 1
4.989 x10-
1.973 x10-
5.240x10 - 2
9.755 x 10-3
1.309 x10-3
1.306 x10- 4
9.779x10 - 6
200
8.324x10-1
4.844x10- 1
1.837x10- 1
4.559 x10-2
7.710 x10 - 3
9.155 x 10- 4
7.627x 10 - 5
4.701 x 10-6
400
8.286 x 10-1
4.750 x 10-1
1.750x 10-'
4.099 x10- 2
6.405 x 10- 3
6.835 x10- 4
5.015 x 10-5
2.580 x 10-6
800
8.256 x 10-
4.682 x10-1
1.686x 10-1
3.815 x 10-2
5.607x 10- 3
5.516 x 10 - 4
3.665 x 10- 5
1.572x 10-6
Table D.2: Monte Carlo calculations for Q, = 0, d = 1.
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nAg 20
6.767x10-
3.999 x 10- 1
1.916x 10- 1
7.359 x 10-2
2.254x 10-2
5.491 x 10-3
1.092 x10-3
1.757x10- 4
50
6.481 x 10- 
3.574 x 10-
1.539x10- '
5.068x10- 2
1.307x10- 2
2.656 x 10- 3
4.366 x10- 4
5.687x10-5
100
6.325 x 10-
3.348x10-'
1.339x10- i
3.968 x10-2
8.961 x10-3
1.561 x10- 3
2.146x10- 4
2.345x10l-
200
6.201 x10-1
3.171x 10-1
1.193x10-'
3.225 x10- 2
6.433 x 10- 3
9.690x10- 4
1.096 x 10- 4
9.880 x10-6
400
6.117x 10- 1
3.050x 10-1
1.095 x 10-1
2.722 x10-2
4.845 x10-3
6.283x10- 4
6.033x 10- 5
4.309 x 10- 6
Table D.3: Monte Carlo calculations for /I, e = -0.05, d = I.
n
8.841x10'-
6.149x10-
3.241 x 10-
1.314x 10-'
4.158x 10-2
1.034x10-2
2.081 x10- 3
3.375 x10- 4
50
8.632 x 10-1
5.610 x 10-1
2.642 x10-1
9.147 x 10-2
2.431 x 10-2
5.035 x 10 - 3
8.375 x 10- 4
1.101 x10- 4
100
8.516 x 10-
5.318x10-'
2.321 x10-1
7.215x10-2
1.675 x 10-2
2.971 x10 -3
4.130x10- 4
4.551 x10- 5
200
8.423 x10-
5.089x 10-'
2.087 x 10-1
5.906 x 10-2
1.209x10 - 2
1.850x 10- 3
2.117x10 - 4
1.922x10- 5
400
8.360x 10'-
4.930x10-'
1.929x10-'
5.011x10- 2
9.144 x 10-3
1.204 x10- 3
1.167x10-4
8.397 x10- 6
Table D.4: Monte Carlo calculations for n, = -0.05, d = 1.
n
A0 20
7.191x10- '
4.632 x 10-1
2.521 x10-
1.137x10-
4.142x10 - 2
1.190x10-2
2.718 x 10 - 3
4.784x10-4
50
6.818 x 10-1
4.075 x 10-1
2.005 x10- 1
7.969 x 10 - 2
2.594x 10-2
6.855 x10- 3
1.489 x 10- 3
2.575 x 10 - 4
100
6.595x10-'
3.744x10l-
1.696x10- 1
6.051 x10-2
1.748x10 - 2
4.089x10- 3
7.902 x10- 4
1.269x10-4
200
6.408 x10-
3.470 x 10-1
1.452 x 10- '
4.650 x 10- 2
1.173x10 -2
2.385 x10- 3
3.832x10- 4
5.304x 10-5
400
6.272x10-'
3.270 x 10-1
1.281 x10-1
3.676 x 10- 2
8.061 x 10- 3
1.368x10-3
1.855x 10 - 4
1.910 X 10 - 5
Table D.5: Monte Carlo calculations for 4i, = -0.10, d = .
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0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
6.053 x 10-1
2.961 x 10-1
1.025 x10-'
2.401 x 10-2
3.879 x 10-3
4.460x10-4
3.676x10-5
2.091 x10 -
A0 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
8.310x 10-
4.812 x 10-1
1.814x 10-1
4.439x 10-2
7.348 x10-3
8.572 x10 - 4
7.125x 10-5
4.075 x 10-6
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
6.165x10-1
3.121x10-1
1.157x 10-1
3.040x10- 2
5.817 x 10 -3
8.467x 10 - 4
9.515 x 10- s
7.868 x 10- 6
6 r - = -- - r r s w r r r .w z w -
w - - f - s I _ w - r -
-
r r! r q w f  w 
<
-
Y R -- - 1 I w ~ ~ _ 1 
= 
_ 
r I
__
n9.136 x 10-1
6.923 x 10-1
4.181x10- 1
2.009x10-1
7.603 x 10-2
2.235x10- 2
5.175x 10-3
9.191 x 10- 4
50
8.867x10l-
6.223 x 10-1
3.365x10- 1
1.416x 10- 1
4.777x10- 2
1.292x10- 2
2.845x10-3
4.974x10- 4
100
8.707x10-'
5.810x10- 1
2.880x10-'
1.083 x10- 1
3.232x10-2
7.725 x10-3
1.512 x10-
2.455 x 10-4
200
8.573 x 10-
5.468 x10- 1
2.498x10 - 1
8.398x10-2
2.181 x 10-2
4.516 x 10- 3
7.354x 10- 4
1.027x10 - 4
400
8.474x10-
5.213 x 10-
2.227x 10 -1
6.693x10- 2
1.507x10- 2
2.603 x 10- 3
3.568 x 10 - 4
3.713x10-5
Table D.6: Monte Carlo calculations for Q, e = -0.10, d = 1.
n
7.778x10-
5.530x10-'
3.430x10-
1.807x10- 1
7.759 x10-2
2.606 x 10-2
6.799x10-3
1.306x 10- 3
50
7.339 x10-1
4.868x10-
2.797x 10-1
1.360x10-1
5.598 x 10-2
1.906x10- 2
5.387 x 10- 3
1.218 x 10- 3
100
7.045x10- 1
4.424x10-
2.353x10- '
1.046x10l-
3.958 x 10- 2
1.258x10- 2
3.424x10-3
7.994 x10- 4
200
6.776x10-
4.009 x 10-1
1.947x10-1
7.821 x 10-2
2.632x10-2
7.608x10-3
1.773x10-3
3.828x10- 4
400
6.561 x 10-1
3.684x10-
1.663 x 10-
5.847x10- 2
1.721 x10-2
4.132x10- 3
8.338 x10- 4
1.241 x10- 4
Table D.7: Monte Carlo calculations for 4, e = -0.15, d = .
n
9.527x10-
7.981x10- 1
5.563 x 10-1
3.157x 10-1
1.417x 10- 1
4.885 x 10-2
1.294x10- 2
2.508 x 10 - 3
50
9.211 x10- '
7.150x10 - 1
4.556 x 10-1
2.369 x 10- 1
1.019x 10- 1
3.566 x 10-2
1.026x10- 2
2.348 x10-3
100
9.007x10- '
6.612 x 10-'
3.874x10 -1
1.831 x10- 1
7.214 x10 - 2
2.355 x10-2
6.512x10- 3
1.541 x10-3
200
8.825x 10-
6.121 x 10- 1
3.260x 10- 1
1.382x 10- 1
4.817x10- 2
1.423x10-2
3.377x 10 - 3
7.386 x 10- 4
400
8.679x10-1
5.724x 10- 1
2.818 x 10- 1
1.044 x 10- 1
3.164x10- 2
7.776 x 10- 3
1.593 x 10-
2.411 x 10- 4
Table D.8: Monte Carlo calculations for fQ, e = -0.15, d = I.
185
Ag 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
8.395x10- I
5.022x10-'
2.027xl0 -1
5.575 x 10- 2
1.094x 10- 2
1.618x10- 3
1.834x10- 4
1.523 x 10-
As 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
6.373x10-1
3.430x10-
1.424 x 1O-
4.513 x 10-2
1.104x10- 2
2.264x10-3
3.866 x 10- 4
4.907x10 -5
A,, 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
8.547x10 - 1
5.412x10 - 1
2.452 x10- 1
8.146x10-2
2.054x10-2
4.296 x 10-3
7.398 x 10- 4
9.415x10- 5
- w - z 1 r
- -r -
r a
-
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nAs 20
8.621 x10-
6.850x10-
4.841x10-'
2.959x10-
1.482 x10- '
5.762x10- 2
1.710x10- 2
3.571 x 10- 3
50
8.210x10- '
6.241 x10-'
4.272 x10-
2.558 x 10-1
1.325x 10- 1
5.721 x 10- 2
2.070x 10- 2
6.016 x10-
100
7.909 x10- '
5.771 x10-
3.760 x 10-
2.147x10-
1.077x10-'
4.646 x10-2
1.769x10- 2
5.856 x10-3
200
7.578x10 - '
5.168 x10-
3.094x10-
1.682 x 10- 1
7.914 x 10- 2
3.427 x 10- 2
1.137x 10- 2
3.660x10-3
400
7.247x10-'
4.686 x10-'
2.798x10-'
1.248 x10-'
5.584x10- 2
2.069x10-2
5.933 x 10-
1.231 x 10 - 3
Table D.9: Monte Carlo calculations for , e = -0.20, d = I.
n
Ag 20
1.006 x 10
9.476x 10-
7.657 x 10-1
5.105x 10-1
2.691 x10- 1
1.078x10 -
3.252 x 10-2
6.860x10- 3
50
9.747x10 - l
8.664x10-'
6.683 x10-'
4.346 x10-'
2.378x10-'
1.063x10-'
3.925x 10-2
1.157x10-2
100
9.534x10-1
8.091 x10- 1
5.900x10 -1
3.640x10- 1
1.928 x10-'
8.605 x 10 - 2
3.340x10-2
1.125x10-2
200
9.326 x10-1
7.441 x10 - 1
4.953 x 10- 1
2.870x10 -1
1.417x10- '
6.279 x 10-2
2.147x10 - 2
7.050x10 - 3
400
9.133x10 - 1
6.887x 10- 1
4.456x10-'
2.156x10- 1
9.963x10- 2
3.847 x 10- 2
1.127x 10- 2
2.398 x 10-3
Table D.10: Monte Carlo calculations for fl, e = -0.20, d = 1.
n
A, 20
9.876 x 10-1
8.862 x 10 -
7.109 x 10 -
4.989 x 10- 1
2.882x10- 1
1.287 x 10 - 1
4.322x 10 - 2
9.787x 10 - 3
50
9.822 x 10-
8.879 x 10- 1
7.320 x 10-
5.392x 10 -
3.464 x10- 1
1.859x10-
8.437 x 10-2
3.102 x10-2
100
9.956 x10-
9.053 x 10-
7.449x10- 1
5.513 x 10-1
3.636 x10-1
2.095 x 10-
1.100x10 - 1
4.955 x 10 - 2
200
9.955 x 10-1
8.376x10 -
6.486x10 - 1
5.237x10- 1
3.469 x10-
2.351 x 10- 1
1.011 xlO- 1
4.418 x 10-2
400
9.572x10 - 1
8.297 x 10-1
9.147x10-'
4.219x 10 -1
3.162x10 - 1
1.947 x 10-1
6.491 x10- 2
1.773 x10-2
Table D.11: onte Carlo calculations for 4I, e = -0.25, d = 1.
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0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
6.845x10-'
4.216 x 10-1
2.153 x 10 - 1
9.804 x10-2
3.184x10-2
1.072 x10-2
2.823 x 10-
4.974 x 10- 4
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
8.878x10-
6.355 x10-'
3.579x10 - 1
1.697x10 - 1
5.835 x 10-2
2.025x10- 2
5.379 x 10-3
9.491 x 10-4
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
8.272x10-'
7.227 x 10- 1
5.251 x 10-1
4.941 x10-'
1.646 x10-
1.004xlO-
3.394x10 - 2
6.919 x 10-3
w | : s . s S - - s __ | - - = - - s
- s ~ ~ _ _ w <~~__s
- -
| : - 4 1-
n1.081 x100
1.166x100
1.094x10
8.495 x 10-
5.207 x 10- 1
2.402x10-'
8.215 x 10- 2
1.880x10 - 2
50
1.066 x 10
1.137x 10
1.087x 10
8.879 x10 -
6.119 x 10-
3.425xlO-
1.593x 10-
5.953 x10- 2
100
1.064 x 10
1.136 x10
1.089x100
8.953x10-1
6.371 x10-
3.841 x10-
2.064x10l-
9.484x10- 2
200
1.064x 10
1.080x 100
9.707 x 10
8.474x 10-
6.058 x10-
4.167x10- '
1.894x10-1
8.517x10-2
400
1.056x 10 °
1.075 x 100
1.270 x 10
6.958 x 10 -
5.428 x10-1
3.597x 10-1
1.229x10-'
3.471x 10 -2
Table D.12: Monte Carlo calculations for fl, e = -0.25, d = I.
n
1.182x 10
1.205 x 100
1.088x100
8.663 x 10 - 1
5.711 x 10-
2.901 x10-
1.098x10- 1
2.687x 10 - 2
50
1.317x 10
1.461 x 100
1.441 x100
1.293x 10
1.008x100
6.549 x 10-1
3.646x10- 1
1.670x10-'
100
1.627x10l
1.952 x 10
1.992 x 100
1.838x100
1.550x 10
1.162x100
8.291 x10-'
4.784x10 -1
200
2.004 x 10
2.039 x100
1.957 x 10
2.591 x 10°
2.274x100
2.484 x 100
1.172 x 10
6.387x 10-
400
2.083 x 10u
2.852 x 100
7.272 x 100
2.355 x 10
2.876 x 100
3.078 x 10°
9.664 x 10- 1
3.296 x 10-1
Table D.13: Monte Carlo calculations for , = -0.30, d = I.
n
1.191x 10"
1.498 x 100
1.624x 100
1.455x 100
1.026 x 100
5.405x10 -1
2.086 x 10-1
5.161 x10- 2
50
1.237x 10
1.682 x 100
2.009 x 100
2.051 x 100
1.748x100
1.195 x 100
6.852 x 10-'
3.196 x 10-1
100
1.357x10l
2.056 x 100
2.650 x 100
2.838x 10
2.655x 10
2.111 x10 0
1.548 x 100
9.123x10- 1
200
1.557x 10
2.218x100
2.714x 100
3.920 x 100
3.882 x 100
4.215 x 100
2.180x 100
1.235x 100
400
1.704 x 10
3.104x100
8.890 x100
3.722x10°
4.795x 100
5.685x100
1.831x 10
6.480 x 10-
Table D.14: Monte Carlo calculations for Q, e = -0.30, d = I.
187
7A 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
9.840x10-'
9.753 x10-'
8.259x10-
7.804x10-'
2.979xl0-'
1.908x10- 1
6.472 x10-2
1.319x 10-2
A, 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
1.417x 10
2.479 x 10
2.602x 10
6.035 x 100
1.432 x 100
1.534x 100
5.429x 10- 1
1.143x10- 1
A, 20
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
800
1.372x10°
2.865 x 100
3.947 x 100
8.787 x 10
2.579x100
2.940 x 100
1.039x 100
2.184 x 10-1
,,[ A A _ _ _ A = _ _ _ : _ A
V
__ I
_ _ 
: ~A
_ _ 
_ 
· _
- -
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Appendix E
Error Analysis for Monte Carlo Simulations
E.1 Probability Estimate Error
Sources of errors in the Monte Carlo calculation of the steric factors can be divided into primary
errors in the determination of the radial probability profile p(i) and propagated errors in the in-
tegration of that profile. In general, rigorous determination of convergence on p(f) would be by
repeating simulations until no change is observed. Unfortunately, time and cost constraints make
this prohibitive except in the case of small chains. As described in Section 5.4.2.3, the following
methods were used as indirect means of determining convergence:
1. symmetry
2. /fl profiles
3. visual assessment of constant n, epsilon plots
E.2 Profile Integration Error
This section presents an analysis of the errors resulting from numerical integration of the proba-
bility profile p(r). These errors are determined primarily by the value of the mesh size across the
pore diameter and are in general much smaller than those resulting from inadequate convergence
on p(f). The following assumes that the estimated probabilities are an accurate measure of the
true probabilities. Poor p(f) estimates will result in fluctuations which are magnified by the Boltz-
mann weighting term, especially for large attractive energies, providing an indirect relative means
of evaluating convergence on p(f).
E.2.1 Definitions
We make the following definitions:
np = number of mass points per chain
m = number of mesh points across pore radius
fj = dimensionless radial mesh point across pore, where m,, = 1
pi = "true" probability that a polymer chain is in state i, where Ei pi = 1
M, = number of chains generated
Si = expected number of chains generated in state i based on pi
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Si = actual number of chains generated in state i
pi = estimated probability from Si
For Me trials, Si and Si are the expected and actual number of observations in category i, so
Me = Si = E S.i (E.1)
i i
The exact value of each pi is unknown but. is estimated from Pi, where
Pi t Pi = M(E.2)
From multinomial statistics, the expected value (E) and variance (Var -= 2 ) of Si are given by6 7
E(Si) = Si, (E.3)
Var(Si) = M¢pi3(1 -Pi). (E.4)
E.2.2 Calculation of Steric Factor Variances
The steric factors and Q are calculated by Simpson integration of the Monte Carlo results, and
thus they can be thought of as functions of two random variables: {Si}, the vector of number of
observations in each category, and {ij}, the vector of radial positions in the pore. Integration is
done by evaluation at fixed points across the diameter, which is equivalent to assuming that each
radial position occurs with uniform probability. A success is defined when every mass point of a
chain fits within the pore.
E.2.2.1 Neutral Pore
The neutral case (E = O) simplifies to a binomial probability distribution:
P fo if success (i = 0)
pP = P =-po if failure (i = 1)
Then,
= E aj ( ) (E.5)
j=-m Me
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E E aaM2 Cov [S(fj), S(rj)], (E.6)
j=-m jj=-m 
where the aj are coefficients from Simpson's rule:
For : aj = 2aj(A)rj, (E.7a)
For : aj = 4ctj(A j(1- ilJ), (E.7b)
and Af are the fixed radial step sizes.
The covariance term in Eq. E.6 is more precisely a binomial multivariate cross-covariance. Ap-
plying the general formulation of Wishart, 25 7
COv [O(fj), §O(jj)] = Mc {h~j n fjj)-PO(fj)PO(ijj)}, (E.8)
where Pio(j n ijj) is the probability of a single chain fitting at both j and jj.
Substituting Eq. E.8 into Eq. E.6 and rearranging to maximize computation speed yields
aM2
Var(E) = E M P°()(1-POA)
j=-m
+2 E M {PO(?j n )-pO(fj)pO(Tjj)}. (E.9)
j=-m jj=j+1
For the Monte Carlo simulation, rigorous calculation of p(j n jj) requires additional bookkeep-
ing in an (2m+ 1) x (2m+ 1) array. As a faster alternative, the cross-covariance can be conservatively
estimated by using the fact that its absolute value is bound by the square root of the product of the
individual variances:6 7
po(~j n jj)-pO(fj)po(~jj) < /Po(j)(-pO(ij)) 'pO(rjj)(1-Po(Ojj)), (E.10)
so that a bound for 4' is given by
m 2
Var(4) S o()(-o())
j=-m
j--m j jj+1 MI
The equation for Var(Q) is exactly the same with different values of aj. Eq. E.11 was used by
Davidson 70 for estimation of variances in the neutral pore case.
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E.2.2.2 Pore with Square-well Potential
For a square-well potential acting on the mass points, we have an (np + 1)-nomial probability
distribution:
Pi =
P0 if success with zero mass-point interactions (i = 0)
P1 if success with one mass-point interaction (i = 1)
Pn, if success with np mass-point interactions (i = np)
P = Pnp,+ if failure (i = np + 1)
where the partition coefficient is now given by
m np
= - E aj )exp(-ei), (E.12)
Var(4) = Var E Eaj M exp(-ei) (E.
j=-m i=0
Davidson originally provided a conservative estimate for Eq. E.13 using a graphical technique.
Here we demonstrate an analytical solution by expanding Eq. E.13:
m me np np
Var() = Z E ajajj exp(-[i + ii]) Cov [i;), S .i(i.)] (E.14)
j=-m jj=-m i=O ii=O 
The covariance term is a generalized multinomial multivariate cross-covariance, given by Wishart2 5 7
as
Cov [Si(fj), Sii(fjj)] = M {finii(fj n fj;)- P (j)Pjj ijj)} (E.15)
Here, inii (i n jj) is defined as the probability of a chain existing in both states i and ii at both j
and jj. The cross-covariance reduces to the following forms depending on the values of the indices:
For i # ii: =-MC(Aj)Pii(jj) (E.16a)
For i = ii: = M {pi(fj n ijj)- p,(j)f(jj)), (E.16b)
For i = ii, j = jj: = Mc {p(f)(1 - (j))}, (E.16c)
where Eq. E.16a results from the fact that states i and ii are mutually exclusive at a give rj.
Substituting Eqs. E.15 and E.16 into Eq. E.14 gives
-p a exp(-2ei) )
Var() =i(ij)(1 - j))
i=0 j=-m
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np m-1 mn
+2E E E ajajj exp(-2) n j )pi 
i=O j=-mjj=j+l
n,-I np a exp(-e[i + ii])
i=O ii=i+l j=-m
n,-1 np m,-I m
-4 Z Z E E ajajj ep(-e[ + i)i(j)ii(jj). (E.17)
i=0 ii=i+i j=-mjj ;j+1 Ml
And finally, rearranging for computational use:
m n-1 m
Var() Q() + 2 E E ajajjV(j, jj) , (E.18a)
=-m j=-mjj=j+i
n,
Q(j) = Eexp(-2ei)Pi(ij)(1-Pi(j))
i=o0
np-1 np
-2 5 E exp(-e[i + ii])Pi()PiiQ(j) (E.18b)
i=O ii=i+l
np
V(j,jj) = Eexp(-2i){pi(*j n jj)-pi(j)p(jj)}
i=0
n,p-1 np
-2 5 : exp(-[i+ ii])i()ii(jj). (E.18c)
i=O ii=i+l
Once again, rigorous calculation of the joint probability requires additional bookkeeping, this time
in an (2m + 1) x (2m + 1) x (np + 1) array. Again, as a practial solution, Eq. E.10 was used as an
upper bound. Finally, to avoid negative values for Var(I) which result from lack of convergence on
p(i), only the additive terms of Eqs. E.18 and E.18 were used; since all terms in the summations
are positive, this also insures an overestimation of the error.
Note that because of a mathematical artifact, the variance calculation for the multinomial case
with = 0 is not equivalent to the binomial neutral pore variance of Section E.2.2.1, i.e., Eq. E.18a
with = 0 does not reduce to Eq. E.9. This is because the multinomial case still considers chains
with different numbers of points in the square well to be in different states, even though in the
neutral case they contribute equally to the calculation of and f.
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Appendix F
Estimation of Molecular Dimensions of Dextran in Water
F.1 Overview and Summary
In this Appendix, we review methods for determining the characteristic dimensions of polymer
molecules in solution from intrinsic viscosity data and radius-of-gyration correlations. In Section F.2,
the pertinent theory and equations are summarized. Section F.3 presents a compilation of data
available in the literature for dextran/water systems. Section F.4 gives the results for the perturbed
dimensions obtained by these methods and the implications for restricted transport.
F.2 Summary of Theory and Equations
F.2.1 Relationship of Ideal and Real Chain Dimensions
The following development is a combination of methods found in Kurata and Stockmayer,l55
Yamakawa 25 9 and Gowariker et al."8 A random-flight chain is defined as one with neither short-
range interactions (i. e., bond angle restriction) nor long-range interactions (i. e., intramolecular
van der Waals forces). All random-flight dimensions will be indicated by a "00" subscript, e. g.,
rgoo. An unperturbed chain is one which does not experience long-range interactions (denoted by
the subscript "0"), and a real chain is one which has both short- and long-range interactions (no
subscript). The unperturbed number of chain segments n and chain length I are related to their real
counterparts N and L by
N = n/(a2 ), (F.la)
go
L = os 9 . (F.lb)go
Short-range interactions are accounted for by the skeletal factor s > 1, where for both the mean-
square radius of gyration r2 and the mean-square end-to-end distance (R2 ),
rgO = sTgO (F.2a)
(R2 )o = s(R2)oo. (F.2b)
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The expansion factors as and aR relate the unperturbed radius of gyration and unperturbed end-
to-end distance to the real radius of gyration and real end-to-end distance:
r = a2 r2, (F.3a)
(R2 ) = a2(R 2 ). (F.3b)
In general, the solvent expansion has a greater effect on end-to-end distance than radius of gyration
and aR > as. The factor g/go is a correction term to account for chain branching. Relating
unperturbed to real dimensions is thus a matter of determining a, as, and g/go, as discussed in the
following sections. As will be seen, the present state of theoretical and experimental work in the
field does not yet allow for a single rigorous means of making these calculations, and so we have
chosen to examine a variety of methods and compare the results.
F.2.2 Determination of Unperturbed Molecular Dimensions from Intrinsic Viscosity
Data
In a similar fashion to the radius of gyration, the unperturbed intrinsic viscosity is related to that
at other conditions by an expansion factor a < as:
[7] = a[r]0o. (F.4)
The difference between the expansion factors results from the fact that as excluded volume increases,
the hydrodynamic radius increases less than the statistical physical radius. At theta conditions for
a nondraining coil the unperturbed intrinsic viscosity [77]o is proportional to the square root of the
molecular weight M and to the 3/2th-power of (R2)o.
[7]o coM / 2 , (F.5a)
K0 = <0 A3o, (F.5b)
Ao = ((R 2 )o/M)' /2 , (F.5c)
00 x 2.5 x 1023, (F.5d)
thus
[.7] = a0oM1/2. (F.6)
In the above equations, KO has units of cm3-g-3/2-moll/ 2 , Ao has units of cm-g-1/2-moll/ 2 , and
0o is a viscosity constant for linear chains which has units of mol- '. The value for 00 shown is
experimentally derived from viscosity and light-scattering data and differs slightly from reported
theoretical values. 25 9 Determination of the unperturbed dimensions from intrinsic viscosity data is
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thus equivalent to calculation of Ao.
There is a body of methods based on the argument that as the chain size decreases, the expansion
factors must approach unity, and [7] - [7]o. Therefore an extrapolation of [7] to M = 0 provides a
value of [7]o from which KO, and hence A0 , can be calculated. The particulars of each method differ
in the functional representation used for as and a,. The Stockmayer-Fixman method2 3 4 results in
O + 0.510oBM /2, (F.7a)M1/2
B = l3/Mseg = (1 - 2X)( NA), (F.7b)
Mseg = M/n, (F.7c)
where B has units of cm 3 -g-2-mol 2, Mseg is the segment molecular weight in g/mol, Pp is the
partial specific volume of the polymer in cm3 /g, V, is the molar volume of solvent in cm3 /mol, and
NA is Avogardo's number. The parameter B can be equivalently expressed as either a function of
the segment excluded volume 3 or of the Flory-Huggins thermodynamics parameter X. A plot of
[I]/M1/ 2 versus M 1/2 will have y-intercept KE0 . In practice, the Stockmayer-Fixman method has
been shown to yield accurate results for good-solvent systems as long as the data is for relatively
low molecular weights. 25 9 When data from higher molecular weights are used, the analysis tends
to overestimate KO. This approach has been seen to be sensitive to different ranges of ac, with
modifications'needed if a3 is greater than 1.6 for any range of the data.27
Inagaki et al.13 8 have proposed an alternative method which complements the Stockmayer-
Fixman approach in that it works best with extrapolations from high molecular weight data. This
expression, obtained from the use of an equation by Ptitsyn,2 0 7 is
[ 4/ 6 = 0.786K;4/5 + 0.4542o/15 2/ 3 B2/3M1/3 (F.8)
M2/5 -
where a plot of [rv]4 5 /M2 5 versus M1/3 has a y-intercept of 0.786 4/ 5. When extrapolation is done
from low molecular weights, the equation is modified so that the y-intercept is K04/5
Finally, an expression of Berry's is suggested as showing linear behavior over a broader range of
molecular weights:9 6
[ti]_ 1/2 M,
= + D [7] ,
where M, is the weight-averaged molecular weight and D is an adjustable parameter. A plot of
[1]/M/2 versus Ml,/[7] will have a y-intercept of 0./2
F.2.3 Effect of Sample Polydispersity on Viscosity Measurements
Newman et al.'90 demonstrated that for polydisperse samples, number-averaged molecular weights
and number-averaged radii of gyration should be used in calculations of molecular dimensions from
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[I]. Shultz2 28 has derived an expression for correcting viscosity data when either Mn or the number-
averaged r are not available, and Mo or z-averaged r must be used. The correction is significant
when M, is used but the form of the radius of gyration has very minor effects. For our purposes,
where M. is available for almost all of the data, no such adjustments are necessary. In related
work, Bohdanecky and Kovar2 7 show that a correlation of M. to [] from a polydisperse sample
overestimates the true value of M.. The inverse is true for correlations of M,, but the magnitude
of the effect is much smaller.
If an analytical form is assumed for the distribution of molecular weights, then it is possible to
derive corrections for polydispersity. Probably the best such function is the Schulz-Zimm distribution
for the mass fraction f(M):
rt+1
f(M) = r( t + 1)' Mt exp(-rM), (F.10)
where t = (M, /M, - 1)-1, r = tM, and r is the gamma function. The Schulz-Zimm distribution
has been found superior to the lognormal distribution in describing fractionated samples, although
the differences are small for M, /M. < 2.148,149 A correction factor for the Stockmayer-Fixman
equation (Eq. F.7a) using the Schulz-Zimm distribution and M, is defined as23 6
[1] = QKO + 0.51qoBM /2 (F.lla)
Q (M'/ 2 ) _ r(t + 1.5) (F.llb)
1/2 (t + 1)/2 r(t + 1)
For branched polymers, the effects of branching and polydispersity are difficult to separate as
branching, when not uniform throughout the molecule, in effect introduces a second probability
distribution into the description of the polymer.2 3 3
F.2.4 Determination of the Linear Expansion Coefficient as
Since there is not presently a unifying theoretical formulation for excluded volume effects, it is
common for results from one type of empirical formulation to be incompatible with supposedly
equivalent results from another formulation. The graphical extrapolation procedures give accurate
values for the unperturbed dimensions, but are generally not useful for directly determining excluded
volumes. In light of this, three alternate methods of calculating as will be considered. Two methods
(using the intrinsic viscosity and the radius of gyration) require calculation of ,o or Ao from one
of the graphical methods previously discussed, and the other (using the second virial coefficient)
requires measurement of the second virial coefficient and radius of gyration.
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F.2.4.1 as from Intrinsic Viscosity Data
Calculation of as from viscosity data requires the assumption of a direct functional relationship to
a,. Such functions are usually of the form
a, = as (F.12)
where 6 is an adjustable parameter so that
as= ( KO/[ 1] (F.13)
According to Kurata and Yamakawa,l56 6 = 2.43 is a suitable general solution.
F.2.4.2 as from Radius of Gyration Data
Having obtained Ao from a graphical method, we can now solve directly for the unperturbed radius
of gyration:
rgo = ( ) = Ao(M/6) 1/2. (F.14)
Given an independent correlation for the real radius of gyration as a function of molecular weight,
Tg = A'Ma, (F.15)
a value for as can be obtained by combining Eqs. F.14 and F.15:
as = rg/rgO - A 6M(a-0.5) (F.16)Ao
F.2.4.3 as from Second Virial Coefficient Data
Yamakawa 25 9 gives a method for determining the expansion coefficient when data for both the second
virial coefficient A2 and the radius of gyration are available for individual fractions. His method
first involves calculation of the variables and T, where
A2M 2
3A2 aM2 (F.17a)
(1 0.547 k -1/0.4683(1- ) 1 (F.17b)
3.903
An iterative solution is then made for as:
as = 0.541 + 0.459(1 + 6.04ca3) °0 46. (F.18)
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F.2.5 Determination of Skeletal Factor and Bond Dimensions n and I
The skeletal factor 8 can be decomposed into two parts: one factor due to bond angle restriction
and the other to the impedance to internal rotations:
(R2 )o (R 2)0,fr(R2 )ofr (R2 )oo (F.19a)(R2),& (R2)00'
2 (R2 )O,fr (F.19b)
n12
where (R2 )o,fr is the mean-square end-to-end dimension of a molecule with fixed valence angles but
free internal rotations and (R2)oo = n12 . The conformation (or flexibility) factor ur2 is defined as
(R 2 )o/(R2 )o,fr. The dimensions n and I are determined by the assumption of some sort of model
used to derive the free-rotation dimensions. Cleland6s calculated the theoretical free-rotation value
of ((R 2)Ofr/n) / 2 for mono- and disaccharide polymers based on an idealized pyranose monomer in
the C1 chair conformation. For a a-1,6 glucose linkage, he reported values of ((R 2 )o,fr/n) / 2 = 5.02
or 5.40 A, depending on the assumed bond angle. Both values are close to the end-to-end glucose
monomer length of 5.15 A, and so the approximations of ((R2)o,fr/n)1/2 ; ((R 2)oo/n)L/ 2 = I and
8 = 0r2 are justified. Since Cleland used the length of a pyranose unit for 1, n is the number of
glucose monomers in a polymer = M/Mmo,, where Mmon = 162 daltons. Then by substitution,
Aoo = ((R2)o,fr/M) 1/ 2 = 0.394 or 0.424 i-(mol/g)1/2 . The skeletal factor is thus given by
Aoo (F.20)
An alternative method of deriving L is from persistence length measurements. The persistence
length a* is related to the radius of gyration for large chains by 10 9
at = 3r2/NL, (F.21)
leading to
L = 2a*. (F.22)
F.2.6 Determination of Branching Factor g/go
The development so far strictly pertains to straight-chain molecules. Dextran is reported to be pre-
dominantly linear, but with a small amount (5-6%) of chain branching through a-1,3 linkages.' 62 245
The length of these branches is the source of some controversy, with results from chemical analysis
at odds with observed physical behavior. Recent studies on large (106-107 dalton) dextrans indicate
a majority of the branches are short chains (~ 1 to 2 glucose residues) with a small number of long
branches (50-100 residues). l5 2 ' 162 Branch length increases with molecular weight, but at dextran
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sizes of concern to us (less than 106 daltons), there is no evidence of long branches. ls 2 ' 2 4
The principal effect of branching is to reduce the effective volume of the molecule compared to a
linear molecule of equivalent weight. This in turn lowers the intrinsic viscosity and radius of gyration
relative to the linear molecule. The effect of chain branching is described by a factor g,7 < 1 which
relates the intrinsic viscosity of a branched chain to that of a linear molecule of equal molecular
weight:
9g = [77]br/[]lin, . (F.23a)
TrgO,li ,n aiO, l fin 
- 2 , fOln
3/2 (Obrb . (li,br (F.23c)
The branching effect is factored into three terms representing, respectively, the effect on unper-
turbed dimensions, the effect on the intramolecular hydrodynamics, and the effect on the excluded
volume. Both g, and go decrease with increasing molecular weight at a constant degree of branching
or increasing number of branches at constant molecular weight.
Analytical formulations for go have been derived as a function of the branching geometry and the
degree of branching. 54" The simplest physical model of dextran is a comb-like chain with uniform,
regularly spaced short branches. The regular comb-like chain model is seen to uniformly under-
estimate experimental values of go for several types of branched chains by up to 30-50%.27 For a
comb-like molecule with a total of m identical side chains dispersed at random points across the
backbone, with each side chain containing nside segments and the backbone having nback segments,
go is given by5 2
go = (1 + mq)-3 [1 + 2mq + (2m + m2 )q2 + (3m2 - 2m)q3 ] , (F.24)
where q = nside/lnback. Eq. F.24 applies in a strict sense only to chains with large side branches
(nside > 1) which can be assumed to obey random flight statistics. Applying it to low molecular
weight dextran, which has mostly short branches, can only yield a rough estimate for go. Using the
results implied from chemical analysis, 5% of the molecular weight of dextran is in branch chains and
nside = 1, 2, or 3 segments. For molecular weights between 40,000 and 10,000, go is then calculated to
be around 0.95. This value does not change appreciably if the the effective segment size is adjusted
to account for short-range interactions.
Experimental calculations of go, on the other hand, indicate a much greater effect of branching
on unperturbed dimensions. Based on persistence length measurements, Garg and Stivalal0 9 deter-
mined values ranging from 0.95 at M, = 5700 to 0.82 at M, = 27, 800 to 0.72 at M. = 48, 500.109
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Senti et al. 2 24 1955 14,500 to 99,600 1.06 to .1.48 0.118 - 0.491
Granath"19 1958 17,000 to 263,000 1.09 to 2.75 0.1'97 0.453
Gekko" 3 1971 32,100 to 410 unknown 0.0986 0.515
Basedow et al.L5 1976 990 to 286,000 1.003 to 1.19 0.130 0.492
Garg and Stivala ° 9 1978 5700 to 112,500 1.39 to 2.25 0.147 0.485
Kuge et al.l 5 2 1987 24,000 to 2,860,000 1.19 to 2.35 0.785 0.320
Table F.1: Summary of literature data available for the intrinsic viscosity of dextran in water
solutions. rK and a are Mark-Houwink constants determined by fitting [] = M to the reported
data.
Their values are consistent with data of Granath"l l and Wales et al.2 5i and suggest a considerably
higher degree of branching than indicated by chemical analysis. Dextran with M, = 1200 is es-
timated to have 7% of the total molecular weight in side chains; for M, = 42, 000 it is 17%; for
M, = 74, 500 it is 28%; and for M., = 246, 000 it is 46%. The basis for the discrepancy with the
results from chemical analysis is not addressed by any of these workers.
Experimental studies with dextran have usually focused on calculating the equivalent of go for
perturbed conditions,
2
rg,br S,br
-9 =9 2 ' (F.25)
Tg,lin S,lin
where as is calculated assuming a linear polymer and then adjusted by a factor g/go. Values for this
ratio based on the data of Garg and Stivala109 range from 1.02 at M, = 5700 to 1.28 at M, = 48, 500.
The hydrodynamic term, the second quotient in Eq. F.23c, has been studied by Stockmayer and
Fixman,2 3 3 who arrived at
70,bri 1/2 r/ (F.26)
where r, is the Stokes-Einstein radius. There is to date no theoretical treatment of the excluded
volume effect of branching, represented by the third quotient in Eq. F.23c. The available data
indicate that the ratio is less than one for comb-like chains with regularly-spaced branching. 27 For
dextran, values of the product of the hydrodynamic and excluded volume terms have been calculated
by Senti et al. to be in the range of 0.9 to 0.7.224
F.3 Summary of Available Dextran/Water Solution Data
Table F.1 summarizes reported measurements of intrinsic viscosity for dextran-in-water systems at
25 °C. For each of these studies, M,, values were determined from light-scattering measurements
and M, was determined from end-group analysis. The Gekkoll3 measurements did not include a
determination of M,. The data of Basedow et al.'5 covers the largest range of molecular weights
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Source Year MN range M IM, range (ml/g) a
and is in general the most monodisperse, however, the agreement between the different sets was
deemed good enough to justify use of all the data (see Figure F-1). At extremely high molecular
weights (> 106), significant departure from ideality (i.e., the square-root dependence on M,) is seen,
believed to be due to increased chain branching.
For use with the graphical calculations, correlations of r, to M, are needed. Results from light-
scattering measurements for dextran from various sources109' 52 22 4 '23 7 are shown in Figure F-2.
There is some scatter in the data, but only that of Garg and Stivala l0 9 are in the molecular weight
range of interest. Their data was correlated to
r = 0.812Mn0 438 (F.27)
where r, is in i.
Only two sources of values for second virial coefficients were found, from Senti et al.2 24 and Kuge
et al..152 These results are shown in Figure F-3. The agreement between the two sets is poor,. but
there is reason to believe that the data of Kuge et al. is more accurate. For one thing, it is the more
recent and there have been significant improvements in the analysis of light-scattering data since
the 1950s.259 Also, use of the Senti et al. values led to unrealistically large values of It in Eq. F.17a,
precluding calculation of T. Hence, though the Senti et al. data is more suitable for the molecular
weight range of interest only calculations from the Kuge et al. data were used.
F.4 Results
F.4.1 Unperturbed Dimensions from Graphical Analyses
Since it is not clearly established what constitutes a "high" versus a "low" molecular weight range
for dextran-water systems in the context of the graphical methods, all three (Stockmayer-Fixman,
Inagaki-Ptitsyn, and Berry) were employed. The results of the plots for the data of Table F.1 are
shown in Figures F-4, F-5, and F-6. For the Berry plot (Figure F-6), only the data for which M,,
was available was used.
The data on each plot correlate reasonably well, with no observed trend for more recent or more
monodisperse data. The solid lines indicate the best-fit for each group. In all cases, the data is
nearly fiat as M -- 0, indicative of near-theta conditions (B = 0 in Eqs. F.7a and F.8). The data
at large M, from Kuge et al.152 show negative slope that is not consistent with the other data and
may be the effects of significant chain branching. The intercepts of the lines are Ko = 0.122 cm3 -
g-3 /2-moll/2 for the Stockmayer-Fixman plot, 0.786c 4o/5 = 0.196 -- K = 0.176 cm3 -g- 3/ 2-mol1 / 2
for the Inagaki-Ptitsyn plot, and Ko/2 = 0.323 -- Ko = 0.104 cm 3-g-3 / 2-mo11/ 2 for the Berry plot.
If the Inagaki-Ptitsyn intercept for low-molecular weight data is used, Ko4/5 = 0.176 and Ko = 0.113
cm 3 -g-3/ 2-moll/ 2 , which is more consistent with the Stockmayer-Fixman and Berry results. These
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Figure F-1: Intrinsic viscosity versus molecular weight for data of Table F.1. Line represents best
fit of [7] = 0.118M0 498 to data.
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Figure F-2: Summary of reported values of r. from light-scattering measurements for dextran/water
systems. Line is corelation given by Eq. F.27.
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Figure F-3: Summary of reported values of the second virial coefficient (A 2) for dextran/water
systems.
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Figure F-4: Stockmayer-Fixman plots for data of
0.122 - 4.17 x 10- 5VMN.
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Figure F-5: Inagaki-Ptitsyn plots for data of Table F.1.
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Figure F-6: Berry plots for data of Table F.1.
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Line is best-fit value of [r7]1/2/Ml/ 4 = 0.323-
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values are somewhat higher than those calculated from the Stockmayer-Fixman equation (Eq. F.7a)
by Wales et al.2 5' (0.092 cm3 -g-3 /2-mol'/ 2), Gekko"l (0.091 cmS3g-S/ 2-mol1/2), and Garg and
Stivala' 0 9 (0.087 cm 3-g-3/ 2-moll/ 2 ).
If the Stockmayer-Fixman plot (except for the data of Gekko, where M,/M, is not known) is
replotted according to Eq. F.lla, the correction for polydispersity, then the intercept q2cO = 0.110.
If an averaged M,I/M, value of 1.38 is assumed, then from Eq. F.llb, q2 = 0.966. The corrected
value for Ko is then 0.114.
Thus, IcO = 0.113 cm3-g-3/2-mol1/ 2 is a justified estimate based on the average of these methods,
and from this Ao = 0.769 A-g-1/2-mol1 / 2, which compares well to values of 0.717 obtained from the
Wales et al.25' result, 0.714 obtained from Gekko,ll s and 0.703 obtained from Garg and Stivala. ° 9
F.4.2 Expansion Factor from Intrinsic Viscosity
Figure F-7 shows the intrinsic viscosity data plotted as ac, = []/KoMll2 versus molecular weight,
with n = 0.113cm3-g-3/ 2 -mol1/ 2 . If only the data for M, < 106 are considered, then a nearly
constant value of a3 = 0.983 is indicated, consistent with theta conditions. This implies that as 1.
Also, since the maximum value of a3 is less than 1.2, the use of Eq. F.7a for the Stockmayer-Fixman
plot is justified.27
Yamakawa 2 5 9 notes that graphical extrapolation methods provide consistent values of unper-
turbed dimensions, but excluded volume parameters derived from them are often not accurate.
Therefore, the alternative methods described previously will be employed in the next two sections.
F.4.3 Expansion Factor from Radius of Gyration
A value for the expansion factor can be calculated by combining Eqs. F.16 and F.27:
as = 2.59M - °0.0 2 (F.28)
which over the range M = 1000 to 100,000 gives as = 1.69 to 1.27. These values are a slight
departure from the theta-condition behavior (as ~ 1) indicated by the flatness of the Stockmayer-
Fixman, Inagaki-Ptitsyn, and Berry plots, which imply that . This method is obviously dependent
on the quality of the radius of gyration correlation used.
F.4.4 Expansion Factor from Second Virial Coefficient
Calculation of a 2 from Eq. F.18 and the data of Kuge et al.'52 is shown in Figure F-8. These results
indicate that the excluded volume effects are negligible (as x 1) at least for M, up to 100,000, in
agreement with the intrinsic viscosity results.
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Figure F-7: Values of the cubed hydrodynamic radius expansion coefficient (a') from data of Ta-
ble F.1. Line is a constant value of a3 = 0.983.
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F.4.5 Skeletal Factor
Having calculated the unperturbed value Ao = 0.769 as described in Section F.4.1, the skeletal factor
is then given by
( A 0 \ 2( A= ) 2 (F.29a)
(F.29b)
Values for Aoo are available from the calculations of Cleland s (Section F.2.5). Using Aoo = 0.394,
a = 3.81, and using Aoo0 = 0.424, s = 3.29. This compares favorably with estimates of as 2.89 to
3.24 by Gekko.113
F.4.6 Equivalent Bond Dimensions N and L
Intrinsic viscosity and second-virial coefficient data indicate that as 1, while the radius of gy-
ration data indicated that as - 4. The value of as from the radius of gyration correlation seems
unrealistically high. Using a value for s = 3.6, an estimate of g/go = 1.2, and as x 1,
L = a2 9 I 4.321 = 4.32 5.2A = 22.5A (F.30a)
go
N = n/(sa -29 ) = n/4.32 (F.30b)
go
Mseg = 4.32Mmon , 700 daltons (F.30c)
Thus an effective segment length is calculated to be equal to 4-5 monomer lengths. Alternatively,
Garg and Stivala 10 9 report values for a* ranging from 20 to 28 A over Mn = 5700 to 112,500. L
is thus estimated to be around 45-50 A (8.71 to 9.61) by this method.10 9 These results are about a
factor of two larger than those from intrinsic viscosity plots.
F.4.7 Discussion
All previously published calculations using the random coil model with dextran have assumed a
segment size corresponding to a glucose monomer. The rationale for doing so is based on ex-
cess thermodynamic measurements that indicate that dextran begins to exhibit the properties of a
random-flight coil in solution at molecular weights of around 2000.114 The results presented here
indicate that N = 2.86 segments at 2000 daltons, which seems an unrealistically small number of
effective segments for random coil behavior. N is even smaller if the persistence length result is used.
Davidson 70 justified using N = n in order to maintain compatibility with the idea of a random coil
at low molecular weights.
Both short-range steric interaction represented by s and branching effects denoted by g/go appear
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to have an effect on the molecular dimensions of dextran. Dextran/water at 20-25 °C is not strictly
a theta system because the second virial coefficient is nonzero, but it appears that there is an effect
of chain branching which leads to a reduction of the molecular dimensions compared to an equivalent
linear molecule. The result is a branched molecule with the solution properties of a lighter linear
molecule in a theta solvent.
The effective contraction of the molecular dimensions resulting from chain branching, which is
more significant than would be predicted by theory, is fortuitously counterbalanced by excluded
volume effects resulting from the expansion of dextran in water. Thus, though it is not strictly a
theta system, dextran/water at 20-25 °C exhibits the behavior of a linear molecule with no excluded
volume. The effective segment size of dextran is estimated to be about 4.3 glucose monomers,
28% of that factor resulting from excluded volume, 72% from impedance to internal rotations, and
essentially negligible bond angle restriction.
The theta-state radius of gyration is seen to be considerably smaller than would have been
predicted based on what is surmised about its chemical structure. Specifically, it would be expected
that dextran's short branches would result in minimal deviation from straight chain behavior, but
instead its radius of gyration is about 70% of an equivalently-sized linear molecule at molecular
weights around 50,000. Whatever physical characteristic of dextran is responsible for this behavior
will probably also influence its hindered transport in pores. It is not clear to what extent this is of
a concern for sieving calculations, but it could be potentially significant for application of results
from the Monte Carlo simulations.
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